{
    "PMC5564609_3": {
        "matches": [
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Delayed gastric emptying"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[15, 32, 0.02]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Delayed gastric emptying",
                        "Group": "ERAS",
                        "Sample size": "76",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[15, 0.02]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Delayed gastric emptying"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[15, 32, 0.02]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Delayed gastric emptying",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[32, 0.02]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Bleeding"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[6, 4, 0.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Delayed gastric emptying",
                        "Group": "ERAS",
                        "Sample size": "76",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[15, 0.02]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Bleeding"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[6, 4, 0.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Bleeding",
                        "Group": "ERAS",
                        "Sample size": "76",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[6, 0.5]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Pancreatic fistula"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[39, 36, 0.52]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Delayed gastric emptying",
                        "Group": "ERAS",
                        "Sample size": "76",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[15, 0.02]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Pancreatic fistula"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[39, 36, 0.52]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Bleeding",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[4, 0.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Pancreatic fistula"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[39, 36, 0.52]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "ERAS",
                        "Sample size": "76",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[39, 0.52]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Grade A (Pancreatic fistula)"
                    },
                    "measures": "[Count (ERAS), Count (Conventional)]",
                    "outcomes": "[8, 6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Delayed gastric emptying",
                        "Group": "ERAS",
                        "Sample size": "76",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[15, 0.02]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Grade A (Pancreatic fistula)"
                    },
                    "measures": "[Count (ERAS), Count (Conventional)]",
                    "outcomes": "[8, 6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Bleeding",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[4, 0.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Grade A (Pancreatic fistula)"
                    },
                    "measures": "[Count (ERAS), Count (Conventional)]",
                    "outcomes": "[8, 6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "ERAS",
                        "Sample size": "76",
                        "Statistical test": "Fisher exact test",
                        "Grade": "A"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[8, 0.52]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Grade B (Pancreatic fistula)"
                    },
                    "measures": "[Count (ERAS), Count (Conventional)]",
                    "outcomes": "[10, 6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Delayed gastric emptying",
                        "Group": "ERAS",
                        "Sample size": "76",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[15, 0.02]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Grade B (Pancreatic fistula)"
                    },
                    "measures": "[Count (ERAS), Count (Conventional)]",
                    "outcomes": "[10, 6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Bleeding",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[4, 0.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Grade B (Pancreatic fistula)"
                    },
                    "measures": "[Count (ERAS), Count (Conventional)]",
                    "outcomes": "[10, 6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test",
                        "Grade": "A"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[6, 0.52]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Grade B (Pancreatic fistula)"
                    },
                    "measures": "[Count (ERAS), Count (Conventional)]",
                    "outcomes": "[10, 6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "ERAS",
                        "Sample size": "76",
                        "Statistical test": "Fisher exact test",
                        "Grade": "B"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[10, 0.52]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Grade C (Pancreatic fistula)"
                    },
                    "measures": "[Count (ERAS), Count (Conventional)]",
                    "outcomes": "[21, 24]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Delayed gastric emptying",
                        "Group": "ERAS",
                        "Sample size": "76",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[15, 0.02]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Grade C (Pancreatic fistula)"
                    },
                    "measures": "[Count (ERAS), Count (Conventional)]",
                    "outcomes": "[21, 24]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Bleeding",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[4, 0.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Grade C (Pancreatic fistula)"
                    },
                    "measures": "[Count (ERAS), Count (Conventional)]",
                    "outcomes": "[21, 24]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test",
                        "Grade": "A"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[6, 0.52]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Grade C (Pancreatic fistula)"
                    },
                    "measures": "[Count (ERAS), Count (Conventional)]",
                    "outcomes": "[21, 24]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test",
                        "Grade": "B"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[6, 0.52]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Grade C (Pancreatic fistula)"
                    },
                    "measures": "[Count (ERAS), Count (Conventional)]",
                    "outcomes": "[21, 24]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "ERAS",
                        "Sample size": "76",
                        "Statistical test": "Fisher exact test",
                        "Grade": "C"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[21, 0.52]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Biliary fistula"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[2, 0, 0.47]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Delayed gastric emptying",
                        "Group": "ERAS",
                        "Sample size": "76",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[15, 0.02]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Biliary fistula"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[2, 0, 0.47]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Bleeding",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[4, 0.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Biliary fistula"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[2, 0, 0.47]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test",
                        "Grade": "A"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[6, 0.52]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Biliary fistula"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[2, 0, 0.47]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test",
                        "Grade": "B"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[6, 0.52]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Biliary fistula"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[2, 0, 0.47]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test",
                        "Grade": "C"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[24, 0.52]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Biliary fistula"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[2, 0, 0.47]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[36, 0.52]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Biliary fistula"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[2, 0, 0.47]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Biliary fistula",
                        "Group": "ERAS",
                        "Sample size": "76",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[2, 0.47]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Wound infection"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[5, 3, 0.66]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Delayed gastric emptying",
                        "Group": "ERAS",
                        "Sample size": "76",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[15, 0.02]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Wound infection"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[5, 3, 0.66]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Bleeding",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[4, 0.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Wound infection"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[5, 3, 0.66]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test",
                        "Grade": "A"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[6, 0.52]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Wound infection"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[5, 3, 0.66]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test",
                        "Grade": "B"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[6, 0.52]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Wound infection"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[5, 3, 0.66]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test",
                        "Grade": "C"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[24, 0.52]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Wound infection"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[5, 3, 0.66]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[36, 0.52]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Wound infection"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[5, 3, 0.66]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Biliary fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[0, 0.47]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Wound infection"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[5, 3, 0.66]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Wound infection",
                        "Group": "ERAS",
                        "Sample size": "76",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[5, 0.66]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Pulmonary complication"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[2, 4, 0.1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Delayed gastric emptying",
                        "Group": "ERAS",
                        "Sample size": "76",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[15, 0.02]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Pulmonary complication"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[2, 4, 0.1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Bleeding",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[4, 0.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Pulmonary complication"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[2, 4, 0.1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test",
                        "Grade": "A"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[6, 0.52]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Pulmonary complication"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[2, 4, 0.1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test",
                        "Grade": "B"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[6, 0.52]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Pulmonary complication"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[2, 4, 0.1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test",
                        "Grade": "C"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[24, 0.52]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Pulmonary complication"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[2, 4, 0.1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[36, 0.52]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Pulmonary complication"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[2, 4, 0.1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Biliary fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[0, 0.47]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Pulmonary complication"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[2, 4, 0.1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Wound infection",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[3, 0.66]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Pulmonary complication"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[2, 4, 0.1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pulmonary complication",
                        "Group": "ERAS",
                        "Sample size": "76",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[2, 0.1]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Skin orifice infection"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[1, 6, 0.012]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Delayed gastric emptying",
                        "Group": "ERAS",
                        "Sample size": "76",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[15, 0.02]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Skin orifice infection"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[1, 6, 0.012]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Bleeding",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[4, 0.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Skin orifice infection"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[1, 6, 0.012]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test",
                        "Grade": "A"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[6, 0.52]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Skin orifice infection"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[1, 6, 0.012]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test",
                        "Grade": "B"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[6, 0.52]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Skin orifice infection"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[1, 6, 0.012]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test",
                        "Grade": "C"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[24, 0.52]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Skin orifice infection"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[1, 6, 0.012]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[36, 0.52]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Skin orifice infection"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[1, 6, 0.012]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Biliary fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[0, 0.47]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Skin orifice infection"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[1, 6, 0.012]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Wound infection",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[3, 0.66]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Skin orifice infection"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[1, 6, 0.012]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pulmonary complication",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[4, 0.1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Skin orifice infection"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[1, 6, 0.012]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Skin orifice infection",
                        "Group": "ERAS",
                        "Sample size": "76",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[1, 0.012]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Abdominal abscess"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[0, 0, /]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Delayed gastric emptying",
                        "Group": "ERAS",
                        "Sample size": "76",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[15, 0.02]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Abdominal abscess"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[0, 0, /]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Bleeding",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[4, 0.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Abdominal abscess"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[0, 0, /]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test",
                        "Grade": "A"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[6, 0.52]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Abdominal abscess"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[0, 0, /]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test",
                        "Grade": "B"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[6, 0.52]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Abdominal abscess"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[0, 0, /]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test",
                        "Grade": "C"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[24, 0.52]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Abdominal abscess"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[0, 0, /]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[36, 0.52]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Abdominal abscess"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[0, 0, /]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Biliary fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[0, 0.47]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Abdominal abscess"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[0, 0, /]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Wound infection",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[3, 0.66]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Abdominal abscess"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[0, 0, /]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pulmonary complication",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[4, 0.1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Abdominal abscess"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[0, 0, /]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Skin orifice infection",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[6, 0.012]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Abdominal abscess"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[0, 0, /]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatitis",
                        "Group": "ERAS",
                        "Sample size": "76",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[2, 1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Abdominal abscess"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[0, 0, /]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatitis",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[1, 1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Abdominal abscess"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[0, 0, /]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Sepsis",
                        "Group": "ERAS",
                        "Sample size": "76",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[1, 1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Abdominal abscess"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[0, 0, /]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Sepsis",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[0, 1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Abdominal abscess"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[0, 0, /]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Re-laparotomy",
                        "Group": "ERAS",
                        "Sample size": "76",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[3, 0.6]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Abdominal abscess"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[0, 0, /]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Re-laparotomy",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[1, 0.6]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Abdominal abscess"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[0, 0, /]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Readmission (in 30 days)",
                        "Group": "ERAS",
                        "Sample size": "76",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[1, 1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Abdominal abscess"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[0, 0, /]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Readmission (in 30 days)",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[1, 1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Abdominal abscess"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[0, 0, /]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Abdominal abscess",
                        "Group": "ERAS",
                        "Sample size": "76",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[0, /]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Pancreatitis"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[2, 1, 1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Delayed gastric emptying",
                        "Group": "ERAS",
                        "Sample size": "76",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[15, 0.02]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Pancreatitis"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[2, 1, 1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Bleeding",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[4, 0.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Pancreatitis"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[2, 1, 1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test",
                        "Grade": "A"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[6, 0.52]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Pancreatitis"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[2, 1, 1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test",
                        "Grade": "B"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[6, 0.52]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Pancreatitis"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[2, 1, 1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test",
                        "Grade": "C"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[24, 0.52]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Pancreatitis"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[2, 1, 1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[36, 0.52]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Pancreatitis"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[2, 1, 1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Biliary fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[0, 0.47]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Pancreatitis"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[2, 1, 1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Wound infection",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[3, 0.66]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Pancreatitis"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[2, 1, 1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pulmonary complication",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[4, 0.1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Pancreatitis"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[2, 1, 1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Skin orifice infection",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[6, 0.012]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Pancreatitis"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[2, 1, 1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatitis",
                        "Group": "ERAS",
                        "Sample size": "76",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[2, 1]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Sepsis"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[1, 0, 1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Delayed gastric emptying",
                        "Group": "ERAS",
                        "Sample size": "76",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[15, 0.02]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Sepsis"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[1, 0, 1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Bleeding",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[4, 0.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Sepsis"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[1, 0, 1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test",
                        "Grade": "A"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[6, 0.52]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Sepsis"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[1, 0, 1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test",
                        "Grade": "B"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[6, 0.52]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Sepsis"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[1, 0, 1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test",
                        "Grade": "C"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[24, 0.52]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Sepsis"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[1, 0, 1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[36, 0.52]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Sepsis"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[1, 0, 1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Biliary fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[0, 0.47]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Sepsis"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[1, 0, 1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Wound infection",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[3, 0.66]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Sepsis"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[1, 0, 1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pulmonary complication",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[4, 0.1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Sepsis"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[1, 0, 1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Skin orifice infection",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[6, 0.012]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Sepsis"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[1, 0, 1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatitis",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[1, 1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Sepsis"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[1, 0, 1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Sepsis",
                        "Group": "ERAS",
                        "Sample size": "76",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[1, 1]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Re-laparotomy"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[3, 1, 0.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Delayed gastric emptying",
                        "Group": "ERAS",
                        "Sample size": "76",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[15, 0.02]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Re-laparotomy"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[3, 1, 0.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Bleeding",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[4, 0.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Re-laparotomy"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[3, 1, 0.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test",
                        "Grade": "A"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[6, 0.52]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Re-laparotomy"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[3, 1, 0.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test",
                        "Grade": "B"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[6, 0.52]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Re-laparotomy"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[3, 1, 0.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test",
                        "Grade": "C"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[24, 0.52]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Re-laparotomy"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[3, 1, 0.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[36, 0.52]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Re-laparotomy"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[3, 1, 0.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Biliary fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[0, 0.47]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Re-laparotomy"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[3, 1, 0.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Wound infection",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[3, 0.66]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Re-laparotomy"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[3, 1, 0.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pulmonary complication",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[4, 0.1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Re-laparotomy"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[3, 1, 0.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Skin orifice infection",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[6, 0.012]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Re-laparotomy"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[3, 1, 0.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatitis",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[1, 1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Re-laparotomy"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[3, 1, 0.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Sepsis",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[0, 1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Re-laparotomy"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[3, 1, 0.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Re-laparotomy",
                        "Group": "ERAS",
                        "Sample size": "76",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[3, 0.6]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Mortality"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[0, 0, /]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Delayed gastric emptying",
                        "Group": "ERAS",
                        "Sample size": "76",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[15, 0.02]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Mortality"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[0, 0, /]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Bleeding",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[4, 0.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Mortality"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[0, 0, /]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test",
                        "Grade": "A"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[6, 0.52]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Mortality"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[0, 0, /]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test",
                        "Grade": "B"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[6, 0.52]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Mortality"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[0, 0, /]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test",
                        "Grade": "C"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[24, 0.52]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Mortality"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[0, 0, /]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[36, 0.52]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Mortality"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[0, 0, /]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Biliary fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[0, 0.47]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Mortality"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[0, 0, /]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Wound infection",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[3, 0.66]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Mortality"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[0, 0, /]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pulmonary complication",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[4, 0.1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Mortality"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[0, 0, /]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Skin orifice infection",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[6, 0.012]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Mortality"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[0, 0, /]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatitis",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[1, 1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Mortality"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[0, 0, /]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Sepsis",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[0, 1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Mortality"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[0, 0, /]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Re-laparotomy",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[1, 0.6]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Mortality"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[0, 0, /]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Readmission (in 30 days)",
                        "Group": "ERAS",
                        "Sample size": "76",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[1, 1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Mortality"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[0, 0, /]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Readmission (in 30 days)",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[1, 1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Mortality"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[0, 0, /]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Abdominal abscess",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[0, /]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Mortality"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[0, 0, /]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Mortality",
                        "Group": "ERAS",
                        "Sample size": "76",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[0, /]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Readmission (in 30 days)"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[1, 1, 1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Delayed gastric emptying",
                        "Group": "ERAS",
                        "Sample size": "76",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[15, 0.02]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Readmission (in 30 days)"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[1, 1, 1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Bleeding",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[4, 0.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Readmission (in 30 days)"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[1, 1, 1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test",
                        "Grade": "A"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[6, 0.52]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Readmission (in 30 days)"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[1, 1, 1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test",
                        "Grade": "B"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[6, 0.52]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Readmission (in 30 days)"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[1, 1, 1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test",
                        "Grade": "C"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[24, 0.52]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Readmission (in 30 days)"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[1, 1, 1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatic fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[36, 0.52]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Readmission (in 30 days)"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[1, 1, 1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Biliary fistula",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[0, 0.47]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Readmission (in 30 days)"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[1, 1, 1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Wound infection",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[3, 0.66]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Readmission (in 30 days)"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[1, 1, 1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pulmonary complication",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[4, 0.1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Readmission (in 30 days)"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[1, 1, 1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Skin orifice infection",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[6, 0.012]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Readmission (in 30 days)"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[1, 1, 1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Pancreatitis",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[1, 1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Readmission (in 30 days)"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[1, 1, 1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Sepsis",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[0, 1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Readmission (in 30 days)"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[1, 1, 1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Re-laparotomy",
                        "Group": "Conventional",
                        "Sample size": "83",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[1, 0.6]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "Conventional",
                        "n (ERAS)": "76",
                        "n (Conventional)": "83",
                        "Parameter": "Readmission (in 30 days)"
                    },
                    "measures": "[Count (ERAS), Count (Conventional), p-value]",
                    "outcomes": "[1, 1, 1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Post-operative complication": "Readmission (in 30 days)",
                        "Group": "ERAS",
                        "Sample size": "76",
                        "Statistical test": "Fisher exact test"
                    },
                    "measures": "[Incidence, p-value]",
                    "outcomes": "[1, 1]"
                },
                "match": "yes"
            }
        ],
        "total_extracted_claims": 16,
        "total_ground_truth_claims": 32,
        "number_of_matches": 16
    },
    "PMC3798558_1": {
        "matches": [
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "selected characteristics of pancreatic cancer (PC) patients and non-cancer controls",
                        "Group": "Controls",
                        "n (Cases)": "185",
                        "n (Controls)": "1465",
                        "Characteristic": "Age",
                        "P-value": "0.999"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Characteristic": "Age",
                        "Group": "Cases",
                        "Sample Size": "185",
                        "Age Range": "<40",
                        "Count": "10",
                        "Percentage": "5.41",
                        "P-value": "0.999"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "selected characteristics of pancreatic cancer (PC) patients and non-cancer controls",
                        "Group": "Controls",
                        "n (Cases)": "185",
                        "n (Controls)": "1465",
                        "Characteristic": "Age <40",
                        "Cases (%)": "10 (5.41)",
                        "Controls (%)": "75 (5.12)"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Characteristic": "Age",
                        "Group": "Controls",
                        "Sample Size": "1465",
                        "Age Range": "<40",
                        "Count": "75",
                        "Percentage": "5.12",
                        "P-value": "0.999"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "selected characteristics of pancreatic cancer (PC) patients and non-cancer controls",
                        "Group": "Controls",
                        "n (Cases)": "185",
                        "n (Controls)": "1465",
                        "Characteristic": "Age \u226540 but <50",
                        "Cases (%)": "19 (10.27)",
                        "Controls (%)": "147 (10.03)"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Characteristic": "Age",
                        "Group": "Cases",
                        "Sample Size": "185",
                        "Age Range": "\u226540 but <50",
                        "Count": "19",
                        "Percentage": "10.27",
                        "P-value": "0.999"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "selected characteristics of pancreatic cancer (PC) patients and non-cancer controls",
                        "Group": "Controls",
                        "n (Cases)": "185",
                        "n (Controls)": "1465",
                        "Characteristic": "Age \u226550 but <60",
                        "Cases (%)": "60 (32.43)",
                        "Controls (%)": "479 (32.70)"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Characteristic": "Age",
                        "Group": "Controls",
                        "Sample Size": "1465",
                        "Age Range": "\u226540 but <50",
                        "Count": "147",
                        "Percentage": "10.03",
                        "P-value": "0.999"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "selected characteristics of pancreatic cancer (PC) patients and non-cancer controls",
                        "Group": "Controls",
                        "n (Cases)": "185",
                        "n (Controls)": "1465",
                        "Characteristic": "Age \u226560 but <70",
                        "Cases (%)": "60 (32.43)",
                        "Controls (%)": "484 (33.04)"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Characteristic": "Age",
                        "Group": "Cases",
                        "Sample Size": "185",
                        "Age Range": "\u226550 but <60",
                        "Count": "60",
                        "Percentage": "32.43",
                        "P-value": "0.999"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "selected characteristics of pancreatic cancer (PC) patients and non-cancer controls",
                        "Group": "Controls",
                        "n (Cases)": "185",
                        "n (Controls)": "1465",
                        "Characteristic": "Age \u226570",
                        "Cases (%)": "36 (19.46)",
                        "Controls (%)": "280 (19.11)"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Characteristic": "Age",
                        "Group": "Controls",
                        "Sample Size": "1465",
                        "Age Range": "\u226550 but <60",
                        "Count": "479",
                        "Percentage": "32.70",
                        "P-value": "0.999"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "selected characteristics of pancreatic cancer (PC) patients and non-cancer controls",
                        "Group": "Controls",
                        "n (Cases)": "185",
                        "n (Controls)": "1465",
                        "Characteristic": "Sex",
                        "P-value": "0.068"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Characteristic": "Age",
                        "Group": "Cases",
                        "Sample Size": "185",
                        "Age Range": "\u226560 but <70",
                        "Count": "60",
                        "Percentage": "32.43",
                        "P-value": "0.999"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "selected characteristics of pancreatic cancer (PC) patients and non-cancer controls",
                        "Group": "Controls",
                        "n (Cases)": "185",
                        "n (Controls)": "1465",
                        "Characteristic": "Male",
                        "Cases (%)": "127 (68.65)",
                        "Controls (%)": "1097 (74.88)"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Characteristic": "Age",
                        "Group": "Controls",
                        "Sample Size": "1465",
                        "Age Range": "\u226560 but <70",
                        "Count": "484",
                        "Percentage": "33.04",
                        "P-value": "0.999"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "selected characteristics of pancreatic cancer (PC) patients and non-cancer controls",
                        "Group": "Controls",
                        "n (Cases)": "185",
                        "n (Controls)": "1465",
                        "Characteristic": "Female",
                        "Cases (%)": "58 (31.35)",
                        "Controls (%)": "368 (25.12)"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Characteristic": "Age",
                        "Group": "Cases",
                        "Sample Size": "185",
                        "Age Range": "\u226570",
                        "Count": "36",
                        "Percentage": "19.46",
                        "P-value": "0.999"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "selected characteristics of pancreatic cancer (PC) patients and non-cancer controls",
                        "Group": "Controls",
                        "n (Cases)": "185",
                        "n (Controls)": "1465",
                        "Characteristic": "Current BMI (kg/m2)",
                        "P-value": "0.021"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Characteristic": "Age",
                        "Group": "Controls",
                        "Sample Size": "1465",
                        "Age Range": "\u226570",
                        "Count": "280",
                        "Percentage": "19.11",
                        "P-value": "0.999"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "selected characteristics of pancreatic cancer (PC) patients and non-cancer controls",
                        "Group": "Controls",
                        "n (Cases)": "185",
                        "n (Controls)": "1465",
                        "Characteristic": "Current BMI <18.5",
                        "Cases (%)": "15 (8.11)",
                        "Controls (%)": "61 (4.16)"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Characteristic": "Sex",
                        "Group": "Cases",
                        "Sample Size": "185",
                        "Sex": "Male",
                        "Count": "127",
                        "Percentage": "68.65",
                        "P-value": "0.068"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "selected characteristics of pancreatic cancer (PC) patients and non-cancer controls",
                        "Group": "Controls",
                        "n (Cases)": "185",
                        "n (Controls)": "1465",
                        "Characteristic": "Current BMI \u226518.5 but <22.5",
                        "Cases (%)": "84 (45.11)",
                        "Controls (%)": "555 (37.88)"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Characteristic": "Sex",
                        "Group": "Controls",
                        "Sample Size": "1465",
                        "Sex": "Male",
                        "Count": "1097",
                        "Percentage": "74.88",
                        "P-value": "0.068"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "selected characteristics of pancreatic cancer (PC) patients and non-cancer controls",
                        "Group": "Controls",
                        "n (Cases)": "185",
                        "n (Controls)": "1465",
                        "Characteristic": "Current BMI \u226522.5 but <25",
                        "Cases (%)": "47 (25.41)",
                        "Controls (%)": "478 (32.63)"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Characteristic": "Sex",
                        "Group": "Cases",
                        "Sample Size": "185",
                        "Sex": "Female",
                        "Count": "58",
                        "Percentage": "31.35",
                        "P-value": "0.068"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "selected characteristics of pancreatic cancer (PC) patients and non-cancer controls",
                        "Group": "Controls",
                        "n (Cases)": "185",
                        "n (Controls)": "1465",
                        "Characteristic": "Current BMI \u226525 but <27.5",
                        "Cases (%)": "25 (13.51)",
                        "Controls (%)": "245 (16.72)"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Characteristic": "Sex",
                        "Group": "Controls",
                        "Sample Size": "1465",
                        "Sex": "Female",
                        "Count": "368",
                        "Percentage": "25.12",
                        "P-value": "0.068"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "selected characteristics of pancreatic cancer (PC) patients and non-cancer controls",
                        "Group": "Controls",
                        "n (Cases)": "185",
                        "n (Controls)": "1465",
                        "Characteristic": "Current BMI \u226527.5",
                        "Cases (%)": "14 (7.57)",
                        "Controls (%)": "111 (7.58)"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Characteristic": "Current BMI",
                        "Group": "Cases",
                        "Sample Size": "185",
                        "BMI Range": "<18.5",
                        "Count": "15",
                        "Percentage": "8.11",
                        "P-value": "0.021"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "selected characteristics of pancreatic cancer (PC) patients and non-cancer controls",
                        "Group": "Controls",
                        "n (Cases)": "185",
                        "n (Controls)": "1465",
                        "Characteristic": "Current BMI Unknown",
                        "Cases (%)": "0 (0.00)",
                        "Controls (%)": "15 (1.02)"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Characteristic": "Current BMI",
                        "Group": "Controls",
                        "Sample Size": "1465",
                        "BMI Range": "<18.5",
                        "Count": "61",
                        "Percentage": "4.16",
                        "P-value": "0.021"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "selected characteristics of pancreatic cancer (PC) patients and non-cancer controls",
                        "Group": "Controls",
                        "n (Cases)": "185",
                        "n (Controls)": "1465",
                        "Characteristic": "BMI at age 20 (kg/m2)",
                        "P-value": "0.018"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Characteristic": "Current BMI",
                        "Group": "Cases",
                        "Sample Size": "185",
                        "BMI Range": "\u226518.5 but <22.5",
                        "Count": "84",
                        "Percentage": "45.11",
                        "P-value": "0.021"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "selected characteristics of pancreatic cancer (PC) patients and non-cancer controls",
                        "Group": "Controls",
                        "n (Cases)": "185",
                        "n (Controls)": "1465",
                        "Characteristic": "BMI at age 20 <18.5",
                        "Cases (%)": "14 (7.57)",
                        "Controls (%)": "168 (11.47)"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Characteristic": "Current BMI",
                        "Group": "Controls",
                        "Sample Size": "1465",
                        "BMI Range": "\u226518.5 but <22.5",
                        "Count": "555",
                        "Percentage": "37.88",
                        "P-value": "0.021"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "selected characteristics of pancreatic cancer (PC) patients and non-cancer controls",
                        "Group": "Controls",
                        "n (Cases)": "185",
                        "n (Controls)": "1465",
                        "Characteristic": "BMI at age 20 \u226518.5 but <22.5",
                        "Cases (%)": "112 (60.54)",
                        "Controls (%)": "950 (64.85)"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Characteristic": "Current BMI",
                        "Group": "Cases",
                        "Sample Size": "185",
                        "BMI Range": "\u226522.5 but <25",
                        "Count": "47",
                        "Percentage": "25.41",
                        "P-value": "0.021"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "selected characteristics of pancreatic cancer (PC) patients and non-cancer controls",
                        "Group": "Controls",
                        "n (Cases)": "185",
                        "n (Controls)": "1465",
                        "Characteristic": "BMI at age 20 \u226522.5 but <25",
                        "Cases (%)": "36 (19.46)",
                        "Controls (%)": "226 (15.43)"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Characteristic": "Current BMI",
                        "Group": "Controls",
                        "Sample Size": "1465",
                        "BMI Range": "\u226522.5 but <25",
                        "Count": "478",
                        "Percentage": "32.63",
                        "P-value": "0.021"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "selected characteristics of pancreatic cancer (PC) patients and non-cancer controls",
                        "Group": "Controls",
                        "n (Cases)": "185",
                        "n (Controls)": "1465",
                        "Characteristic": "BMI at age 20 \u226525 but <27.5",
                        "Cases (%)": "11 (5.95)",
                        "Controls (%)": "72 (4.91)"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Characteristic": "Current BMI",
                        "Group": "Cases",
                        "Sample Size": "185",
                        "BMI Range": "\u226525 but <27.5",
                        "Count": "25",
                        "Percentage": "13.51",
                        "P-value": "0.021"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "selected characteristics of pancreatic cancer (PC) patients and non-cancer controls",
                        "Group": "Controls",
                        "n (Cases)": "185",
                        "n (Controls)": "1465",
                        "Characteristic": "BMI at age 20 \u226527.5",
                        "Cases (%)": "6 (3.24)",
                        "Controls (%)": "14 (0.96)"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Characteristic": "Current BMI",
                        "Group": "Controls",
                        "Sample Size": "1465",
                        "BMI Range": "\u226525 but <27.5",
                        "Count": "245",
                        "Percentage": "16.72",
                        "P-value": "0.021"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "selected characteristics of pancreatic cancer (PC) patients and non-cancer controls",
                        "Group": "Controls",
                        "n (Cases)": "185",
                        "n (Controls)": "1465",
                        "Characteristic": "BMI at age 20 Unknown",
                        "Cases (%)": "6 (3.24)",
                        "Controls (%)": "35 (2.39)"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Characteristic": "Current BMI",
                        "Group": "Cases",
                        "Sample Size": "185",
                        "BMI Range": "\u226527.5",
                        "Count": "14",
                        "Percentage": "7.57",
                        "P-value": "0.021"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "selected characteristics of pancreatic cancer (PC) patients and non-cancer controls",
                        "Group": "Controls",
                        "n (Cases)": "185",
                        "n (Controls)": "1465",
                        "Characteristic": "Cigarette pack-years",
                        "P-value": "0.005"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Characteristic": "Current BMI",
                        "Group": "Controls",
                        "Sample Size": "1465",
                        "BMI Range": "\u226527.5",
                        "Count": "111",
                        "Percentage": "7.58",
                        "P-value": "0.021"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "selected characteristics of pancreatic cancer (PC) patients and non-cancer controls",
                        "Group": "Controls",
                        "n (Cases)": "185",
                        "n (Controls)": "1465",
                        "Characteristic": "Cigarette pack-years <5",
                        "Cases (%)": "69 (37.30)",
                        "Controls (%)": "638 (43.55)"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Characteristic": "Current BMI",
                        "Group": "Cases",
                        "Sample Size": "185",
                        "BMI Range": "Unknown",
                        "Count": "0",
                        "Percentage": "0.00",
                        "P-value": "0.021"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "selected characteristics of pancreatic cancer (PC) patients and non-cancer controls",
                        "Group": "Controls",
                        "n (Cases)": "185",
                        "n (Controls)": "1465",
                        "Characteristic": "Cigarette pack-years \u22655 but <20",
                        "Cases (%)": "22 (11.89)",
                        "Controls (%)": "206 (14.06)"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Characteristic": "Current BMI",
                        "Group": "Controls",
                        "Sample Size": "1465",
                        "BMI Range": "Unknown",
                        "Count": "15",
                        "Percentage": "1.02",
                        "P-value": "0.021"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "selected characteristics of pancreatic cancer (PC) patients and non-cancer controls",
                        "Group": "Controls",
                        "n (Cases)": "185",
                        "n (Controls)": "1465",
                        "Characteristic": "Cigarette pack-years \u226520 but <40",
                        "Cases (%)": "34 (18.38)",
                        "Controls (%)": "308 (21.02)"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Characteristic": "BMI at age 20",
                        "Group": "Cases",
                        "Sample Size": "185",
                        "BMI Range": "<18.5",
                        "Count": "14",
                        "Percentage": "7.57",
                        "P-value": "0.018"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "selected characteristics of pancreatic cancer (PC) patients and non-cancer controls",
                        "Group": "Controls",
                        "n (Cases)": "185",
                        "n (Controls)": "1465",
                        "Characteristic": "Cigarette pack-years \u226540",
                        "Cases (%)": "60 (32.43)",
                        "Controls (%)": "304 (20.75)"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Characteristic": "BMI at age 20",
                        "Group": "Controls",
                        "Sample Size": "1465",
                        "BMI Range": "<18.5",
                        "Count": "168",
                        "Percentage": "11.47",
                        "P-value": "0.018"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "selected characteristics of pancreatic cancer (PC) patients and non-cancer controls",
                        "Group": "Controls",
                        "n (Cases)": "185",
                        "n (Controls)": "1465",
                        "Characteristic": "Cigarette pack-years Unknown",
                        "Cases (%)": "0 (0.00)",
                        "Controls (%)": "9 (0.61)"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Characteristic": "BMI at age 20",
                        "Group": "Cases",
                        "Sample Size": "185",
                        "BMI Range": "\u226518.5 but <22.5",
                        "Count": "112",
                        "Percentage": "60.54",
                        "P-value": "0.018"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "selected characteristics of pancreatic cancer (PC) patients and non-cancer controls",
                        "Group": "Controls",
                        "n (Cases)": "185",
                        "n (Controls)": "1465",
                        "Characteristic": "Drinking, g ethanol/day",
                        "P-value": "0.568"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Characteristic": "BMI at age 20",
                        "Group": "Controls",
                        "Sample Size": "1465",
                        "BMI Range": "\u226518.5 but <22.5",
                        "Count": "950",
                        "Percentage": "64.85",
                        "P-value": "0.018"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "selected characteristics of pancreatic cancer (PC) patients and non-cancer controls",
                        "Group": "Controls",
                        "n (Cases)": "185",
                        "n (Controls)": "1465",
                        "Characteristic": "Drinking Non",
                        "Cases (%)": "56 (30.27)",
                        "Controls (%)": "488 (33.31)"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Characteristic": "BMI at age 20",
                        "Group": "Cases",
                        "Sample Size": "185",
                        "BMI Range": "\u226522.5 but <25",
                        "Count": "36",
                        "Percentage": "19.46",
                        "P-value": "0.018"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "selected characteristics of pancreatic cancer (PC) patients and non-cancer controls",
                        "Group": "Controls",
                        "n (Cases)": "185",
                        "n (Controls)": "1465",
                        "Characteristic": "Drinking <23",
                        "Cases (%)": "53 (28.65)",
                        "Controls (%)": "425 (29.01)"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Characteristic": "BMI at age 20",
                        "Group": "Controls",
                        "Sample Size": "1465",
                        "BMI Range": "\u226522.5 but <25",
                        "Count": "226",
                        "Percentage": "15.43",
                        "P-value": "0.018"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "selected characteristics of pancreatic cancer (PC) patients and non-cancer controls",
                        "Group": "Controls",
                        "n (Cases)": "185",
                        "n (Controls)": "1465",
                        "Characteristic": "Drinking \u226523 but <46",
                        "Cases (%)": "43 (23.24)",
                        "Controls (%)": "342 (23.34)"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Characteristic": "BMI at age 20",
                        "Group": "Cases",
                        "Sample Size": "185",
                        "BMI Range": "\u226525 but <27.5",
                        "Count": "11",
                        "Percentage": "5.95",
                        "P-value": "0.018"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "selected characteristics of pancreatic cancer (PC) patients and non-cancer controls",
                        "Group": "Controls",
                        "n (Cases)": "185",
                        "n (Controls)": "1465",
                        "Characteristic": "Drinking \u226546",
                        "Cases (%)": "31 (16.76)",
                        "Controls (%)": "193 (13.17)"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Characteristic": "BMI at age 20",
                        "Group": "Controls",
                        "Sample Size": "1465",
                        "BMI Range": "\u226525 but <27.5",
                        "Count": "72",
                        "Percentage": "4.91",
                        "P-value": "0.018"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "selected characteristics of pancreatic cancer (PC) patients and non-cancer controls",
                        "Group": "Controls",
                        "n (Cases)": "185",
                        "n (Controls)": "1465",
                        "Characteristic": "Drinking Unknown",
                        "Cases (%)": "2 (1.08)",
                        "Controls (%)": "17 (1.16)"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Characteristic": "BMI at age 20",
                        "Group": "Cases",
                        "Sample Size": "185",
                        "BMI Range": "\u226527.5",
                        "Count": "6",
                        "Percentage": "3.24",
                        "P-value": "0.018"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "selected characteristics of pancreatic cancer (PC) patients and non-cancer controls",
                        "Group": "Controls",
                        "n (Cases)": "185",
                        "n (Controls)": "1465",
                        "Characteristic": "History of diabetes mellitus",
                        "P-value": "<0.001"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Characteristic": "BMI at age 20",
                        "Group": "Controls",
                        "Sample Size": "1465",
                        "BMI Range": "\u226527.5",
                        "Count": "14",
                        "Percentage": "0.96",
                        "P-value": "0.018"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "selected characteristics of pancreatic cancer (PC) patients and non-cancer controls",
                        "Group": "Controls",
                        "n (Cases)": "185",
                        "n (Controls)": "1465",
                        "Characteristic": "History of diabetes mellitus Yes",
                        "Cases (%)": "37 (20.00)",
                        "Controls (%)": "126 (8.60)"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Characteristic": "BMI at age 20",
                        "Group": "Cases",
                        "Sample Size": "185",
                        "BMI Range": "Unknown",
                        "Count": "6",
                        "Percentage": "3.24",
                        "P-value": "0.018"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "selected characteristics of pancreatic cancer (PC) patients and non-cancer controls",
                        "Group": "Controls",
                        "n (Cases)": "185",
                        "n (Controls)": "1465",
                        "Characteristic": "History of diabetes mellitus No",
                        "Cases (%)": "148 (80.00)",
                        "Controls (%)": "1339 (91.40)"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Characteristic": "BMI at age 20",
                        "Group": "Controls",
                        "Sample Size": "1465",
                        "BMI Range": "Unknown",
                        "Count": "35",
                        "Percentage": "2.39",
                        "P-value": "0.018"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "selected characteristics of pancreatic cancer (PC) patients and non-cancer controls",
                        "Group": "Controls",
                        "n (Cases)": "185",
                        "n (Controls)": "1465",
                        "Characteristic": "Family history of PC",
                        "P-value": "0.811"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Characteristic": "Cigarette pack-years",
                        "Group": "Cases",
                        "Sample Size": "185",
                        "Pack-years Range": "<5",
                        "Count": "69",
                        "Percentage": "37.30",
                        "P-value": "0.005"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "selected characteristics of pancreatic cancer (PC) patients and non-cancer controls",
                        "Group": "Controls",
                        "n (Cases)": "185",
                        "n (Controls)": "1465",
                        "Characteristic": "Family history of PC Yes",
                        "Cases (%)": "8 (4.32)",
                        "Controls (%)": "58 (3.96)"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Characteristic": "Cigarette pack-years",
                        "Group": "Controls",
                        "Sample Size": "1465",
                        "Pack-years Range": "<5",
                        "Count": "638",
                        "Percentage": "43.55",
                        "P-value": "0.005"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "selected characteristics of pancreatic cancer (PC) patients and non-cancer controls",
                        "Group": "Controls",
                        "n (Cases)": "185",
                        "n (Controls)": "1465",
                        "Characteristic": "Family history of PC No",
                        "Cases (%)": "177 (95.68)",
                        "Controls (%)": "1407 (96.04)"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Characteristic": "Cigarette pack-years",
                        "Group": "Cases",
                        "Sample Size": "185",
                        "Pack-years Range": "\u22655 but <20",
                        "Count": "22",
                        "Percentage": "11.89",
                        "P-value": "0.005"
                    }
                },
                "match": "yes"
            }
        ],
        "total_extracted_claims": 41,
        "total_ground_truth_claims": 47,
        "number_of_matches": 41
    },
    "PMC5762325_3": {
        "matches": [
            {
                "Extracted_claim": {
                    "subject": {
                        "Caption": "Correlation analysis between E-cadherin and STYK1 expression in pancreatic cancer",
                        "Tumor tissue sample": "E-cadherin Low",
                        "STYK1 expression": "High",
                        "Correlation coefficient": "-0.420",
                        "P-value": "<0.001"
                    },
                    "measures": "[STYK1 Low count, STYK1 High count, Correlation coefficient, P-value]",
                    "outcomes": "[9, 23, -0.420, <0.001]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Tumor tissue sample": "E-cadherin Low",
                        "STYK1 Low": "9",
                        "STYK1 High": "23",
                        "Cancer type": "pancreatic cancer",
                        "Analysis type": "Correlation analysis"
                    },
                    "measures": "[Correlation coefficient, p-value]",
                    "outcomes": "[-0.420, <0.001]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Caption": "Correlation analysis between E-cadherin and STYK1 expression in pancreatic cancer",
                        "Tumor tissue sample": "E-cadherin High",
                        "STYK1 expression": "High"
                    },
                    "measures": "[STYK1 Low count, STYK1 High count]",
                    "outcomes": "[34, 14]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Tumor tissue sample": "E-cadherin High",
                        "STYK1 Low": "34",
                        "STYK1 High": "14",
                        "Cancer type": "pancreatic cancer",
                        "Analysis type": "Correlation analysis"
                    },
                    "measures": "[]",
                    "outcomes": "[]"
                },
                "match": "yes"
            }
        ],
        "total_extracted_claims": 2,
        "total_ground_truth_claims": 2,
        "number_of_matches": 2
    },
    "PMC4423458_3": {
        "matches": [
            {
                "Extracted_claim": {
                    "subject": {
                        "Context": "Proteins more abundant in cancer than in controls",
                        "Comparison": "Cancer vs Control",
                        "Protein": "Fibrinogen beta chain isoform 1 pre-pro-protein",
                        "Accession": "70906435",
                        "MW (kDa)": "56"
                    },
                    "measures": "[Average SC (Cancer), Average SC (Control), NSAF ratio, p-value]",
                    "outcomes": "[138.8, 52.1, 2.2, 0.01481]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                        "protein": "Fibrinogen beta chain isoform 1 pre-pro-protein",
                        "accession": "70906435",
                        "Molecural weight (MW) (kDa)": "56",
                        "statistical test": "t-test"
                    },
                    "measures": "[Average Spectral Count (SC)(Cancer), Average Spectral Count (SC)(Control), Normalized Spectral Abundance Factor (NSAF) ratio, P-value]",
                    "outcomes": "[138.8, 52.1, 2.2, 0.01481]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Context": "Proteins more abundant in cancer than in controls",
                        "Comparison": "Cancer vs Control",
                        "Protein": "C4b-binding protein alpha chain precursor",
                        "Accession": "4502503",
                        "MW (kDa)": "67"
                    },
                    "measures": "[Average SC (Cancer), Average SC (Control), NSAF ratio, p-value]",
                    "outcomes": "[37.3, 11.5, 2.3, 0.04311]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                        "protein": "C4b-binding protein alpha chain precursor",
                        "accession": "4502503",
                        "Molecural weight (MW) (kDa)": "67",
                        "statistical test": "t-test"
                    },
                    "measures": "[Average Spectral Count (SC)(Cancer), Average Spectral Count (SC)(Control), Normalized Spectral Abundance Factor (NSAF) ratio, P-value]",
                    "outcomes": "[37.3, 11.5, 2.3, 0.04311]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Context": "Proteins more abundant in cancer than in controls",
                        "Comparison": "Cancer vs Control",
                        "Protein": "Serum albumin pre-pro-protein",
                        "Accession": "4502027",
                        "MW (kDa)": "69"
                    },
                    "measures": "[Average SC (Cancer), Average SC (Control), NSAF ratio, p-value]",
                    "outcomes": "[986.0, 332.8, 2.4, 0.00006]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                        "protein": "Serum albumin pre-pro-protein",
                        "accession": "4502027",
                        "Molecural weight (MW) (kDa)": "69",
                        "statistical test": "t-test"
                    },
                    "measures": "[Average Spectral Count (SC)(Cancer), Average Spectral Count (SC)(Control), Normalized Spectral Abundance Factor (NSAF) ratio, P-value]",
                    "outcomes": "[986.0, 332.8, 2.4, 0.00006]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Context": "Proteins more abundant in cancer than in controls",
                        "Comparison": "Cancer vs Control",
                        "Protein": "Vitamin D-binding protein isoform 1 precursor",
                        "Accession": "32483410",
                        "MW (kDa)": "53"
                    },
                    "measures": "[Average SC (Cancer), Average SC (Control), NSAF ratio, p-value]",
                    "outcomes": "[51.9, 19.2, 2.4, 0.03919]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                        "protein": "Vitamin D-binding protein isoform 1 precursor",
                        "accession": "32483410",
                        "Molecural weight (MW) (kDa)": "53",
                        "statistical test": "t-test"
                    },
                    "measures": "[Average Spectral Count (SC)(Cancer), Average Spectral Count (SC)(Control), Normalized Spectral Abundance Factor (NSAF) ratio, P-value]",
                    "outcomes": "[51.9, 19.2, 2.4, 0.03919]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Context": "Proteins more abundant in cancer than in controls",
                        "Comparison": "Cancer vs Control",
                        "Protein": "Kininogen-1 isoform 2 precursor",
                        "Accession": "4504893",
                        "MW (kDa)": "48"
                    },
                    "measures": "[Average SC (Cancer), Average SC (Control), NSAF ratio, p-value]",
                    "outcomes": "[21.3, 5.5, 3.8, 0.01109]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                        "protein": "Kininogen-1 isoform 2 precursor",
                        "accession": "4504893",
                        "Molecural weight (MW) (kDa)": "48",
                        "statistical test": "t-test"
                    },
                    "measures": "[Average Spectral Count (SC)(Cancer), Average Spectral Count (SC)(Control), Normalized Spectral Abundance Factor (NSAF) ratio, P-value]",
                    "outcomes": "[21.3, 5.5, 3.8, 0.01109]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Context": "Proteins more abundant in cancer than in controls",
                        "Comparison": "Cancer vs Control",
                        "Protein": "Alpha-2-macroglobulin precursor",
                        "Accession": "66932947",
                        "MW (kDa)": "163"
                    },
                    "measures": "[Average SC (Cancer), Average SC (Control), NSAF ratio, p-value]",
                    "outcomes": "[127.9, 29.3, 3.9, 0.00618]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                        "protein": "Alpha-2-macroglobulin precursor",
                        "accession": "66932947",
                        "Molecural weight (MW) (kDa)": "163",
                        "statistical test": "t-test"
                    },
                    "measures": "[Average Spectral Count (SC)(Cancer), Average Spectral Count (SC)(Control), Normalized Spectral Abundance Factor (NSAF) ratio, P-value]",
                    "outcomes": "[127.9, 29.3, 3.9, 0.00618]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Context": "Proteins more abundant in cancer than in controls",
                        "Comparison": "Cancer vs Control",
                        "Protein": "Haptoglobin isoform 1 pre-pro-pro-protein",
                        "Accession": "4826762",
                        "MW (kDa)": "45"
                    },
                    "measures": "[Average SC (Cancer), Average SC (Control), NSAF ratio, p-value]",
                    "outcomes": "[83.8, 18.0, 4.2, 0.00024]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                        "protein": "Haptoglobin isoform 1 pre-pro-protein",
                        "accession": "4826762",
                        "Molecural weight (MW) (kDa)": "45",
                        "statistical test": "t-test"
                    },
                    "measures": "[Average Spectral Count (SC)(Cancer), Average Spectral Count (SC)(Control), Normalized Spectral Abundance Factor (NSAF) ratio, P-value]",
                    "outcomes": "[83.8, 18.0, 4.2, 0.00024]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Context": "Proteins more abundant in cancer than in controls",
                        "Comparison": "Cancer vs Control",
                        "Protein": "Fibrinogen gamma chain isoform gamma-B precursor",
                        "Accession": "70906439",
                        "MW (kDa)": "52"
                    },
                    "measures": "[Average SC (Cancer), Average SC (Control), NSAF ratio, p-value]",
                    "outcomes": "[89.3, 17.3, 4.3, 0.00133]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                        "protein": "Fibrinogen gamma chain isoform gamma-B precursor",
                        "accession": "70906439",
                        "Molecural weight (MW) (kDa)": "52",
                        "statistical test": "t-test"
                    },
                    "measures": "[Average Spectral Count (SC)(Cancer), Average Spectral Count (SC)(Control), Normalized Spectral Abundance Factor (NSAF) ratio, P-value]",
                    "outcomes": "[89.3, 17.3, 4.3, 0.00133]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Context": "Proteins more abundant in cancer than in controls",
                        "Comparison": "Cancer vs Control",
                        "Protein": "Complement C3 precursor",
                        "Accession": "115298678",
                        "MW (kDa)": "187"
                    },
                    "measures": "[Average SC (Cancer), Average SC (Control), NSAF ratio, p-value]",
                    "outcomes": "[174.7, 35.6, 4.3, 0.00612]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                        "protein": "Complement C3 precursor",
                        "accession": "115298678",
                        "Molecural weight (MW) (kDa)": "187",
                        "statistical test": "t-test"
                    },
                    "measures": "[Average Spectral Count (SC)(Cancer), Average Spectral Count (SC)(Control), Normalized Spectral Abundance Factor (NSAF) ratio, P-value]",
                    "outcomes": "[174.7, 35.6, 4.3, 0.00612]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Context": "Proteins more abundant in cancer than in controls",
                        "Comparison": "Cancer vs Control",
                        "Protein": "Myeloperoxidase precursor",
                        "Accession": "4557759",
                        "MW (kDa)": "84"
                    },
                    "measures": "[Average SC (Cancer), Average SC (Control), NSAF ratio, p-value]",
                    "outcomes": "[70.2, 11.0, 5.3, 0.02501]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                        "protein": "Myeloperoxidase precursor",
                        "accession": "4557759",
                        "Molecural weight (MW) (kDa)": "84",
                        "statistical test": "t-test"
                    },
                    "measures": "[Average Spectral Count (SC)(Cancer), Average Spectral Count (SC)(Control), Normalized Spectral Abundance Factor (NSAF) ratio, P-value]",
                    "outcomes": "[70.2, 11.0, 5.3, 0.02501]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Context": "Proteins more abundant in cancer than in controls",
                        "Comparison": "Cancer vs Control",
                        "Protein": "Apolipoprotein A-I pre-pro-pro-protein",
                        "Accession": "4557321",
                        "MW (kDa)": "31"
                    },
                    "measures": "[Average SC (Cancer), Average SC (Control), NSAF ratio, p-value]",
                    "outcomes": "[29.8, 5.9, 5.7, 0.02170]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                        "protein": "Apolipoprotein A-I pre-pro-protein",
                        "accession": "4557321",
                        "Molecural weight (MW) (kDa)": "31",
                        "statistical test": "t-test"
                    },
                    "measures": "[Average Spectral Count (SC)(Cancer), Average Spectral Count (SC)(Control), Normalized Spectral Abundance Factor (NSAF) ratio, P-value]",
                    "outcomes": "[29.8, 5.9, 5.7, 0.02170]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Context": "Proteins more abundant in cancer than in controls",
                        "Comparison": "Cancer vs Control",
                        "Protein": "Fibrinogen alpha chain isoform alpha-E pre-pro-pro-protein",
                        "Accession": "4503689",
                        "MW (kDa)": "95"
                    },
                    "measures": "[Average SC (Cancer), Average SC (Control), NSAF ratio, p-value]",
                    "outcomes": "[63.3, 9.3, 6.4, 0.00031]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                        "protein": "Fibrinogen alpha chain isoform alpha-E pre-pro-protein",
                        "accession": "4503689",
                        "Molecural weight (MW) (kDa)": "95",
                        "statistical test": "t-test"
                    },
                    "measures": "[Average Spectral Count (SC)(Cancer), Average Spectral Count (SC)(Control), Normalized Spectral Abundance Factor (NSAF) ratio, P-value]",
                    "outcomes": "[63.3, 9.3, 6.4, 0.00031]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Context": "Proteins more abundant in cancer than in controls",
                        "Comparison": "Cancer vs Control",
                        "Protein": "Alpha-2-HS-glycoprotein pre-pro-pro-protein",
                        "Accession": "156523970",
                        "MW (kDa)": "39"
                    },
                    "measures": "[Average SC (Cancer), Average SC (Control), NSAF ratio, p-value]",
                    "outcomes": "[7.3, 1.1, 6.5, 0.00173]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                        "protein": "Alpha-2-HS-glycoprotein pre-pro-protein",
                        "accession": "156523970",
                        "Molecural weight (MW) (kDa)": "39",
                        "statistical test": "t-test"
                    },
                    "measures": "[Average Spectral Count (SC)(Cancer), Average Spectral Count (SC)(Control), Normalized Spectral Abundance Factor (NSAF) ratio, P-value]",
                    "outcomes": "[7.3, 1.1, 6.5, 0.00173]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Context": "Proteins more abundant in cancer than in controls",
                        "Comparison": "Cancer vs Control",
                        "Protein": "Ceruloplasmin precursor",
                        "Accession": "4557485",
                        "MW (kDa)": "122"
                    },
                    "measures": "[Average SC (Cancer), Average SC (Control), NSAF ratio, p-value]",
                    "outcomes": "[47.3, 5.6, 7.5, 0.00114]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                        "protein": "Ceruloplasmin precursor",
                        "accession": "4557485",
                        "Molecural weight (MW) (kDa)": "122",
                        "statistical test": "t-test"
                    },
                    "measures": "[Average Spectral Count (SC)(Cancer), Average Spectral Count (SC)(Control), Normalized Spectral Abundance Factor (NSAF) ratio, P-value]",
                    "outcomes": "[47.3, 5.6, 7.5, 0.00114]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Context": "Proteins more abundant in cancer than in controls",
                        "Comparison": "Cancer vs Control",
                        "Protein": "PREDICTED: complement C4-A isoform 1",
                        "Accession": "341916194",
                        "MW (kDa)": "193"
                    },
                    "measures": "[Average SC (Cancer), Average SC (Control), NSAF ratio, p-value]",
                    "outcomes": "[32.1, 4.5, 7.7, 0.01791]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                        "protein": "PREDICTED: complement C4-A isoform 1",
                        "accession": "341916194",
                        "Molecural weight (MW) (kDa)": "193",
                        "statistical test": "t-test"
                    },
                    "measures": "[Average Spectral Count (SC)(Cancer), Average Spectral Count (SC)(Control), Normalized Spectral Abundance Factor (NSAF) ratio, P-value]",
                    "outcomes": "[32.1, 4.5, 7.7, 0.01791]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Context": "Proteins more abundant in cancer than in controls",
                        "Comparison": "Cancer vs Control",
                        "Protein": "Alpha-1B-glycoprotein precursor",
                        "Accession": "21071030",
                        "MW (kDa)": "54"
                    },
                    "measures": "[Average SC (Cancer), Average SC (Control), NSAF ratio, p-value]",
                    "outcomes": "[10.9, 1.2, 8.3, 0.00468]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                        "protein": "Alpha-1B-glycoprotein precursor",
                        "accession": "21071030",
                        "Molecural weight (MW) (kDa)": "54",
                        "statistical test": "t-test"
                    },
                    "measures": "[Average Spectral Count (SC)(Cancer), Average Spectral Count (SC)(Control), Normalized Spectral Abundance Factor (NSAF) ratio, P-value]",
                    "outcomes": "[10.9, 1.2, 8.3, 0.00468]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Context": "Proteins more abundant in cancer than in controls",
                        "Comparison": "Cancer vs Control",
                        "Protein": "Inter-alpha-trypsin inhibitor heavy chain H4 isoform 1 precursor",
                        "Accession": "31542984",
                        "MW (kDa)": "103"
                    },
                    "measures": "[Average SC (Cancer), Average SC (Control), NSAF ratio, p-value]",
                    "outcomes": "[5.5, 0.2, 35.4, 0.00484]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                        "protein": "Inter-alpha-trypsin inhibitor heavy chain H4 isoform 1 precursor",
                        "accession": "31542984",
                        "Molecural weight (MW) (kDa)": "103",
                        "statistical test": "t-test"
                    },
                    "measures": "[Average Spectral Count (SC)(Cancer), Average Spectral Count (SC)(Control), Normalized Spectral Abundance Factor (NSAF) ratio, P-value]",
                    "outcomes": "[5.5, 0.2, 35.4, 0.00484]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Context": "Proteins more abundant in cancer than in controls",
                        "Comparison": "Cancer vs Control",
                        "Protein": "Apolipoprotein B-100 precursor",
                        "Accession": "105990532",
                        "MW (kDa)": "516"
                    },
                    "measures": "[Average SC (Cancer), Average SC (Control), NSAF ratio, p-value]",
                    "outcomes": "[49.3, 1.0, 55.7, 0.02595]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                        "protein": "Apolipoprotein B-100 precursor",
                        "accession": "105990532",
                        "Molecural weight (MW) (kDa)": "516",
                        "statistical test": "t-test"
                    },
                    "measures": "[Average Spectral Count (SC)(Cancer), Average Spectral Count (SC)(Control), Normalized Spectral Abundance Factor (NSAF) ratio, P-value]",
                    "outcomes": "[49.3, 1.0, 55.7, 0.02595]"
                },
                "match": "yes"
            }
        ],
        "total_extracted_claims": 18,
        "total_ground_truth_claims": 18,
        "number_of_matches": 18
    },
    "PMC5589562_2": {
        "matches": [
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in TAS cells",
                        "miRNA probe ID": "hsa-miR-145-5p",
                        "Accession no.": "MIMAT0000437"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[8980.05]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-145-5p",
                        "Accession no.": "MIMAT0000437",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "1"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['8980.05']"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-205-5p",
                        "Accession no.": "MIMAT0000266"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[23077.19]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-199a-5p",
                        "Accession no.": "MIMAT0000231",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "2"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['1563.68']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-205-5p",
                        "Accession no.": "MIMAT0000266"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[23077.19]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-199b-5p",
                        "Accession no.": "MIMAT0000263",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "3"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['296.31']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-205-5p",
                        "Accession no.": "MIMAT0000266"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[23077.19]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-136-5p",
                        "Accession no.": "MIMAT0000448",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "4"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['228.24']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-205-5p",
                        "Accession no.": "MIMAT0000266"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[23077.19]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-137",
                        "Accession no.": "MIMAT0000429",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "5"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['227.70']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-205-5p",
                        "Accession no.": "MIMAT0000266"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[23077.19]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-139-5p",
                        "Accession no.": "MIMAT0000250",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "6"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['216.83']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-205-5p",
                        "Accession no.": "MIMAT0000266"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[23077.19]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-127-3p",
                        "Accession no.": "MIMAT0000446",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "7"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['159.72']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-205-5p",
                        "Accession no.": "MIMAT0000266"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[23077.19]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-337-5p",
                        "Accession no.": "MIMAT0004695",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "8"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['148.57']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-205-5p",
                        "Accession no.": "MIMAT0000266"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[23077.19]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-139-3p",
                        "Accession no.": "MIMAT0004552",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "9"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['146.36']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-205-5p",
                        "Accession no.": "MIMAT0000266"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[23077.19]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-487b",
                        "Accession no.": "MIMAT0003180",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "10"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['118.72']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-205-5p",
                        "Accession no.": "MIMAT0000266"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[23077.19]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-199a-3p+hsa-miR-199b-3p",
                        "Accession no.": "MIMAT0000232",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "11"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['107.49']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-205-5p",
                        "Accession no.": "MIMAT0000266"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[23077.19]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-1233",
                        "Accession no.": "MIMAT0005588",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "12"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['66.04']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-205-5p",
                        "Accession no.": "MIMAT0000266"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[23077.19]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-379-5p",
                        "Accession no.": "MIMAT0000733",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "13"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['62.89']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-205-5p",
                        "Accession no.": "MIMAT0000266"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[23077.19]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-660-5p",
                        "Accession no.": "MIMAT0003338",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "14"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['62.50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-205-5p",
                        "Accession no.": "MIMAT0000266"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[23077.19]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-335-5p",
                        "Accession no.": "MIMAT0000765",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "15"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['60.53']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-205-5p",
                        "Accession no.": "MIMAT0000266"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[23077.19]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-205-5p",
                        "Accession no.": "MIMAT0000266",
                        "Cell type": "PC cells",
                        "Expression level": "highly expressed",
                        "Rank": "1"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['23077.19']"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in TAS cells",
                        "miRNA probe ID": "hsa-miR-199a-5p",
                        "Accession no.": "MIMAT0000231"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[1563.68]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-199a-5p",
                        "Accession no.": "MIMAT0000231",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "2"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['1563.68']"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-200c-3p",
                        "Accession no.": "MIMAT0000617"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[5968.64]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-199b-5p",
                        "Accession no.": "MIMAT0000263",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "3"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['296.31']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-200c-3p",
                        "Accession no.": "MIMAT0000617"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[5968.64]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-136-5p",
                        "Accession no.": "MIMAT0000448",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "4"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['228.24']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-200c-3p",
                        "Accession no.": "MIMAT0000617"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[5968.64]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-137",
                        "Accession no.": "MIMAT0000429",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "5"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['227.70']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-200c-3p",
                        "Accession no.": "MIMAT0000617"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[5968.64]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-139-5p",
                        "Accession no.": "MIMAT0000250",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "6"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['216.83']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-200c-3p",
                        "Accession no.": "MIMAT0000617"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[5968.64]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-127-3p",
                        "Accession no.": "MIMAT0000446",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "7"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['159.72']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-200c-3p",
                        "Accession no.": "MIMAT0000617"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[5968.64]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-337-5p",
                        "Accession no.": "MIMAT0004695",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "8"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['148.57']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-200c-3p",
                        "Accession no.": "MIMAT0000617"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[5968.64]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-139-3p",
                        "Accession no.": "MIMAT0004552",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "9"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['146.36']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-200c-3p",
                        "Accession no.": "MIMAT0000617"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[5968.64]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-487b",
                        "Accession no.": "MIMAT0003180",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "10"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['118.72']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-200c-3p",
                        "Accession no.": "MIMAT0000617"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[5968.64]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-199a-3p+hsa-miR-199b-3p",
                        "Accession no.": "MIMAT0000232",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "11"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['107.49']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-200c-3p",
                        "Accession no.": "MIMAT0000617"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[5968.64]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-1233",
                        "Accession no.": "MIMAT0005588",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "12"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['66.04']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-200c-3p",
                        "Accession no.": "MIMAT0000617"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[5968.64]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-379-5p",
                        "Accession no.": "MIMAT0000733",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "13"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['62.89']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-200c-3p",
                        "Accession no.": "MIMAT0000617"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[5968.64]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-660-5p",
                        "Accession no.": "MIMAT0003338",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "14"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['62.50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-200c-3p",
                        "Accession no.": "MIMAT0000617"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[5968.64]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-335-5p",
                        "Accession no.": "MIMAT0000765",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "15"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['60.53']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-200c-3p",
                        "Accession no.": "MIMAT0000617"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[5968.64]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-200c-3p",
                        "Accession no.": "MIMAT0000617",
                        "Cell type": "PC cells",
                        "Expression level": "highly expressed",
                        "Rank": "2"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['5968.64']"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in TAS cells",
                        "miRNA probe ID": "hsa-miR-199b-5p",
                        "Accession no.": "MIMAT0000263"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[296.31]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-199b-5p",
                        "Accession no.": "MIMAT0000263",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "3"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['296.31']"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-200b-3p",
                        "Accession no.": "MIMAT0000318"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[467.15]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-136-5p",
                        "Accession no.": "MIMAT0000448",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "4"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['228.24']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-200b-3p",
                        "Accession no.": "MIMAT0000318"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[467.15]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-137",
                        "Accession no.": "MIMAT0000429",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "5"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['227.70']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-200b-3p",
                        "Accession no.": "MIMAT0000318"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[467.15]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-139-5p",
                        "Accession no.": "MIMAT0000250",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "6"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['216.83']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-200b-3p",
                        "Accession no.": "MIMAT0000318"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[467.15]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-127-3p",
                        "Accession no.": "MIMAT0000446",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "7"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['159.72']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-200b-3p",
                        "Accession no.": "MIMAT0000318"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[467.15]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-337-5p",
                        "Accession no.": "MIMAT0004695",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "8"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['148.57']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-200b-3p",
                        "Accession no.": "MIMAT0000318"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[467.15]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-139-3p",
                        "Accession no.": "MIMAT0004552",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "9"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['146.36']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-200b-3p",
                        "Accession no.": "MIMAT0000318"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[467.15]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-487b",
                        "Accession no.": "MIMAT0003180",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "10"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['118.72']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-200b-3p",
                        "Accession no.": "MIMAT0000318"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[467.15]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-199a-3p+hsa-miR-199b-3p",
                        "Accession no.": "MIMAT0000232",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "11"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['107.49']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-200b-3p",
                        "Accession no.": "MIMAT0000318"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[467.15]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-1233",
                        "Accession no.": "MIMAT0005588",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "12"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['66.04']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-200b-3p",
                        "Accession no.": "MIMAT0000318"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[467.15]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-379-5p",
                        "Accession no.": "MIMAT0000733",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "13"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['62.89']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-200b-3p",
                        "Accession no.": "MIMAT0000318"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[467.15]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-660-5p",
                        "Accession no.": "MIMAT0003338",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "14"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['62.50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-200b-3p",
                        "Accession no.": "MIMAT0000318"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[467.15]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-335-5p",
                        "Accession no.": "MIMAT0000765",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "15"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['60.53']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-200b-3p",
                        "Accession no.": "MIMAT0000318"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[467.15]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-200b-3p",
                        "Accession no.": "MIMAT0000318",
                        "Cell type": "PC cells",
                        "Expression level": "highly expressed",
                        "Rank": "3"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['467.15']"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in TAS cells",
                        "miRNA probe ID": "hsa-miR-136-5p",
                        "Accession no.": "MIMAT0000448"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[228.24]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-136-5p",
                        "Accession no.": "MIMAT0000448",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "4"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['228.24']"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-429",
                        "Accession no.": "MIMAT0001536"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[171.07]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-137",
                        "Accession no.": "MIMAT0000429",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "5"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['227.70']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-429",
                        "Accession no.": "MIMAT0001536"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[171.07]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-139-5p",
                        "Accession no.": "MIMAT0000250",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "6"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['216.83']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-429",
                        "Accession no.": "MIMAT0001536"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[171.07]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-127-3p",
                        "Accession no.": "MIMAT0000446",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "7"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['159.72']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-429",
                        "Accession no.": "MIMAT0001536"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[171.07]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-337-5p",
                        "Accession no.": "MIMAT0004695",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "8"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['148.57']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-429",
                        "Accession no.": "MIMAT0001536"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[171.07]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-139-3p",
                        "Accession no.": "MIMAT0004552",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "9"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['146.36']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-429",
                        "Accession no.": "MIMAT0001536"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[171.07]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-487b",
                        "Accession no.": "MIMAT0003180",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "10"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['118.72']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-429",
                        "Accession no.": "MIMAT0001536"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[171.07]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-199a-3p+hsa-miR-199b-3p",
                        "Accession no.": "MIMAT0000232",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "11"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['107.49']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-429",
                        "Accession no.": "MIMAT0001536"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[171.07]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-1233",
                        "Accession no.": "MIMAT0005588",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "12"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['66.04']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-429",
                        "Accession no.": "MIMAT0001536"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[171.07]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-379-5p",
                        "Accession no.": "MIMAT0000733",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "13"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['62.89']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-429",
                        "Accession no.": "MIMAT0001536"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[171.07]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-660-5p",
                        "Accession no.": "MIMAT0003338",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "14"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['62.50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-429",
                        "Accession no.": "MIMAT0001536"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[171.07]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-335-5p",
                        "Accession no.": "MIMAT0000765",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "15"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['60.53']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-429",
                        "Accession no.": "MIMAT0001536"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[171.07]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-429",
                        "Accession no.": "MIMAT0001536",
                        "Cell type": "PC cells",
                        "Expression level": "highly expressed",
                        "Rank": "4"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['171.07']"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in TAS cells",
                        "miRNA probe ID": "hsa-miR-137",
                        "Accession no.": "MIMAT0000429"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[227.70]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-137",
                        "Accession no.": "MIMAT0000429",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "5"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['227.70']"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-196b-5p",
                        "Accession no.": "MIMAT0001080"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[116.42]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-139-5p",
                        "Accession no.": "MIMAT0000250",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "6"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['216.83']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-196b-5p",
                        "Accession no.": "MIMAT0001080"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[116.42]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-127-3p",
                        "Accession no.": "MIMAT0000446",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "7"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['159.72']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-196b-5p",
                        "Accession no.": "MIMAT0001080"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[116.42]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-337-5p",
                        "Accession no.": "MIMAT0004695",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "8"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['148.57']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-196b-5p",
                        "Accession no.": "MIMAT0001080"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[116.42]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-139-3p",
                        "Accession no.": "MIMAT0004552",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "9"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['146.36']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-196b-5p",
                        "Accession no.": "MIMAT0001080"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[116.42]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-487b",
                        "Accession no.": "MIMAT0003180",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "10"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['118.72']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-196b-5p",
                        "Accession no.": "MIMAT0001080"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[116.42]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-199a-3p+hsa-miR-199b-3p",
                        "Accession no.": "MIMAT0000232",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "11"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['107.49']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-196b-5p",
                        "Accession no.": "MIMAT0001080"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[116.42]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-1233",
                        "Accession no.": "MIMAT0005588",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "12"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['66.04']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-196b-5p",
                        "Accession no.": "MIMAT0001080"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[116.42]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-379-5p",
                        "Accession no.": "MIMAT0000733",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "13"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['62.89']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-196b-5p",
                        "Accession no.": "MIMAT0001080"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[116.42]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-660-5p",
                        "Accession no.": "MIMAT0003338",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "14"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['62.50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-196b-5p",
                        "Accession no.": "MIMAT0001080"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[116.42]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-335-5p",
                        "Accession no.": "MIMAT0000765",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "15"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['60.53']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-196b-5p",
                        "Accession no.": "MIMAT0001080"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[116.42]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-196b-5p",
                        "Accession no.": "MIMAT0001080",
                        "Cell type": "PC cells",
                        "Expression level": "highly expressed",
                        "Rank": "5"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['116.42']"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in TAS cells",
                        "miRNA probe ID": "hsa-miR-139-5p",
                        "Accession no.": "MIMAT0000250"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[216.83]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-139-5p",
                        "Accession no.": "MIMAT0000250",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "6"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['216.83']"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-582-5p",
                        "Accession no.": "MIMAT0003247"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[99.53]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-127-3p",
                        "Accession no.": "MIMAT0000446",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "7"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['159.72']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-582-5p",
                        "Accession no.": "MIMAT0003247"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[99.53]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-337-5p",
                        "Accession no.": "MIMAT0004695",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "8"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['148.57']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-582-5p",
                        "Accession no.": "MIMAT0003247"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[99.53]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-139-3p",
                        "Accession no.": "MIMAT0004552",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "9"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['146.36']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-582-5p",
                        "Accession no.": "MIMAT0003247"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[99.53]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-487b",
                        "Accession no.": "MIMAT0003180",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "10"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['118.72']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-582-5p",
                        "Accession no.": "MIMAT0003247"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[99.53]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-199a-3p+hsa-miR-199b-3p",
                        "Accession no.": "MIMAT0000232",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "11"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['107.49']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-582-5p",
                        "Accession no.": "MIMAT0003247"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[99.53]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-1233",
                        "Accession no.": "MIMAT0005588",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "12"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['66.04']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-582-5p",
                        "Accession no.": "MIMAT0003247"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[99.53]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-379-5p",
                        "Accession no.": "MIMAT0000733",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "13"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['62.89']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-582-5p",
                        "Accession no.": "MIMAT0003247"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[99.53]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-660-5p",
                        "Accession no.": "MIMAT0003338",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "14"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['62.50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-582-5p",
                        "Accession no.": "MIMAT0003247"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[99.53]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-335-5p",
                        "Accession no.": "MIMAT0000765",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "15"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['60.53']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-582-5p",
                        "Accession no.": "MIMAT0003247"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[99.53]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-582-5p",
                        "Accession no.": "MIMAT0003247",
                        "Cell type": "PC cells",
                        "Expression level": "highly expressed",
                        "Rank": "6"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['99.53']"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in TAS cells",
                        "miRNA probe ID": "hsa-miR-127-3p",
                        "Accession no.": "MIMAT0000446"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[159.72]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-127-3p",
                        "Accession no.": "MIMAT0000446",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "7"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['159.72']"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-135b-5p",
                        "Accession no.": "MIMAT0000758"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[87.82]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-337-5p",
                        "Accession no.": "MIMAT0004695",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "8"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['148.57']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-135b-5p",
                        "Accession no.": "MIMAT0000758"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[87.82]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-139-3p",
                        "Accession no.": "MIMAT0004552",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "9"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['146.36']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-135b-5p",
                        "Accession no.": "MIMAT0000758"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[87.82]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-487b",
                        "Accession no.": "MIMAT0003180",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "10"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['118.72']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-135b-5p",
                        "Accession no.": "MIMAT0000758"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[87.82]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-199a-3p+hsa-miR-199b-3p",
                        "Accession no.": "MIMAT0000232",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "11"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['107.49']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-135b-5p",
                        "Accession no.": "MIMAT0000758"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[87.82]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-1233",
                        "Accession no.": "MIMAT0005588",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "12"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['66.04']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-135b-5p",
                        "Accession no.": "MIMAT0000758"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[87.82]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-379-5p",
                        "Accession no.": "MIMAT0000733",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "13"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['62.89']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-135b-5p",
                        "Accession no.": "MIMAT0000758"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[87.82]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-660-5p",
                        "Accession no.": "MIMAT0003338",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "14"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['62.50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-135b-5p",
                        "Accession no.": "MIMAT0000758"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[87.82]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-335-5p",
                        "Accession no.": "MIMAT0000765",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "15"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['60.53']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-135b-5p",
                        "Accession no.": "MIMAT0000758"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[87.82]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-135b-5p",
                        "Accession no.": "MIMAT0000758",
                        "Cell type": "PC cells",
                        "Expression level": "highly expressed",
                        "Rank": "7"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['87.82']"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in TAS cells",
                        "miRNA probe ID": "hsa-miR-337-5p",
                        "Accession no.": "MIMAT0004695"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[148.57]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-337-5p",
                        "Accession no.": "MIMAT0004695",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "8"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['148.57']"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-182-5p",
                        "Accession no.": "MIMAT0000259"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[55.81]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-139-3p",
                        "Accession no.": "MIMAT0004552",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "9"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['146.36']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-182-5p",
                        "Accession no.": "MIMAT0000259"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[55.81]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-487b",
                        "Accession no.": "MIMAT0003180",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "10"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['118.72']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-182-5p",
                        "Accession no.": "MIMAT0000259"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[55.81]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-199a-3p+hsa-miR-199b-3p",
                        "Accession no.": "MIMAT0000232",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "11"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['107.49']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-182-5p",
                        "Accession no.": "MIMAT0000259"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[55.81]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-1233",
                        "Accession no.": "MIMAT0005588",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "12"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['66.04']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-182-5p",
                        "Accession no.": "MIMAT0000259"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[55.81]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-379-5p",
                        "Accession no.": "MIMAT0000733",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "13"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['62.89']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-182-5p",
                        "Accession no.": "MIMAT0000259"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[55.81]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-660-5p",
                        "Accession no.": "MIMAT0003338",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "14"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['62.50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-182-5p",
                        "Accession no.": "MIMAT0000259"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[55.81]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-335-5p",
                        "Accession no.": "MIMAT0000765",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "15"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['60.53']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-182-5p",
                        "Accession no.": "MIMAT0000259"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[55.81]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-182-5p",
                        "Accession no.": "MIMAT0000259",
                        "Cell type": "PC cells",
                        "Expression level": "highly expressed",
                        "Rank": "8"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['55.81']"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in TAS cells",
                        "miRNA probe ID": "hsa-miR-139-3p",
                        "Accession no.": "MIMAT0004552"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[146.36]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-139-3p",
                        "Accession no.": "MIMAT0004552",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "9"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['146.36']"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-96-5p",
                        "Accession no.": "MIMAT0000095"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[53.82]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-487b",
                        "Accession no.": "MIMAT0003180",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "10"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['118.72']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-96-5p",
                        "Accession no.": "MIMAT0000095"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[53.82]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-199a-3p+hsa-miR-199b-3p",
                        "Accession no.": "MIMAT0000232",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "11"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['107.49']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-96-5p",
                        "Accession no.": "MIMAT0000095"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[53.82]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-1233",
                        "Accession no.": "MIMAT0005588",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "12"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['66.04']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-96-5p",
                        "Accession no.": "MIMAT0000095"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[53.82]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-379-5p",
                        "Accession no.": "MIMAT0000733",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "13"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['62.89']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-96-5p",
                        "Accession no.": "MIMAT0000095"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[53.82]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-660-5p",
                        "Accession no.": "MIMAT0003338",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "14"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['62.50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-96-5p",
                        "Accession no.": "MIMAT0000095"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[53.82]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-335-5p",
                        "Accession no.": "MIMAT0000765",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "15"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['60.53']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-96-5p",
                        "Accession no.": "MIMAT0000095"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[53.82]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-96-5p",
                        "Accession no.": "MIMAT0000095",
                        "Cell type": "PC cells",
                        "Expression level": "highly expressed",
                        "Rank": "9"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['53.82']"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in TAS cells",
                        "miRNA probe ID": "hsa-miR-487b",
                        "Accession no.": "MIMAT0003180"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[118.72]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-487b",
                        "Accession no.": "MIMAT0003180",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "10"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['118.72']"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-200a-3p",
                        "Accession no.": "MIMAT0000682"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[44.88]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-199a-3p+hsa-miR-199b-3p",
                        "Accession no.": "MIMAT0000232",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "11"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['107.49']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-200a-3p",
                        "Accession no.": "MIMAT0000682"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[44.88]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-1233",
                        "Accession no.": "MIMAT0005588",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "12"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['66.04']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-200a-3p",
                        "Accession no.": "MIMAT0000682"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[44.88]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-379-5p",
                        "Accession no.": "MIMAT0000733",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "13"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['62.89']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-200a-3p",
                        "Accession no.": "MIMAT0000682"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[44.88]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-660-5p",
                        "Accession no.": "MIMAT0003338",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "14"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['62.50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-200a-3p",
                        "Accession no.": "MIMAT0000682"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[44.88]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-335-5p",
                        "Accession no.": "MIMAT0000765",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "15"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['60.53']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-200a-3p",
                        "Accession no.": "MIMAT0000682"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[44.88]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-200a-3p",
                        "Accession no.": "MIMAT0000682",
                        "Cell type": "PC cells",
                        "Expression level": "highly expressed",
                        "Rank": "10"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['44.88']"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in TAS cells",
                        "miRNA probe ID": "hsa-miR-199a-3p+hsa-miR-199b-3p",
                        "Accession no.": "MIMAT0000232"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[107.49]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-199a-3p+hsa-miR-199b-3p",
                        "Accession no.": "MIMAT0000232",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "11"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['107.49']"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-4284",
                        "Accession no.": "MIMAT0016915"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[41.90]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-1233",
                        "Accession no.": "MIMAT0005588",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "12"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['66.04']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-4284",
                        "Accession no.": "MIMAT0016915"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[41.90]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-379-5p",
                        "Accession no.": "MIMAT0000733",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "13"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['62.89']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-4284",
                        "Accession no.": "MIMAT0016915"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[41.90]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-660-5p",
                        "Accession no.": "MIMAT0003338",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "14"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['62.50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-4284",
                        "Accession no.": "MIMAT0016915"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[41.90]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-335-5p",
                        "Accession no.": "MIMAT0000765",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "15"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['60.53']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-4284",
                        "Accession no.": "MIMAT0016915"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[41.90]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-4284",
                        "Accession no.": "MIMAT0016915",
                        "Cell type": "PC cells",
                        "Expression level": "highly expressed",
                        "Rank": "11"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['41.90']"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in TAS cells",
                        "miRNA probe ID": "hsa-miR-1233",
                        "Accession no.": "MIMAT0005588"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[66.04]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-1233",
                        "Accession no.": "MIMAT0005588",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "12"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['66.04']"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-345-5p",
                        "Accession no.": "MIMAT0000772"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[27.99]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-379-5p",
                        "Accession no.": "MIMAT0000733",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "13"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['62.89']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-345-5p",
                        "Accession no.": "MIMAT0000772"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[27.99]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-660-5p",
                        "Accession no.": "MIMAT0003338",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "14"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['62.50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-345-5p",
                        "Accession no.": "MIMAT0000772"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[27.99]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-335-5p",
                        "Accession no.": "MIMAT0000765",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "15"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['60.53']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-345-5p",
                        "Accession no.": "MIMAT0000772"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[27.99]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-345-5p",
                        "Accession no.": "MIMAT0000772",
                        "Cell type": "PC cells",
                        "Expression level": "highly expressed",
                        "Rank": "12"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['27.99']"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in TAS cells",
                        "miRNA probe ID": "hsa-miR-379-5p",
                        "Accession no.": "MIMAT0000733"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[62.89]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-379-5p",
                        "Accession no.": "MIMAT0000733",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "13"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['62.89']"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-378g",
                        "Accession no.": "MIMAT0018937"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[25.01]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-660-5p",
                        "Accession no.": "MIMAT0003338",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "14"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['62.50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-378g",
                        "Accession no.": "MIMAT0018937"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[25.01]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-335-5p",
                        "Accession no.": "MIMAT0000765",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "15"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['60.53']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-378g",
                        "Accession no.": "MIMAT0018937"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[25.01]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-378g",
                        "Accession no.": "MIMAT0018937",
                        "Cell type": "PC cells",
                        "Expression level": "highly expressed",
                        "Rank": "13"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['25.01']"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in TAS cells",
                        "miRNA probe ID": "hsa-miR-660-5p",
                        "Accession no.": "MIMAT0003338"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[62.50]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-660-5p",
                        "Accession no.": "MIMAT0003338",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "14"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['62.50']"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-203",
                        "Accession no.": "MIMAT0000264"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[22.43]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-335-5p",
                        "Accession no.": "MIMAT0000765",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "15"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['60.53']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-203",
                        "Accession no.": "MIMAT0000264"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[22.43]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-203",
                        "Accession no.": "MIMAT0000264",
                        "Cell type": "PC cells",
                        "Expression level": "highly expressed",
                        "Rank": "14"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['22.43']"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in TAS cells",
                        "miRNA probe ID": "hsa-miR-335-5p",
                        "Accession no.": "MIMAT0000765"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[60.53]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-335-5p",
                        "Accession no.": "MIMAT0000765",
                        "Cell type": "TAS cells",
                        "Expression level": "highly expressed",
                        "Rank": "15"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['60.53']"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Comparison": "TAS cells vs PC cells",
                        "Study focus": "Differentially expressed miRNAs",
                        "Expression group": "Top 15 highly expressed in PC cells",
                        "miRNA probe ID": "hsa-miR-141-3p",
                        "Accession no.": "MIMAT0000432"
                    },
                    "measures": "[Ratio]",
                    "outcomes": "[21.69]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "miRNA probe ID": "hsa-miR-141-3p",
                        "Accession no.": "MIMAT0000432",
                        "Cell type": "PC cells",
                        "Expression level": "highly expressed",
                        "Rank": "15"
                    },
                    "measures": "['Expression ratio']",
                    "outcomes": "['21.69']"
                },
                "match": "yes"
            }
        ],
        "total_extracted_claims": 30,
        "total_ground_truth_claims": 30,
        "number_of_matches": 30
    },
    "PMC4190529_6": {
        "matches": [
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "gemcitabine",
                        "Control": "5-fluorouracil",
                        "Phase": "3",
                        "Median Survival Therapy": "5.7 months",
                        "Median Survival Control": "4.2 months",
                        "One-Year Survival Therapy": "18%",
                        "One-Year Survival Control": "2%",
                        "Side Effects": "more favorable than 5-fluorouracil",
                        "FDA Approval": "1996"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[5.7, 4.2, 18, 2]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "gemcitabine",
                        "Control": "5-fluorouracil",
                        "Phase": "3",
                        "Side Effects": "more favorable than 5-fluorouracil",
                        "FDA Approval": "1996",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['Median Survival Therapy', 'Median Survival Control]",
                    "outcomes": "['5.7', '4.2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "gemcitabine",
                        "Control": "5-fluorouracil",
                        "Phase": "3",
                        "Median Survival Therapy": "5.7 months",
                        "Median Survival Control": "4.2 months",
                        "One-Year Survival Therapy": "18%",
                        "One-Year Survival Control": "2%",
                        "Side Effects": "more favorable than 5-fluorouracil",
                        "FDA Approval": "1996"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[5.7, 4.2, 18, 2]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "gemcitabine",
                        "Control": "5-fluorouracil",
                        "Phase": "3",
                        "Side Effects": "more favorable than 5-fluorouracil",
                        "FDA Approval": "1996",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['One-Year Survival Therapy', 'One-Year Survival Control']",
                    "outcomes": "['18%', '2%']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "gemcitabine",
                        "Control": "5-fluorouracil",
                        "Phase": "3",
                        "Median Survival Therapy": "5.7 months",
                        "Median Survival Control": "4.2 months",
                        "One-Year Survival Therapy": "18%",
                        "One-Year Survival Control": "2%",
                        "Side Effects": "more favorable than 5-fluorouracil",
                        "FDA Approval": "1996"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[5.7, 4.2, 18, 2]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "gemcitabine + erlotinib hydrochloride (Tarceva)",
                        "Control": "gemcitabine",
                        "Phase": "3",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "2005",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['Median Survival Therapy', 'Median Survival Control']",
                    "outcomes": "['6.4', '6']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "gemcitabine",
                        "Control": "5-fluorouracil",
                        "Phase": "3",
                        "Median Survival Therapy": "5.7 months",
                        "Median Survival Control": "4.2 months",
                        "One-Year Survival Therapy": "18%",
                        "One-Year Survival Control": "2%",
                        "Side Effects": "more favorable than 5-fluorouracil",
                        "FDA Approval": "1996"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[5.7, 4.2, 18, 2]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "gemcitabine + erlotinib hydrochloride (Tarceva)",
                        "Control": "gemcitabine",
                        "Phase": "3",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "2005",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['One-Year Survival Therapy', 'One-Year Survival Control']",
                    "outcomes": "['24%', '19%']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "gemcitabine",
                        "Control": "5-fluorouracil",
                        "Phase": "3",
                        "Median Survival Therapy": "5.7 months",
                        "Median Survival Control": "4.2 months",
                        "One-Year Survival Therapy": "18%",
                        "One-Year Survival Control": "2%",
                        "Side Effects": "more favorable than 5-fluorouracil",
                        "FDA Approval": "1996"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[5.7, 4.2, 18, 2]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "gemcitabine + protein-bound paclitaxel (Abraxane)",
                        "Control": "gemcitabine",
                        "Phase": "3",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "2013",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['Median Survival Therapy', 'Median Survival Control']",
                    "outcomes": "['8.5', '6.7']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "gemcitabine",
                        "Control": "5-fluorouracil",
                        "Phase": "3",
                        "Median Survival Therapy": "5.7 months",
                        "Median Survival Control": "4.2 months",
                        "One-Year Survival Therapy": "18%",
                        "One-Year Survival Control": "2%",
                        "Side Effects": "more favorable than 5-fluorouracil",
                        "FDA Approval": "1996"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[5.7, 4.2, 18, 2]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "gemcitabine + protein-bound paclitaxel (Abraxane)",
                        "Control": "gemcitabine",
                        "Phase": "3",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "2013",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['One-Year Survival Therapy', 'One-Year Survival Control']",
                    "outcomes": "['35%', '22%']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "gemcitabine",
                        "Control": "5-fluorouracil",
                        "Phase": "3",
                        "Median Survival Therapy": "5.7 months",
                        "Median Survival Control": "4.2 months",
                        "One-Year Survival Therapy": "18%",
                        "One-Year Survival Control": "2%",
                        "Side Effects": "more favorable than 5-fluorouracil",
                        "FDA Approval": "1996"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[5.7, 4.2, 18, 2]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "FOLFIRINOX",
                        "Control": "gemcitabine",
                        "Phase": "2/3",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "n/a",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['Median Survival Therapy', 'Median Survival Control']",
                    "outcomes": "['11.1', '6.8']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "gemcitabine",
                        "Control": "5-fluorouracil",
                        "Phase": "3",
                        "Median Survival Therapy": "5.7 months",
                        "Median Survival Control": "4.2 months",
                        "One-Year Survival Therapy": "18%",
                        "One-Year Survival Control": "2%",
                        "Side Effects": "more favorable than 5-fluorouracil",
                        "FDA Approval": "1996"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[5.7, 4.2, 18, 2]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "FOLFIRINOX",
                        "Control": "gemcitabine",
                        "Phase": "2/3",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "n/a",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['One-Year Survival Therapy', 'One-Year Survival Control']",
                    "outcomes": "['48.4%', '20.6%']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "gemcitabine",
                        "Control": "5-fluorouracil",
                        "Phase": "3",
                        "Median Survival Therapy": "5.7 months",
                        "Median Survival Control": "4.2 months",
                        "One-Year Survival Therapy": "18%",
                        "One-Year Survival Control": "2%",
                        "Side Effects": "more favorable than 5-fluorouracil",
                        "FDA Approval": "1996"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[5.7, 4.2, 18, 2]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "cell encapsulation + ifosfamide",
                        "Control": "5-fluorouracil",
                        "Phase": "2",
                        "Side Effects": "more favorable than 5-fluorouracil or gemcitabine",
                        "FDA Approval": "n/a",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['Median Survival Therapy', 'Median Survival Control']",
                    "outcomes": "['10', '5']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "gemcitabine",
                        "Control": "5-fluorouracil",
                        "Phase": "3",
                        "Median Survival Therapy": "5.7 months",
                        "Median Survival Control": "4.2 months",
                        "One-Year Survival Therapy": "18%",
                        "One-Year Survival Control": "2%",
                        "Side Effects": "more favorable than 5-fluorouracil",
                        "FDA Approval": "1996"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[5.7, 4.2, 18, 2]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "cell encapsulation + ifosfamide",
                        "Control": "5-fluorouracil",
                        "Phase": "2",
                        "Side Effects": "more favorable than 5-fluorouracil or gemcitabine",
                        "FDA Approval": "n/a",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['One-Year Survival Therapy', 'One-Year Survival Control']",
                    "outcomes": "['36%', '18%']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "gemcitabine + erlotinib hydrochloride (Tarceva)",
                        "Control": "gemcitabine",
                        "Phase": "3",
                        "Median Survival Therapy": "6.4 months",
                        "Median Survival Control": "6 months",
                        "One-Year Survival Therapy": "24%",
                        "One-Year Survival Control": "19%",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "2005"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[6.4, 6, 24, 19]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "gemcitabine",
                        "Control": "5-fluorouracil",
                        "Phase": "3",
                        "Side Effects": "more favorable than 5-fluorouracil",
                        "FDA Approval": "1996",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['Median Survival Therapy', 'Median Survival Control]",
                    "outcomes": "['5.7', '4.2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "gemcitabine + erlotinib hydrochloride (Tarceva)",
                        "Control": "gemcitabine",
                        "Phase": "3",
                        "Median Survival Therapy": "6.4 months",
                        "Median Survival Control": "6 months",
                        "One-Year Survival Therapy": "24%",
                        "One-Year Survival Control": "19%",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "2005"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[6.4, 6, 24, 19]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "gemcitabine",
                        "Control": "5-fluorouracil",
                        "Phase": "3",
                        "Side Effects": "more favorable than 5-fluorouracil",
                        "FDA Approval": "1996",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['One-Year Survival Therapy', 'One-Year Survival Control']",
                    "outcomes": "['18%', '2%']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "gemcitabine + erlotinib hydrochloride (Tarceva)",
                        "Control": "gemcitabine",
                        "Phase": "3",
                        "Median Survival Therapy": "6.4 months",
                        "Median Survival Control": "6 months",
                        "One-Year Survival Therapy": "24%",
                        "One-Year Survival Control": "19%",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "2005"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[6.4, 6, 24, 19]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "gemcitabine + erlotinib hydrochloride (Tarceva)",
                        "Control": "gemcitabine",
                        "Phase": "3",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "2005",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['Median Survival Therapy', 'Median Survival Control']",
                    "outcomes": "['6.4', '6']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "gemcitabine + erlotinib hydrochloride (Tarceva)",
                        "Control": "gemcitabine",
                        "Phase": "3",
                        "Median Survival Therapy": "6.4 months",
                        "Median Survival Control": "6 months",
                        "One-Year Survival Therapy": "24%",
                        "One-Year Survival Control": "19%",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "2005"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[6.4, 6, 24, 19]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "gemcitabine + erlotinib hydrochloride (Tarceva)",
                        "Control": "gemcitabine",
                        "Phase": "3",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "2005",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['One-Year Survival Therapy', 'One-Year Survival Control']",
                    "outcomes": "['24%', '19%']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "gemcitabine + erlotinib hydrochloride (Tarceva)",
                        "Control": "gemcitabine",
                        "Phase": "3",
                        "Median Survival Therapy": "6.4 months",
                        "Median Survival Control": "6 months",
                        "One-Year Survival Therapy": "24%",
                        "One-Year Survival Control": "19%",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "2005"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[6.4, 6, 24, 19]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "gemcitabine + protein-bound paclitaxel (Abraxane)",
                        "Control": "gemcitabine",
                        "Phase": "3",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "2013",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['Median Survival Therapy', 'Median Survival Control']",
                    "outcomes": "['8.5', '6.7']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "gemcitabine + erlotinib hydrochloride (Tarceva)",
                        "Control": "gemcitabine",
                        "Phase": "3",
                        "Median Survival Therapy": "6.4 months",
                        "Median Survival Control": "6 months",
                        "One-Year Survival Therapy": "24%",
                        "One-Year Survival Control": "19%",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "2005"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[6.4, 6, 24, 19]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "gemcitabine + protein-bound paclitaxel (Abraxane)",
                        "Control": "gemcitabine",
                        "Phase": "3",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "2013",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['One-Year Survival Therapy', 'One-Year Survival Control']",
                    "outcomes": "['35%', '22%']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "gemcitabine + erlotinib hydrochloride (Tarceva)",
                        "Control": "gemcitabine",
                        "Phase": "3",
                        "Median Survival Therapy": "6.4 months",
                        "Median Survival Control": "6 months",
                        "One-Year Survival Therapy": "24%",
                        "One-Year Survival Control": "19%",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "2005"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[6.4, 6, 24, 19]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "FOLFIRINOX",
                        "Control": "gemcitabine",
                        "Phase": "2/3",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "n/a",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['Median Survival Therapy', 'Median Survival Control']",
                    "outcomes": "['11.1', '6.8']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "gemcitabine + erlotinib hydrochloride (Tarceva)",
                        "Control": "gemcitabine",
                        "Phase": "3",
                        "Median Survival Therapy": "6.4 months",
                        "Median Survival Control": "6 months",
                        "One-Year Survival Therapy": "24%",
                        "One-Year Survival Control": "19%",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "2005"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[6.4, 6, 24, 19]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "FOLFIRINOX",
                        "Control": "gemcitabine",
                        "Phase": "2/3",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "n/a",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['One-Year Survival Therapy', 'One-Year Survival Control']",
                    "outcomes": "['48.4%', '20.6%']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "gemcitabine + erlotinib hydrochloride (Tarceva)",
                        "Control": "gemcitabine",
                        "Phase": "3",
                        "Median Survival Therapy": "6.4 months",
                        "Median Survival Control": "6 months",
                        "One-Year Survival Therapy": "24%",
                        "One-Year Survival Control": "19%",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "2005"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[6.4, 6, 24, 19]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "cell encapsulation + ifosfamide",
                        "Control": "5-fluorouracil",
                        "Phase": "2",
                        "Side Effects": "more favorable than 5-fluorouracil or gemcitabine",
                        "FDA Approval": "n/a",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['Median Survival Therapy', 'Median Survival Control']",
                    "outcomes": "['10', '5']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "gemcitabine + erlotinib hydrochloride (Tarceva)",
                        "Control": "gemcitabine",
                        "Phase": "3",
                        "Median Survival Therapy": "6.4 months",
                        "Median Survival Control": "6 months",
                        "One-Year Survival Therapy": "24%",
                        "One-Year Survival Control": "19%",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "2005"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[6.4, 6, 24, 19]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "cell encapsulation + ifosfamide",
                        "Control": "5-fluorouracil",
                        "Phase": "2",
                        "Side Effects": "more favorable than 5-fluorouracil or gemcitabine",
                        "FDA Approval": "n/a",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['One-Year Survival Therapy', 'One-Year Survival Control']",
                    "outcomes": "['36%', '18%']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "gemcitabine + protein-bound paclitaxel (Abraxane)",
                        "Control": "gemcitabine",
                        "Phase": "3",
                        "Median Survival Therapy": "8.5 months",
                        "Median Survival Control": "6.7 months",
                        "One-Year Survival Therapy": "35%",
                        "One-Year Survival Control": "22%",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "2013"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[8.5, 6.7, 35, 22]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "gemcitabine",
                        "Control": "5-fluorouracil",
                        "Phase": "3",
                        "Side Effects": "more favorable than 5-fluorouracil",
                        "FDA Approval": "1996",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['Median Survival Therapy', 'Median Survival Control]",
                    "outcomes": "['5.7', '4.2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "gemcitabine + protein-bound paclitaxel (Abraxane)",
                        "Control": "gemcitabine",
                        "Phase": "3",
                        "Median Survival Therapy": "8.5 months",
                        "Median Survival Control": "6.7 months",
                        "One-Year Survival Therapy": "35%",
                        "One-Year Survival Control": "22%",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "2013"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[8.5, 6.7, 35, 22]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "gemcitabine",
                        "Control": "5-fluorouracil",
                        "Phase": "3",
                        "Side Effects": "more favorable than 5-fluorouracil",
                        "FDA Approval": "1996",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['One-Year Survival Therapy', 'One-Year Survival Control']",
                    "outcomes": "['18%', '2%']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "gemcitabine + protein-bound paclitaxel (Abraxane)",
                        "Control": "gemcitabine",
                        "Phase": "3",
                        "Median Survival Therapy": "8.5 months",
                        "Median Survival Control": "6.7 months",
                        "One-Year Survival Therapy": "35%",
                        "One-Year Survival Control": "22%",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "2013"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[8.5, 6.7, 35, 22]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "gemcitabine + erlotinib hydrochloride (Tarceva)",
                        "Control": "gemcitabine",
                        "Phase": "3",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "2005",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['Median Survival Therapy', 'Median Survival Control']",
                    "outcomes": "['6.4', '6']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "gemcitabine + protein-bound paclitaxel (Abraxane)",
                        "Control": "gemcitabine",
                        "Phase": "3",
                        "Median Survival Therapy": "8.5 months",
                        "Median Survival Control": "6.7 months",
                        "One-Year Survival Therapy": "35%",
                        "One-Year Survival Control": "22%",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "2013"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[8.5, 6.7, 35, 22]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "gemcitabine + erlotinib hydrochloride (Tarceva)",
                        "Control": "gemcitabine",
                        "Phase": "3",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "2005",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['One-Year Survival Therapy', 'One-Year Survival Control']",
                    "outcomes": "['24%', '19%']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "gemcitabine + protein-bound paclitaxel (Abraxane)",
                        "Control": "gemcitabine",
                        "Phase": "3",
                        "Median Survival Therapy": "8.5 months",
                        "Median Survival Control": "6.7 months",
                        "One-Year Survival Therapy": "35%",
                        "One-Year Survival Control": "22%",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "2013"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[8.5, 6.7, 35, 22]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "gemcitabine + protein-bound paclitaxel (Abraxane)",
                        "Control": "gemcitabine",
                        "Phase": "3",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "2013",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['Median Survival Therapy', 'Median Survival Control']",
                    "outcomes": "['8.5', '6.7']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "gemcitabine + protein-bound paclitaxel (Abraxane)",
                        "Control": "gemcitabine",
                        "Phase": "3",
                        "Median Survival Therapy": "8.5 months",
                        "Median Survival Control": "6.7 months",
                        "One-Year Survival Therapy": "35%",
                        "One-Year Survival Control": "22%",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "2013"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[8.5, 6.7, 35, 22]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "gemcitabine + protein-bound paclitaxel (Abraxane)",
                        "Control": "gemcitabine",
                        "Phase": "3",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "2013",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['One-Year Survival Therapy', 'One-Year Survival Control']",
                    "outcomes": "['35%', '22%']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "gemcitabine + protein-bound paclitaxel (Abraxane)",
                        "Control": "gemcitabine",
                        "Phase": "3",
                        "Median Survival Therapy": "8.5 months",
                        "Median Survival Control": "6.7 months",
                        "One-Year Survival Therapy": "35%",
                        "One-Year Survival Control": "22%",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "2013"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[8.5, 6.7, 35, 22]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "FOLFIRINOX",
                        "Control": "gemcitabine",
                        "Phase": "2/3",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "n/a",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['Median Survival Therapy', 'Median Survival Control']",
                    "outcomes": "['11.1', '6.8']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "gemcitabine + protein-bound paclitaxel (Abraxane)",
                        "Control": "gemcitabine",
                        "Phase": "3",
                        "Median Survival Therapy": "8.5 months",
                        "Median Survival Control": "6.7 months",
                        "One-Year Survival Therapy": "35%",
                        "One-Year Survival Control": "22%",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "2013"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[8.5, 6.7, 35, 22]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "FOLFIRINOX",
                        "Control": "gemcitabine",
                        "Phase": "2/3",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "n/a",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['One-Year Survival Therapy', 'One-Year Survival Control']",
                    "outcomes": "['48.4%', '20.6%']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "gemcitabine + protein-bound paclitaxel (Abraxane)",
                        "Control": "gemcitabine",
                        "Phase": "3",
                        "Median Survival Therapy": "8.5 months",
                        "Median Survival Control": "6.7 months",
                        "One-Year Survival Therapy": "35%",
                        "One-Year Survival Control": "22%",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "2013"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[8.5, 6.7, 35, 22]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "cell encapsulation + ifosfamide",
                        "Control": "5-fluorouracil",
                        "Phase": "2",
                        "Side Effects": "more favorable than 5-fluorouracil or gemcitabine",
                        "FDA Approval": "n/a",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['Median Survival Therapy', 'Median Survival Control']",
                    "outcomes": "['10', '5']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "gemcitabine + protein-bound paclitaxel (Abraxane)",
                        "Control": "gemcitabine",
                        "Phase": "3",
                        "Median Survival Therapy": "8.5 months",
                        "Median Survival Control": "6.7 months",
                        "One-Year Survival Therapy": "35%",
                        "One-Year Survival Control": "22%",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "2013"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[8.5, 6.7, 35, 22]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "cell encapsulation + ifosfamide",
                        "Control": "5-fluorouracil",
                        "Phase": "2",
                        "Side Effects": "more favorable than 5-fluorouracil or gemcitabine",
                        "FDA Approval": "n/a",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['One-Year Survival Therapy', 'One-Year Survival Control']",
                    "outcomes": "['36%', '18%']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "FOLFIRINOX",
                        "Control": "gemcitabine",
                        "Phase": "2/3",
                        "Median Survival Therapy": "11.1 months",
                        "Median Survival Control": "6.8 months",
                        "One-Year Survival Therapy": "48.4%",
                        "One-Year Survival Control": "20.6%",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "n/a",
                        "Citation": "Oxaliplatin, irinotecan, fluorouracil and leucovorin"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[11.1, 6.8, 48.4, 20.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "gemcitabine",
                        "Control": "5-fluorouracil",
                        "Phase": "3",
                        "Side Effects": "more favorable than 5-fluorouracil",
                        "FDA Approval": "1996",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['Median Survival Therapy', 'Median Survival Control]",
                    "outcomes": "['5.7', '4.2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "FOLFIRINOX",
                        "Control": "gemcitabine",
                        "Phase": "2/3",
                        "Median Survival Therapy": "11.1 months",
                        "Median Survival Control": "6.8 months",
                        "One-Year Survival Therapy": "48.4%",
                        "One-Year Survival Control": "20.6%",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "n/a",
                        "Citation": "Oxaliplatin, irinotecan, fluorouracil and leucovorin"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[11.1, 6.8, 48.4, 20.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "gemcitabine",
                        "Control": "5-fluorouracil",
                        "Phase": "3",
                        "Side Effects": "more favorable than 5-fluorouracil",
                        "FDA Approval": "1996",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['One-Year Survival Therapy', 'One-Year Survival Control']",
                    "outcomes": "['18%', '2%']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "FOLFIRINOX",
                        "Control": "gemcitabine",
                        "Phase": "2/3",
                        "Median Survival Therapy": "11.1 months",
                        "Median Survival Control": "6.8 months",
                        "One-Year Survival Therapy": "48.4%",
                        "One-Year Survival Control": "20.6%",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "n/a",
                        "Citation": "Oxaliplatin, irinotecan, fluorouracil and leucovorin"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[11.1, 6.8, 48.4, 20.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "gemcitabine + erlotinib hydrochloride (Tarceva)",
                        "Control": "gemcitabine",
                        "Phase": "3",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "2005",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['Median Survival Therapy', 'Median Survival Control']",
                    "outcomes": "['6.4', '6']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "FOLFIRINOX",
                        "Control": "gemcitabine",
                        "Phase": "2/3",
                        "Median Survival Therapy": "11.1 months",
                        "Median Survival Control": "6.8 months",
                        "One-Year Survival Therapy": "48.4%",
                        "One-Year Survival Control": "20.6%",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "n/a",
                        "Citation": "Oxaliplatin, irinotecan, fluorouracil and leucovorin"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[11.1, 6.8, 48.4, 20.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "gemcitabine + erlotinib hydrochloride (Tarceva)",
                        "Control": "gemcitabine",
                        "Phase": "3",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "2005",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['One-Year Survival Therapy', 'One-Year Survival Control']",
                    "outcomes": "['24%', '19%']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "FOLFIRINOX",
                        "Control": "gemcitabine",
                        "Phase": "2/3",
                        "Median Survival Therapy": "11.1 months",
                        "Median Survival Control": "6.8 months",
                        "One-Year Survival Therapy": "48.4%",
                        "One-Year Survival Control": "20.6%",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "n/a",
                        "Citation": "Oxaliplatin, irinotecan, fluorouracil and leucovorin"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[11.1, 6.8, 48.4, 20.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "gemcitabine + protein-bound paclitaxel (Abraxane)",
                        "Control": "gemcitabine",
                        "Phase": "3",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "2013",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['Median Survival Therapy', 'Median Survival Control']",
                    "outcomes": "['8.5', '6.7']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "FOLFIRINOX",
                        "Control": "gemcitabine",
                        "Phase": "2/3",
                        "Median Survival Therapy": "11.1 months",
                        "Median Survival Control": "6.8 months",
                        "One-Year Survival Therapy": "48.4%",
                        "One-Year Survival Control": "20.6%",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "n/a",
                        "Citation": "Oxaliplatin, irinotecan, fluorouracil and leucovorin"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[11.1, 6.8, 48.4, 20.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "gemcitabine + protein-bound paclitaxel (Abraxane)",
                        "Control": "gemcitabine",
                        "Phase": "3",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "2013",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['One-Year Survival Therapy', 'One-Year Survival Control']",
                    "outcomes": "['35%', '22%']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "FOLFIRINOX",
                        "Control": "gemcitabine",
                        "Phase": "2/3",
                        "Median Survival Therapy": "11.1 months",
                        "Median Survival Control": "6.8 months",
                        "One-Year Survival Therapy": "48.4%",
                        "One-Year Survival Control": "20.6%",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "n/a",
                        "Citation": "Oxaliplatin, irinotecan, fluorouracil and leucovorin"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[11.1, 6.8, 48.4, 20.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "FOLFIRINOX",
                        "Control": "gemcitabine",
                        "Phase": "2/3",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "n/a",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['Median Survival Therapy', 'Median Survival Control']",
                    "outcomes": "['11.1', '6.8']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "FOLFIRINOX",
                        "Control": "gemcitabine",
                        "Phase": "2/3",
                        "Median Survival Therapy": "11.1 months",
                        "Median Survival Control": "6.8 months",
                        "One-Year Survival Therapy": "48.4%",
                        "One-Year Survival Control": "20.6%",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "n/a",
                        "Citation": "Oxaliplatin, irinotecan, fluorouracil and leucovorin"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[11.1, 6.8, 48.4, 20.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "FOLFIRINOX",
                        "Control": "gemcitabine",
                        "Phase": "2/3",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "n/a",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['One-Year Survival Therapy', 'One-Year Survival Control']",
                    "outcomes": "['48.4%', '20.6%']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "FOLFIRINOX",
                        "Control": "gemcitabine",
                        "Phase": "2/3",
                        "Median Survival Therapy": "11.1 months",
                        "Median Survival Control": "6.8 months",
                        "One-Year Survival Therapy": "48.4%",
                        "One-Year Survival Control": "20.6%",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "n/a",
                        "Citation": "Oxaliplatin, irinotecan, fluorouracil and leucovorin"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[11.1, 6.8, 48.4, 20.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "cell encapsulation + ifosfamide",
                        "Control": "5-fluorouracil",
                        "Phase": "2",
                        "Side Effects": "more favorable than 5-fluorouracil or gemcitabine",
                        "FDA Approval": "n/a",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['Median Survival Therapy', 'Median Survival Control']",
                    "outcomes": "['10', '5']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "FOLFIRINOX",
                        "Control": "gemcitabine",
                        "Phase": "2/3",
                        "Median Survival Therapy": "11.1 months",
                        "Median Survival Control": "6.8 months",
                        "One-Year Survival Therapy": "48.4%",
                        "One-Year Survival Control": "20.6%",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "n/a",
                        "Citation": "Oxaliplatin, irinotecan, fluorouracil and leucovorin"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[11.1, 6.8, 48.4, 20.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "cell encapsulation + ifosfamide",
                        "Control": "5-fluorouracil",
                        "Phase": "2",
                        "Side Effects": "more favorable than 5-fluorouracil or gemcitabine",
                        "FDA Approval": "n/a",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['One-Year Survival Therapy', 'One-Year Survival Control']",
                    "outcomes": "['36%', '18%']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "cell encapsulation + ifosfamide",
                        "Control": "5-fluorouracil",
                        "Phase": "2",
                        "Median Survival Therapy": "10 months",
                        "Median Survival Control": "5 months",
                        "One-Year Survival Therapy": "36%",
                        "One-Year Survival Control": "18%",
                        "Side Effects": "more favorable than 5-fluorouracil or gemcitabine",
                        "FDA Approval": "n/a",
                        "Citation": "five patients experienced Grade 3 or Grade 4 NCI toxicities with a higher dose of 2 g/m2 and a median survival of 9.5 months"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[10, 5, 36, 18]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "gemcitabine",
                        "Control": "5-fluorouracil",
                        "Phase": "3",
                        "Side Effects": "more favorable than 5-fluorouracil",
                        "FDA Approval": "1996",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['Median Survival Therapy', 'Median Survival Control]",
                    "outcomes": "['5.7', '4.2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "cell encapsulation + ifosfamide",
                        "Control": "5-fluorouracil",
                        "Phase": "2",
                        "Median Survival Therapy": "10 months",
                        "Median Survival Control": "5 months",
                        "One-Year Survival Therapy": "36%",
                        "One-Year Survival Control": "18%",
                        "Side Effects": "more favorable than 5-fluorouracil or gemcitabine",
                        "FDA Approval": "n/a",
                        "Citation": "five patients experienced Grade 3 or Grade 4 NCI toxicities with a higher dose of 2 g/m2 and a median survival of 9.5 months"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[10, 5, 36, 18]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "gemcitabine",
                        "Control": "5-fluorouracil",
                        "Phase": "3",
                        "Side Effects": "more favorable than 5-fluorouracil",
                        "FDA Approval": "1996",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['One-Year Survival Therapy', 'One-Year Survival Control']",
                    "outcomes": "['18%', '2%']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "cell encapsulation + ifosfamide",
                        "Control": "5-fluorouracil",
                        "Phase": "2",
                        "Median Survival Therapy": "10 months",
                        "Median Survival Control": "5 months",
                        "One-Year Survival Therapy": "36%",
                        "One-Year Survival Control": "18%",
                        "Side Effects": "more favorable than 5-fluorouracil or gemcitabine",
                        "FDA Approval": "n/a",
                        "Citation": "five patients experienced Grade 3 or Grade 4 NCI toxicities with a higher dose of 2 g/m2 and a median survival of 9.5 months"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[10, 5, 36, 18]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "gemcitabine + erlotinib hydrochloride (Tarceva)",
                        "Control": "gemcitabine",
                        "Phase": "3",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "2005",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['Median Survival Therapy', 'Median Survival Control']",
                    "outcomes": "['6.4', '6']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "cell encapsulation + ifosfamide",
                        "Control": "5-fluorouracil",
                        "Phase": "2",
                        "Median Survival Therapy": "10 months",
                        "Median Survival Control": "5 months",
                        "One-Year Survival Therapy": "36%",
                        "One-Year Survival Control": "18%",
                        "Side Effects": "more favorable than 5-fluorouracil or gemcitabine",
                        "FDA Approval": "n/a",
                        "Citation": "five patients experienced Grade 3 or Grade 4 NCI toxicities with a higher dose of 2 g/m2 and a median survival of 9.5 months"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[10, 5, 36, 18]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "gemcitabine + erlotinib hydrochloride (Tarceva)",
                        "Control": "gemcitabine",
                        "Phase": "3",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "2005",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['One-Year Survival Therapy', 'One-Year Survival Control']",
                    "outcomes": "['24%', '19%']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "cell encapsulation + ifosfamide",
                        "Control": "5-fluorouracil",
                        "Phase": "2",
                        "Median Survival Therapy": "10 months",
                        "Median Survival Control": "5 months",
                        "One-Year Survival Therapy": "36%",
                        "One-Year Survival Control": "18%",
                        "Side Effects": "more favorable than 5-fluorouracil or gemcitabine",
                        "FDA Approval": "n/a",
                        "Citation": "five patients experienced Grade 3 or Grade 4 NCI toxicities with a higher dose of 2 g/m2 and a median survival of 9.5 months"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[10, 5, 36, 18]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "gemcitabine + protein-bound paclitaxel (Abraxane)",
                        "Control": "gemcitabine",
                        "Phase": "3",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "2013",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['Median Survival Therapy', 'Median Survival Control']",
                    "outcomes": "['8.5', '6.7']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "cell encapsulation + ifosfamide",
                        "Control": "5-fluorouracil",
                        "Phase": "2",
                        "Median Survival Therapy": "10 months",
                        "Median Survival Control": "5 months",
                        "One-Year Survival Therapy": "36%",
                        "One-Year Survival Control": "18%",
                        "Side Effects": "more favorable than 5-fluorouracil or gemcitabine",
                        "FDA Approval": "n/a",
                        "Citation": "five patients experienced Grade 3 or Grade 4 NCI toxicities with a higher dose of 2 g/m2 and a median survival of 9.5 months"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[10, 5, 36, 18]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "gemcitabine + protein-bound paclitaxel (Abraxane)",
                        "Control": "gemcitabine",
                        "Phase": "3",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "2013",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['One-Year Survival Therapy', 'One-Year Survival Control']",
                    "outcomes": "['35%', '22%']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "cell encapsulation + ifosfamide",
                        "Control": "5-fluorouracil",
                        "Phase": "2",
                        "Median Survival Therapy": "10 months",
                        "Median Survival Control": "5 months",
                        "One-Year Survival Therapy": "36%",
                        "One-Year Survival Control": "18%",
                        "Side Effects": "more favorable than 5-fluorouracil or gemcitabine",
                        "FDA Approval": "n/a",
                        "Citation": "five patients experienced Grade 3 or Grade 4 NCI toxicities with a higher dose of 2 g/m2 and a median survival of 9.5 months"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[10, 5, 36, 18]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "FOLFIRINOX",
                        "Control": "gemcitabine",
                        "Phase": "2/3",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "n/a",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['Median Survival Therapy', 'Median Survival Control']",
                    "outcomes": "['11.1', '6.8']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "cell encapsulation + ifosfamide",
                        "Control": "5-fluorouracil",
                        "Phase": "2",
                        "Median Survival Therapy": "10 months",
                        "Median Survival Control": "5 months",
                        "One-Year Survival Therapy": "36%",
                        "One-Year Survival Control": "18%",
                        "Side Effects": "more favorable than 5-fluorouracil or gemcitabine",
                        "FDA Approval": "n/a",
                        "Citation": "five patients experienced Grade 3 or Grade 4 NCI toxicities with a higher dose of 2 g/m2 and a median survival of 9.5 months"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[10, 5, 36, 18]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "FOLFIRINOX",
                        "Control": "gemcitabine",
                        "Phase": "2/3",
                        "Side Effects": "less favorable than gemcitabine",
                        "FDA Approval": "n/a",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['One-Year Survival Therapy', 'One-Year Survival Control']",
                    "outcomes": "['48.4%', '20.6%']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "cell encapsulation + ifosfamide",
                        "Control": "5-fluorouracil",
                        "Phase": "2",
                        "Median Survival Therapy": "10 months",
                        "Median Survival Control": "5 months",
                        "One-Year Survival Therapy": "36%",
                        "One-Year Survival Control": "18%",
                        "Side Effects": "more favorable than 5-fluorouracil or gemcitabine",
                        "FDA Approval": "n/a",
                        "Citation": "five patients experienced Grade 3 or Grade 4 NCI toxicities with a higher dose of 2 g/m2 and a median survival of 9.5 months"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[10, 5, 36, 18]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "cell encapsulation + ifosfamide",
                        "Control": "5-fluorouracil",
                        "Phase": "2",
                        "Side Effects": "more favorable than 5-fluorouracil or gemcitabine",
                        "FDA Approval": "n/a",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['Median Survival Therapy', 'Median Survival Control']",
                    "outcomes": "['10', '5']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Treatment": "cell encapsulation + ifosfamide",
                        "Control": "5-fluorouracil",
                        "Phase": "2",
                        "Median Survival Therapy": "10 months",
                        "Median Survival Control": "5 months",
                        "One-Year Survival Therapy": "36%",
                        "One-Year Survival Control": "18%",
                        "Side Effects": "more favorable than 5-fluorouracil or gemcitabine",
                        "FDA Approval": "n/a",
                        "Citation": "five patients experienced Grade 3 or Grade 4 NCI toxicities with a higher dose of 2 g/m2 and a median survival of 9.5 months"
                    },
                    "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
                    "outcomes": "[10, 5, 36, 18]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Treatment": "cell encapsulation + ifosfamide",
                        "Control": "5-fluorouracil",
                        "Phase": "2",
                        "Side Effects": "more favorable than 5-fluorouracil or gemcitabine",
                        "FDA Approval": "n/a",
                        "Cancer Type": "pancreatic cancer"
                    },
                    "measures": "['One-Year Survival Therapy', 'One-Year Survival Control']",
                    "outcomes": "['36%', '18%']"
                },
                "match": "no"
            }
        ],
        "total_extracted_claims": 5,
        "total_ground_truth_claims": 10,
        "number_of_matches": 0
    },
    "PMC5675623_3": {
        "matches": [
            {
                "Extracted_claim": {
                    "subject": {
                        "Analysis type": "Multivariate Cox proportional hazards regression",
                        "Outcome assessed": "Overall survival (OS)",
                        "Treatment phase": "First phase I treatment",
                        "Variable": "ECOG performance status",
                        "Contrast": "> 0 vs. 0"
                    },
                    "measures": "[Hazard ratio (95% CI), P value]",
                    "outcomes": "[1.47 (0.90, 2.41), 0.12]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Variable": "ECOG performance status",
                        "Contrast": "> 0 vs. 0",
                        "Analysis Type": "multivariate Cox proportional hazards regression",
                        "Outcome Measure": "overall survival",
                        "Treatment Phase": "first phase I"
                    },
                    "measures": "[Hazard ratio, 95% CI, p-value]",
                    "outcomes": "[1.47, 0.90-2.41, 0.12]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Analysis type": "Multivariate Cox proportional hazards regression",
                        "Outcome assessed": "Overall survival (OS)",
                        "Treatment phase": "First phase I treatment",
                        "Variable": "Liver metastases",
                        "Contrast": "Yes vs. No"
                    },
                    "measures": "[Hazard ratio (95% CI), P value]",
                    "outcomes": "[1.72 (1.01, 2.91), 0.045]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Variable": "Liver metastases",
                        "Contrast": "Yes vs. No",
                        "Analysis Type": "multivariate Cox proportional hazards regression",
                        "Outcome Measure": "overall survival",
                        "Treatment Phase": "first phase I"
                    },
                    "measures": "[Hazard ratio, 95% CI, p-value]",
                    "outcomes": "[1.72, 1.01-2.91, 0.045]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Analysis type": "Multivariate Cox proportional hazards regression",
                        "Outcome assessed": "Overall survival (OS)",
                        "Treatment phase": "First phase I treatment",
                        "Variable": "No. of metastatic sites",
                        "Contrast": ">2 vs. <= 2"
                    },
                    "measures": "[Hazard ratio (95% CI), P value]",
                    "outcomes": "[1.33 (0.9, 2.25), 0.28]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Variable": "No. of metastatic sites",
                        "Contrast": ">2 vs. <= 2",
                        "Analysis Type": "multivariate Cox proportional hazards regression",
                        "Outcome Measure": "overall survival",
                        "Treatment Phase": "first phase I"
                    },
                    "measures": "[Hazard ratio, 95% CI, p-value]",
                    "outcomes": "[1.33, 0.9-2.25, 0-28]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Analysis type": "Multivariate Cox proportional hazards regression",
                        "Outcome assessed": "Overall survival (OS)",
                        "Treatment phase": "First phase I treatment",
                        "Variable": "Prior radiation therapy",
                        "Contrast": "Yes vs. No"
                    },
                    "measures": "[Hazard ratio (95% CI), P value]",
                    "outcomes": "[1.58 (0.95, 2.61), 0.077]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Variable": "Prior radiation therapy",
                        "Contrast": "Yes vs. No",
                        "Analysis Type": "multivariate Cox proportional hazards regression",
                        "Outcome Measure": "overall survival",
                        "Treatment Phase": "first phase I"
                    },
                    "measures": "[Hazard ratio, 95% CI, p-value]",
                    "outcomes": "[1.58, 0.95-2.61, 0.077]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Analysis type": "Multivariate Cox proportional hazards regression",
                        "Outcome assessed": "Overall survival (OS)",
                        "Treatment phase": "First phase I treatment",
                        "Variable": "Prior FOLFIRINOX",
                        "Contrast": "Yes vs. No"
                    },
                    "measures": "[Hazard ratio (95% CI), P value]",
                    "outcomes": "[1.73 (1.01, 2.98), 0.046]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Variable": "Prior FOLFIRINOX",
                        "Contrast": "Yes vs. No",
                        "Analysis Type": "multivariate Cox proportional hazards regression",
                        "Outcome Measure": "overall survival",
                        "Treatment Phase": "first phase I"
                    },
                    "measures": "[Hazard ratio, 95% CI, p-value]",
                    "outcomes": "[1.73, 1.01-2.98, 0.046]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Analysis type": "Multivariate Cox proportional hazards regression",
                        "Outcome assessed": "Overall survival (OS)",
                        "Treatment phase": "First phase I treatment",
                        "Variable": "Prior gemcitabine plus nab-paclitaxel treatment",
                        "Contrast": "Yes vs. No"
                    },
                    "measures": "[Hazard ratio (95% CI), P value]",
                    "outcomes": "[1.08 (0.58, 2.01), 0.80]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Variable": "Prior gemcitabine plus nab-paclitaxel treatment",
                        "Contrast": "Yes vs. No",
                        "Confidence Interval Lower": "0.58",
                        "Confidence Interval Upper": "2.01",
                        "Analysis Type": "multivariate Cox proportional hazards regression",
                        "Outcome Measure": "overall survival",
                        "Treatment Phase": "first phase I"
                    },
                    "measures": "[Hazard ratio, 95% CI, p-value]",
                    "outcomes": "[1.08, 0.58-2.01, 0.80]"
                },
                "match": "yes"
            }
        ],
        "total_extracted_claims": 6,
        "total_ground_truth_claims": 6,
        "number_of_matches": 6
    },
    "PMC4941379_3": {
        "matches": [
            {
                "Extracted_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "None",
                        "H. pylori infection": "IgG\u2212/CagA\u2212",
                        "Sample size": "4555",
                        "Cases": "5",
                        "Crude incidence rate": "10.42 per 100,000 person-years",
                        "HR1 (95% CI)": "Ref",
                        "HR2 (95% CI)": "Ref"
                    },
                    "measures": "[Crude incidence rate]",
                    "outcomes": "[10.42]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "None",
                        "H. pylori infection": "IgG\u2212/CagA\u2212",
                        "Sample size": "4555",
                        "Cases": "5",
                        "Unit": ", Per 100,000 person-years"
                    },
                    "measures": "['Crude incidence rate']",
                    "outcomes": "['10.42']"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "None",
                        "H. pylori infection": "IgG+/CagA\u2212",
                        "Sample size": "1984",
                        "Cases": "2",
                        "Crude incidence rate": "9.54 per 100,000 person-years",
                        "HR1 (95% CI)": "0.79 (0.15\u20134.08)",
                        "HR2 (95% CI)": "Ref"
                    },
                    "measures": "[Crude incidence rate, HR1]",
                    "outcomes": "[9.54, 0.79]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "None",
                        "H. pylori infection": "IgG\u2212/CagA\u2212",
                        "Sample size": "4555",
                        "Cases": "5",
                        "Unit": ", Per 100,000 person-years",
                        "HR1 description": "comparing participants with and without chronic atrophic gastritis",
                        "Adjustment factors": ", age, sex, education level, smoking status, alcohol consumption"
                    },
                    "measures": "[HR1, 95% CI]",
                    "outcomes": "[Ref, NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "None",
                        "H. pylori infection": "IgG+/CagA\u2212",
                        "Sample size": "1984",
                        "Cases": "2",
                        "Crude incidence rate": "9.54 per 100,000 person-years",
                        "HR1 (95% CI)": "0.79 (0.15\u20134.08)",
                        "HR2 (95% CI)": "Ref"
                    },
                    "measures": "[Crude incidence rate, HR1]",
                    "outcomes": "[9.54, 0.79]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "None",
                        "H. pylori infection": "IgG\u2212/CagA\u2212",
                        "Sample size": "4555",
                        "Cases": "5",
                        "Unit": ", Per 100,000 person-years",
                        "HR2 description": "comparing different groups with participants without chronic atrophic gastritis and without H. pylori infection",
                        "Adjustment factors": ", age, sex, education level, smoking status, alcohol consumption"
                    },
                    "measures": "[HR2, 95% CI]",
                    "outcomes": "[Ref, NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "None",
                        "H. pylori infection": "IgG+/CagA\u2212",
                        "Sample size": "1984",
                        "Cases": "2",
                        "Crude incidence rate": "9.54 per 100,000 person-years",
                        "HR1 (95% CI)": "0.79 (0.15\u20134.08)",
                        "HR2 (95% CI)": "Ref"
                    },
                    "measures": "[Crude incidence rate, HR1]",
                    "outcomes": "[9.54, 0.79]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "None",
                        "H. pylori infection": "IgG+/CagA-",
                        "Sample size": "1984",
                        "Cases": "2",
                        "Unit": ", Per 100,000 person-years"
                    },
                    "measures": "['Crude incidence rate']",
                    "outcomes": "['9.54']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "None",
                        "H. pylori infection": "IgG+/CagA\u2212",
                        "Sample size": "1984",
                        "Cases": "2",
                        "Crude incidence rate": "9.54 per 100,000 person-years",
                        "HR1 (95% CI)": "0.79 (0.15\u20134.08)",
                        "HR2 (95% CI)": "Ref"
                    },
                    "measures": "[Crude incidence rate, HR1]",
                    "outcomes": "[9.54, 0.79]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "None",
                        "H. pylori infection": "IgG+/CagA-",
                        "Sample size": "1984",
                        "Cases": "2",
                        "Unit": ", Per 100,000 person-years",
                        "HR1 description": "comparing participants with and without chronic atrophic gastritis",
                        "Adjustment factors": ", age, sex, education level, smoking status, alcohol consumption"
                    },
                    "measures": "[HR1, 95% CI]",
                    "outcomes": "[NA, NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "None",
                        "H. pylori infection": "IgG+/CagA\u2212",
                        "Sample size": "1984",
                        "Cases": "2",
                        "Crude incidence rate": "9.54 per 100,000 person-years",
                        "HR1 (95% CI)": "0.79 (0.15\u20134.08)",
                        "HR2 (95% CI)": "Ref"
                    },
                    "measures": "[Crude incidence rate, HR1]",
                    "outcomes": "[9.54, 0.79]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "None",
                        "H. pylori infection": "IgG+/CagA-",
                        "Sample size": "1984",
                        "Cases": "2",
                        "Unit": ", Per 100,000 person-years",
                        "HR2 description": "comparing different groups with participants without chronic atrophic gastritis and without H. pylori infection",
                        "Adjustment factors": ", age, sex, education level, smoking status, alcohol consumption"
                    },
                    "measures": "[HR2, 95% CI]",
                    "outcomes": "[0.79, (0.15-4.08)]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "None",
                        "H. pylori infection": "IgG+/CagA+",
                        "Sample size": "2295",
                        "Cases": "14",
                        "Crude incidence rate": "58.13 per 100,000 person-years",
                        "HR1 (95% CI)": "5.05 (1.81\u201314.09)",
                        "HR2 (95% CI)": "Ref"
                    },
                    "measures": "[Crude incidence rate, HR1]",
                    "outcomes": "[58.13, 5.05]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "None",
                        "H. pylori infection": "IgG\u2212/CagA\u2212",
                        "Sample size": "4555",
                        "Cases": "5",
                        "Unit": ", Per 100,000 person-years",
                        "HR1 description": "comparing participants with and without chronic atrophic gastritis",
                        "Adjustment factors": ", age, sex, education level, smoking status, alcohol consumption"
                    },
                    "measures": "[HR1, 95% CI]",
                    "outcomes": "[Ref, NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "None",
                        "H. pylori infection": "IgG+/CagA+",
                        "Sample size": "2295",
                        "Cases": "14",
                        "Crude incidence rate": "58.13 per 100,000 person-years",
                        "HR1 (95% CI)": "5.05 (1.81\u201314.09)",
                        "HR2 (95% CI)": "Ref"
                    },
                    "measures": "[Crude incidence rate, HR1]",
                    "outcomes": "[58.13, 5.05]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "None",
                        "H. pylori infection": "IgG\u2212/CagA\u2212",
                        "Sample size": "4555",
                        "Cases": "5",
                        "Unit": ", Per 100,000 person-years",
                        "HR2 description": "comparing different groups with participants without chronic atrophic gastritis and without H. pylori infection",
                        "Adjustment factors": ", age, sex, education level, smoking status, alcohol consumption"
                    },
                    "measures": "[HR2, 95% CI]",
                    "outcomes": "[Ref, NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "None",
                        "H. pylori infection": "IgG+/CagA+",
                        "Sample size": "2295",
                        "Cases": "14",
                        "Crude incidence rate": "58.13 per 100,000 person-years",
                        "HR1 (95% CI)": "5.05 (1.81\u201314.09)",
                        "HR2 (95% CI)": "Ref"
                    },
                    "measures": "[Crude incidence rate, HR1]",
                    "outcomes": "[58.13, 5.05]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "None",
                        "H. pylori infection": "IgG+/CagA-",
                        "Sample size": "1984",
                        "Cases": "2",
                        "Unit": ", Per 100,000 person-years"
                    },
                    "measures": "['Crude incidence rate']",
                    "outcomes": "['9.54']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "None",
                        "H. pylori infection": "IgG+/CagA+",
                        "Sample size": "2295",
                        "Cases": "14",
                        "Crude incidence rate": "58.13 per 100,000 person-years",
                        "HR1 (95% CI)": "5.05 (1.81\u201314.09)",
                        "HR2 (95% CI)": "Ref"
                    },
                    "measures": "[Crude incidence rate, HR1]",
                    "outcomes": "[58.13, 5.05]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "None",
                        "H. pylori infection": "IgG+/CagA-",
                        "Sample size": "1984",
                        "Cases": "2",
                        "Unit": ", Per 100,000 person-years",
                        "HR1 description": "comparing participants with and without chronic atrophic gastritis",
                        "Adjustment factors": ", age, sex, education level, smoking status, alcohol consumption"
                    },
                    "measures": "[HR1, 95% CI]",
                    "outcomes": "[NA, NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "None",
                        "H. pylori infection": "IgG+/CagA+",
                        "Sample size": "2295",
                        "Cases": "14",
                        "Crude incidence rate": "58.13 per 100,000 person-years",
                        "HR1 (95% CI)": "5.05 (1.81\u201314.09)",
                        "HR2 (95% CI)": "Ref"
                    },
                    "measures": "[Crude incidence rate, HR1]",
                    "outcomes": "[58.13, 5.05]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "None",
                        "H. pylori infection": "IgG+/CagA+",
                        "Sample size": "2295",
                        "Cases": "14",
                        "Unit": ", Per 100,000 person-years"
                    },
                    "measures": "['Crude incidence rate']",
                    "outcomes": "['58.13']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "None",
                        "H. pylori infection": "IgG+/CagA+",
                        "Sample size": "2295",
                        "Cases": "14",
                        "Crude incidence rate": "58.13 per 100,000 person-years",
                        "HR1 (95% CI)": "5.05 (1.81\u201314.09)",
                        "HR2 (95% CI)": "Ref"
                    },
                    "measures": "[Crude incidence rate, HR1]",
                    "outcomes": "[58.13, 5.05]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "None",
                        "H. pylori infection": "IgG+/CagA+",
                        "Sample size": "2295",
                        "Cases": "14",
                        "Unit": ", Per 100,000 person-years",
                        "HR1 description": "comparing participants with and without chronic atrophic gastritis",
                        "Adjustment factors": ", age, sex, education level, smoking status, alcohol consumption"
                    },
                    "measures": "[HR1, 95% CI]",
                    "outcomes": "[NA, NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "None",
                        "H. pylori infection": "IgG+/CagA+",
                        "Sample size": "2295",
                        "Cases": "14",
                        "Crude incidence rate": "58.13 per 100,000 person-years",
                        "HR1 (95% CI)": "5.05 (1.81\u201314.09)",
                        "HR2 (95% CI)": "Ref"
                    },
                    "measures": "[Crude incidence rate, HR1]",
                    "outcomes": "[58.13, 5.05]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "None",
                        "H. pylori infection": "IgG+/CagA+",
                        "Sample size": "2295",
                        "Cases": "14",
                        "Unit": ", Per 100,000 person-years",
                        "HR2 description": "comparing different groups with participants without chronic atrophic gastritis and without H. pylori infection",
                        "Adjustment factors": ", age, sex, education level, smoking status, alcohol consumption"
                    },
                    "measures": "[HR2, 95% CI]",
                    "outcomes": "[5.05, (1.81-14.09)]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG\u2212/CagA\u2212",
                        "Sample size": "205",
                        "Cases": "0",
                        "Crude incidence rate": "0 per 100,000 person-years",
                        "HR1 (95% CI)": "3.45 (1.38\u20138.64)",
                        "HR2 (95% CI)": "Not estimable"
                    },
                    "measures": "[Crude incidence rate, HR1]",
                    "outcomes": "[0, 3.45]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "None",
                        "H. pylori infection": "IgG\u2212/CagA\u2212",
                        "Sample size": "4555",
                        "Cases": "5",
                        "Unit": ", Per 100,000 person-years",
                        "HR1 description": "comparing participants with and without chronic atrophic gastritis",
                        "Adjustment factors": ", age, sex, education level, smoking status, alcohol consumption"
                    },
                    "measures": "[HR1, 95% CI]",
                    "outcomes": "[Ref, NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG\u2212/CagA\u2212",
                        "Sample size": "205",
                        "Cases": "0",
                        "Crude incidence rate": "0 per 100,000 person-years",
                        "HR1 (95% CI)": "3.45 (1.38\u20138.64)",
                        "HR2 (95% CI)": "Not estimable"
                    },
                    "measures": "[Crude incidence rate, HR1]",
                    "outcomes": "[0, 3.45]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "None",
                        "H. pylori infection": "IgG\u2212/CagA\u2212",
                        "Sample size": "4555",
                        "Cases": "5",
                        "Unit": ", Per 100,000 person-years",
                        "HR2 description": "comparing different groups with participants without chronic atrophic gastritis and without H. pylori infection",
                        "Adjustment factors": ", age, sex, education level, smoking status, alcohol consumption"
                    },
                    "measures": "[HR2, 95% CI]",
                    "outcomes": "[Ref, NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG\u2212/CagA\u2212",
                        "Sample size": "205",
                        "Cases": "0",
                        "Crude incidence rate": "0 per 100,000 person-years",
                        "HR1 (95% CI)": "3.45 (1.38\u20138.64)",
                        "HR2 (95% CI)": "Not estimable"
                    },
                    "measures": "[Crude incidence rate, HR1]",
                    "outcomes": "[0, 3.45]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "None",
                        "H. pylori infection": "IgG+/CagA-",
                        "Sample size": "1984",
                        "Cases": "2",
                        "Unit": ", Per 100,000 person-years"
                    },
                    "measures": "['Crude incidence rate']",
                    "outcomes": "['9.54']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG\u2212/CagA\u2212",
                        "Sample size": "205",
                        "Cases": "0",
                        "Crude incidence rate": "0 per 100,000 person-years",
                        "HR1 (95% CI)": "3.45 (1.38\u20138.64)",
                        "HR2 (95% CI)": "Not estimable"
                    },
                    "measures": "[Crude incidence rate, HR1]",
                    "outcomes": "[0, 3.45]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "None",
                        "H. pylori infection": "IgG+/CagA-",
                        "Sample size": "1984",
                        "Cases": "2",
                        "Unit": ", Per 100,000 person-years",
                        "HR1 description": "comparing participants with and without chronic atrophic gastritis",
                        "Adjustment factors": ", age, sex, education level, smoking status, alcohol consumption"
                    },
                    "measures": "[HR1, 95% CI]",
                    "outcomes": "[NA, NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG\u2212/CagA\u2212",
                        "Sample size": "205",
                        "Cases": "0",
                        "Crude incidence rate": "0 per 100,000 person-years",
                        "HR1 (95% CI)": "3.45 (1.38\u20138.64)",
                        "HR2 (95% CI)": "Not estimable"
                    },
                    "measures": "[Crude incidence rate, HR1]",
                    "outcomes": "[0, 3.45]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "None",
                        "H. pylori infection": "IgG+/CagA+",
                        "Sample size": "2295",
                        "Cases": "14",
                        "Unit": ", Per 100,000 person-years"
                    },
                    "measures": "['Crude incidence rate']",
                    "outcomes": "['58.13']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG\u2212/CagA\u2212",
                        "Sample size": "205",
                        "Cases": "0",
                        "Crude incidence rate": "0 per 100,000 person-years",
                        "HR1 (95% CI)": "3.45 (1.38\u20138.64)",
                        "HR2 (95% CI)": "Not estimable"
                    },
                    "measures": "[Crude incidence rate, HR1]",
                    "outcomes": "[0, 3.45]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "None",
                        "H. pylori infection": "IgG+/CagA+",
                        "Sample size": "2295",
                        "Cases": "14",
                        "Unit": ", Per 100,000 person-years",
                        "HR1 description": "comparing participants with and without chronic atrophic gastritis",
                        "Adjustment factors": ", age, sex, education level, smoking status, alcohol consumption"
                    },
                    "measures": "[HR1, 95% CI]",
                    "outcomes": "[NA, NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG\u2212/CagA\u2212",
                        "Sample size": "205",
                        "Cases": "0",
                        "Crude incidence rate": "0 per 100,000 person-years",
                        "HR1 (95% CI)": "3.45 (1.38\u20138.64)",
                        "HR2 (95% CI)": "Not estimable"
                    },
                    "measures": "[Crude incidence rate, HR1]",
                    "outcomes": "[0, 3.45]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG-/CagA-",
                        "Sample size": "205",
                        "Cases": "0",
                        "Unit": ", Per 100,000 person-years"
                    },
                    "measures": "['Crude incidence rate']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG\u2212/CagA\u2212",
                        "Sample size": "205",
                        "Cases": "0",
                        "Crude incidence rate": "0 per 100,000 person-years",
                        "HR1 (95% CI)": "3.45 (1.38\u20138.64)",
                        "HR2 (95% CI)": "Not estimable"
                    },
                    "measures": "[Crude incidence rate, HR1]",
                    "outcomes": "[0, 3.45]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG-/CagA-",
                        "Sample size": "205",
                        "Cases": "0",
                        "Unit": ", Per 100,000 person-years",
                        "HR1 description": "comparing participants with and without chronic atrophic gastritis",
                        "Adjustment factors": ", age, sex, education level, smoking status, alcohol consumption"
                    },
                    "measures": "[HR1, 95% CI]",
                    "outcomes": "[3.45, (1.38-8.64)]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG+/CagA\u2212",
                        "Sample size": "143",
                        "Cases": "1",
                        "Crude incidence rate": "64.61 per 100,000 person-years",
                        "HR1 (95% CI)": "5.50 (0.63\u201347.57)",
                        "HR2 (95% CI)": "Not estimable"
                    },
                    "measures": "[Crude incidence rate, HR1]",
                    "outcomes": "[64.61, 5.50]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "None",
                        "H. pylori infection": "IgG\u2212/CagA\u2212",
                        "Sample size": "4555",
                        "Cases": "5",
                        "Unit": ", Per 100,000 person-years",
                        "HR1 description": "comparing participants with and without chronic atrophic gastritis",
                        "Adjustment factors": ", age, sex, education level, smoking status, alcohol consumption"
                    },
                    "measures": "[HR1, 95% CI]",
                    "outcomes": "[Ref, NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG+/CagA\u2212",
                        "Sample size": "143",
                        "Cases": "1",
                        "Crude incidence rate": "64.61 per 100,000 person-years",
                        "HR1 (95% CI)": "5.50 (0.63\u201347.57)",
                        "HR2 (95% CI)": "Not estimable"
                    },
                    "measures": "[Crude incidence rate, HR1]",
                    "outcomes": "[64.61, 5.50]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "None",
                        "H. pylori infection": "IgG\u2212/CagA\u2212",
                        "Sample size": "4555",
                        "Cases": "5",
                        "Unit": ", Per 100,000 person-years",
                        "HR2 description": "comparing different groups with participants without chronic atrophic gastritis and without H. pylori infection",
                        "Adjustment factors": ", age, sex, education level, smoking status, alcohol consumption"
                    },
                    "measures": "[HR2, 95% CI]",
                    "outcomes": "[Ref, NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG+/CagA\u2212",
                        "Sample size": "143",
                        "Cases": "1",
                        "Crude incidence rate": "64.61 per 100,000 person-years",
                        "HR1 (95% CI)": "5.50 (0.63\u201347.57)",
                        "HR2 (95% CI)": "Not estimable"
                    },
                    "measures": "[Crude incidence rate, HR1]",
                    "outcomes": "[64.61, 5.50]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "None",
                        "H. pylori infection": "IgG+/CagA-",
                        "Sample size": "1984",
                        "Cases": "2",
                        "Unit": ", Per 100,000 person-years"
                    },
                    "measures": "['Crude incidence rate']",
                    "outcomes": "['9.54']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG+/CagA\u2212",
                        "Sample size": "143",
                        "Cases": "1",
                        "Crude incidence rate": "64.61 per 100,000 person-years",
                        "HR1 (95% CI)": "5.50 (0.63\u201347.57)",
                        "HR2 (95% CI)": "Not estimable"
                    },
                    "measures": "[Crude incidence rate, HR1]",
                    "outcomes": "[64.61, 5.50]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "None",
                        "H. pylori infection": "IgG+/CagA-",
                        "Sample size": "1984",
                        "Cases": "2",
                        "Unit": ", Per 100,000 person-years",
                        "HR1 description": "comparing participants with and without chronic atrophic gastritis",
                        "Adjustment factors": ", age, sex, education level, smoking status, alcohol consumption"
                    },
                    "measures": "[HR1, 95% CI]",
                    "outcomes": "[NA, NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG+/CagA\u2212",
                        "Sample size": "143",
                        "Cases": "1",
                        "Crude incidence rate": "64.61 per 100,000 person-years",
                        "HR1 (95% CI)": "5.50 (0.63\u201347.57)",
                        "HR2 (95% CI)": "Not estimable"
                    },
                    "measures": "[Crude incidence rate, HR1]",
                    "outcomes": "[64.61, 5.50]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "None",
                        "H. pylori infection": "IgG+/CagA+",
                        "Sample size": "2295",
                        "Cases": "14",
                        "Unit": ", Per 100,000 person-years"
                    },
                    "measures": "['Crude incidence rate']",
                    "outcomes": "['58.13']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG+/CagA\u2212",
                        "Sample size": "143",
                        "Cases": "1",
                        "Crude incidence rate": "64.61 per 100,000 person-years",
                        "HR1 (95% CI)": "5.50 (0.63\u201347.57)",
                        "HR2 (95% CI)": "Not estimable"
                    },
                    "measures": "[Crude incidence rate, HR1]",
                    "outcomes": "[64.61, 5.50]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "None",
                        "H. pylori infection": "IgG+/CagA+",
                        "Sample size": "2295",
                        "Cases": "14",
                        "Unit": ", Per 100,000 person-years",
                        "HR1 description": "comparing participants with and without chronic atrophic gastritis",
                        "Adjustment factors": ", age, sex, education level, smoking status, alcohol consumption"
                    },
                    "measures": "[HR1, 95% CI]",
                    "outcomes": "[NA, NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG+/CagA\u2212",
                        "Sample size": "143",
                        "Cases": "1",
                        "Crude incidence rate": "64.61 per 100,000 person-years",
                        "HR1 (95% CI)": "5.50 (0.63\u201347.57)",
                        "HR2 (95% CI)": "Not estimable"
                    },
                    "measures": "[Crude incidence rate, HR1]",
                    "outcomes": "[64.61, 5.50]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG-/CagA-",
                        "Sample size": "205",
                        "Cases": "0",
                        "Unit": ", Per 100,000 person-years"
                    },
                    "measures": "['Crude incidence rate']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG+/CagA\u2212",
                        "Sample size": "143",
                        "Cases": "1",
                        "Crude incidence rate": "64.61 per 100,000 person-years",
                        "HR1 (95% CI)": "5.50 (0.63\u201347.57)",
                        "HR2 (95% CI)": "Not estimable"
                    },
                    "measures": "[Crude incidence rate, HR1]",
                    "outcomes": "[64.61, 5.50]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG-/CagA-",
                        "Sample size": "205",
                        "Cases": "0",
                        "Unit": ", Per 100,000 person-years",
                        "HR2 description": "comparing different groups with participants without chronic atrophic gastritis and without H. pylori infection",
                        "Adjustment factors": ", age, sex, education level, smoking status, alcohol consumption"
                    },
                    "measures": "[HR2, 95% CI]",
                    "outcomes": "[NA, Not estimable]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG+/CagA\u2212",
                        "Sample size": "143",
                        "Cases": "1",
                        "Crude incidence rate": "64.61 per 100,000 person-years",
                        "HR1 (95% CI)": "5.50 (0.63\u201347.57)",
                        "HR2 (95% CI)": "Not estimable"
                    },
                    "measures": "[Crude incidence rate, HR1]",
                    "outcomes": "[64.61, 5.50]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG+/CagA-",
                        "Sample size": "143",
                        "Cases": "1",
                        "Unit": ", Per 100,000 person-years"
                    },
                    "measures": "['Crude incidence rate']",
                    "outcomes": "['64.61']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG+/CagA\u2212",
                        "Sample size": "143",
                        "Cases": "1",
                        "Crude incidence rate": "64.61 per 100,000 person-years",
                        "HR1 (95% CI)": "5.50 (0.63\u201347.57)",
                        "HR2 (95% CI)": "Not estimable"
                    },
                    "measures": "[Crude incidence rate, HR1]",
                    "outcomes": "[64.61, 5.50]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG+/CagA-",
                        "Sample size": "143",
                        "Cases": "1",
                        "Unit": ", Per 100,000 person-years",
                        "HR1 description": "comparing participants with and without chronic atrophic gastritis",
                        "Adjustment factors": ", age, sex, education level, smoking status, alcohol consumption"
                    },
                    "measures": "[HR1, 95% CI]",
                    "outcomes": "[NA, NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG+/CagA\u2212",
                        "Sample size": "143",
                        "Cases": "1",
                        "Crude incidence rate": "64.61 per 100,000 person-years",
                        "HR1 (95% CI)": "5.50 (0.63\u201347.57)",
                        "HR2 (95% CI)": "Not estimable"
                    },
                    "measures": "[Crude incidence rate, HR1]",
                    "outcomes": "[64.61, 5.50]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG+/CagA-",
                        "Sample size": "143",
                        "Cases": "1",
                        "Unit": ", Per 100,000 person-years",
                        "HR2 description": "comparing different groups with participants without chronic atrophic gastritis and without H. pylori infection",
                        "Adjustment factors": ", age, sex, education level, smoking status, alcohol consumption"
                    },
                    "measures": "[HR2, 95% CI]",
                    "outcomes": "[5.50, (0.63-47.57)]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG+/CagA+",
                        "Sample size": "315",
                        "Cases": "5",
                        "Crude incidence rate": "151.20 per 100,000 person-years",
                        "HR1 (95% CI)": "12.51 (3.57\u201343.22)",
                        "HR2 (95% CI)": "Not estimable"
                    },
                    "measures": "[Crude incidence rate, HR1]",
                    "outcomes": "[151.20, 12.51]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "None",
                        "H. pylori infection": "IgG\u2212/CagA\u2212",
                        "Sample size": "4555",
                        "Cases": "5",
                        "Unit": ", Per 100,000 person-years",
                        "HR1 description": "comparing participants with and without chronic atrophic gastritis",
                        "Adjustment factors": ", age, sex, education level, smoking status, alcohol consumption"
                    },
                    "measures": "[HR1, 95% CI]",
                    "outcomes": "[Ref, NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG+/CagA+",
                        "Sample size": "315",
                        "Cases": "5",
                        "Crude incidence rate": "151.20 per 100,000 person-years",
                        "HR1 (95% CI)": "12.51 (3.57\u201343.22)",
                        "HR2 (95% CI)": "Not estimable"
                    },
                    "measures": "[Crude incidence rate, HR1]",
                    "outcomes": "[151.20, 12.51]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "None",
                        "H. pylori infection": "IgG\u2212/CagA\u2212",
                        "Sample size": "4555",
                        "Cases": "5",
                        "Unit": ", Per 100,000 person-years",
                        "HR2 description": "comparing different groups with participants without chronic atrophic gastritis and without H. pylori infection",
                        "Adjustment factors": ", age, sex, education level, smoking status, alcohol consumption"
                    },
                    "measures": "[HR2, 95% CI]",
                    "outcomes": "[Ref, NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG+/CagA+",
                        "Sample size": "315",
                        "Cases": "5",
                        "Crude incidence rate": "151.20 per 100,000 person-years",
                        "HR1 (95% CI)": "12.51 (3.57\u201343.22)",
                        "HR2 (95% CI)": "Not estimable"
                    },
                    "measures": "[Crude incidence rate, HR1]",
                    "outcomes": "[151.20, 12.51]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "None",
                        "H. pylori infection": "IgG+/CagA-",
                        "Sample size": "1984",
                        "Cases": "2",
                        "Unit": ", Per 100,000 person-years"
                    },
                    "measures": "['Crude incidence rate']",
                    "outcomes": "['9.54']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG+/CagA+",
                        "Sample size": "315",
                        "Cases": "5",
                        "Crude incidence rate": "151.20 per 100,000 person-years",
                        "HR1 (95% CI)": "12.51 (3.57\u201343.22)",
                        "HR2 (95% CI)": "Not estimable"
                    },
                    "measures": "[Crude incidence rate, HR1]",
                    "outcomes": "[151.20, 12.51]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "None",
                        "H. pylori infection": "IgG+/CagA-",
                        "Sample size": "1984",
                        "Cases": "2",
                        "Unit": ", Per 100,000 person-years",
                        "HR1 description": "comparing participants with and without chronic atrophic gastritis",
                        "Adjustment factors": ", age, sex, education level, smoking status, alcohol consumption"
                    },
                    "measures": "[HR1, 95% CI]",
                    "outcomes": "[NA, NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG+/CagA+",
                        "Sample size": "315",
                        "Cases": "5",
                        "Crude incidence rate": "151.20 per 100,000 person-years",
                        "HR1 (95% CI)": "12.51 (3.57\u201343.22)",
                        "HR2 (95% CI)": "Not estimable"
                    },
                    "measures": "[Crude incidence rate, HR1]",
                    "outcomes": "[151.20, 12.51]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "None",
                        "H. pylori infection": "IgG+/CagA+",
                        "Sample size": "2295",
                        "Cases": "14",
                        "Unit": ", Per 100,000 person-years"
                    },
                    "measures": "['Crude incidence rate']",
                    "outcomes": "['58.13']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG+/CagA+",
                        "Sample size": "315",
                        "Cases": "5",
                        "Crude incidence rate": "151.20 per 100,000 person-years",
                        "HR1 (95% CI)": "12.51 (3.57\u201343.22)",
                        "HR2 (95% CI)": "Not estimable"
                    },
                    "measures": "[Crude incidence rate, HR1]",
                    "outcomes": "[151.20, 12.51]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "None",
                        "H. pylori infection": "IgG+/CagA+",
                        "Sample size": "2295",
                        "Cases": "14",
                        "Unit": ", Per 100,000 person-years",
                        "HR1 description": "comparing participants with and without chronic atrophic gastritis",
                        "Adjustment factors": ", age, sex, education level, smoking status, alcohol consumption"
                    },
                    "measures": "[HR1, 95% CI]",
                    "outcomes": "[NA, NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG+/CagA+",
                        "Sample size": "315",
                        "Cases": "5",
                        "Crude incidence rate": "151.20 per 100,000 person-years",
                        "HR1 (95% CI)": "12.51 (3.57\u201343.22)",
                        "HR2 (95% CI)": "Not estimable"
                    },
                    "measures": "[Crude incidence rate, HR1]",
                    "outcomes": "[151.20, 12.51]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG-/CagA-",
                        "Sample size": "205",
                        "Cases": "0",
                        "Unit": ", Per 100,000 person-years"
                    },
                    "measures": "['Crude incidence rate']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG+/CagA+",
                        "Sample size": "315",
                        "Cases": "5",
                        "Crude incidence rate": "151.20 per 100,000 person-years",
                        "HR1 (95% CI)": "12.51 (3.57\u201343.22)",
                        "HR2 (95% CI)": "Not estimable"
                    },
                    "measures": "[Crude incidence rate, HR1]",
                    "outcomes": "[151.20, 12.51]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG-/CagA-",
                        "Sample size": "205",
                        "Cases": "0",
                        "Unit": ", Per 100,000 person-years",
                        "HR2 description": "comparing different groups with participants without chronic atrophic gastritis and without H. pylori infection",
                        "Adjustment factors": ", age, sex, education level, smoking status, alcohol consumption"
                    },
                    "measures": "[HR2, 95% CI]",
                    "outcomes": "[NA, Not estimable]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG+/CagA+",
                        "Sample size": "315",
                        "Cases": "5",
                        "Crude incidence rate": "151.20 per 100,000 person-years",
                        "HR1 (95% CI)": "12.51 (3.57\u201343.22)",
                        "HR2 (95% CI)": "Not estimable"
                    },
                    "measures": "[Crude incidence rate, HR1]",
                    "outcomes": "[151.20, 12.51]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG+/CagA-",
                        "Sample size": "143",
                        "Cases": "1",
                        "Unit": ", Per 100,000 person-years"
                    },
                    "measures": "['Crude incidence rate']",
                    "outcomes": "['64.61']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG+/CagA+",
                        "Sample size": "315",
                        "Cases": "5",
                        "Crude incidence rate": "151.20 per 100,000 person-years",
                        "HR1 (95% CI)": "12.51 (3.57\u201343.22)",
                        "HR2 (95% CI)": "Not estimable"
                    },
                    "measures": "[Crude incidence rate, HR1]",
                    "outcomes": "[151.20, 12.51]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG+/CagA-",
                        "Sample size": "143",
                        "Cases": "1",
                        "Unit": ", Per 100,000 person-years",
                        "HR1 description": "comparing participants with and without chronic atrophic gastritis",
                        "Adjustment factors": ", age, sex, education level, smoking status, alcohol consumption"
                    },
                    "measures": "[HR1, 95% CI]",
                    "outcomes": "[NA, NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG+/CagA+",
                        "Sample size": "315",
                        "Cases": "5",
                        "Crude incidence rate": "151.20 per 100,000 person-years",
                        "HR1 (95% CI)": "12.51 (3.57\u201343.22)",
                        "HR2 (95% CI)": "Not estimable"
                    },
                    "measures": "[Crude incidence rate, HR1]",
                    "outcomes": "[151.20, 12.51]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG+/CagA+",
                        "Sample size": "315",
                        "Cases": "5",
                        "Unit": ", Per 100,000 person-years"
                    },
                    "measures": "['Crude incidence rate']",
                    "outcomes": "['151.20']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG+/CagA+",
                        "Sample size": "315",
                        "Cases": "5",
                        "Crude incidence rate": "151.20 per 100,000 person-years",
                        "HR1 (95% CI)": "12.51 (3.57\u201343.22)",
                        "HR2 (95% CI)": "Not estimable"
                    },
                    "measures": "[Crude incidence rate, HR1]",
                    "outcomes": "[151.20, 12.51]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG+/CagA+",
                        "Sample size": "315",
                        "Cases": "5",
                        "Unit": ", Per 100,000 person-years",
                        "HR1 description": "comparing participants with and without chronic atrophic gastritis",
                        "Adjustment factors": ", age, sex, education level, smoking status, alcohol consumption"
                    },
                    "measures": "[HR1, 95% CI]",
                    "outcomes": "[NA, NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG+/CagA+",
                        "Sample size": "315",
                        "Cases": "5",
                        "Crude incidence rate": "151.20 per 100,000 person-years",
                        "HR1 (95% CI)": "12.51 (3.57\u201343.22)",
                        "HR2 (95% CI)": "Not estimable"
                    },
                    "measures": "[Crude incidence rate, HR1]",
                    "outcomes": "[151.20, 12.51]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Chronic atrophic gastritis": "Present",
                        "H. pylori infection": "IgG+/CagA+",
                        "Sample size": "315",
                        "Cases": "5",
                        "Unit": ", Per 100,000 person-years",
                        "HR2 description": "comparing different groups with participants without chronic atrophic gastritis and without H. pylori infection",
                        "Adjustment factors": ", age, sex, education level, smoking status, alcohol consumption"
                    },
                    "measures": "[HR2, 95% CI]",
                    "outcomes": "[12.51, (3.57-43.22)]"
                },
                "match": "no"
            }
        ],
        "total_extracted_claims": 6,
        "total_ground_truth_claims": 18,
        "number_of_matches": 5
    },
    "PMC3497287_3": {
        "matches": [
            {
                "Extracted_claim": {
                    "subject": {
                        "Inherited Syndrome": "Lynch Syndrome",
                        "Mutated Gene": "Mismatch Repair Genes (MMR): MLH1, MSH2, MSH6 and PMS2"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Inherited Syndrome": "Lynch Syndrome",
                        "Mutated Gene": ", Mismatch Repair Genes (MMR): MLH1, MSH2, MSH6 and PMS2"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Inherited Syndrome": "Peutz-Jeghers Syndrome",
                        "Mutated Gene": "STK11/LKB1"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Inherited Syndrome": "Peutz-Jeghers Syndrome",
                        "Mutated Gene": "STK11/LKB1"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Inherited Syndrome": "Hereditary Breast Cancer",
                        "Mutated Gene": "BRCA1/BRCA2"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Inherited Syndrome": "Hereditary Breast Cancer",
                        "Mutated Gene": "BRCA1/BRCA2"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Inherited Syndrome": "Familial Atypical Multiple Mole Melanoma",
                        "Mutated Gene": "CDKN2A mutation"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Inherited Syndrome": "Familial Atypical Multiple Mole Melanoma",
                        "Mutated Gene": "CDKN2A mutation"
                    }
                },
                "match": "yes"
            }
        ],
        "total_extracted_claims": 4,
        "total_ground_truth_claims": 4,
        "number_of_matches": 4
    },
    "PMC4728116_3": {
        "matches": [
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Family history of pancreatic cancer",
                        "Subgroup": "No",
                        "Cases (n)": "312",
                        "Cases (%)": "\u221296.6",
                        "Controls (n)": "320",
                        "Controls (%)": "\u221299.1",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "family history of pancreatic cancer",
                        "group": "no",
                        "cases_n": "312",
                        "cases_percentage": "96.6",
                        "controls_n": "320",
                        "controls_percentage": "99.1"
                    },
                    "measures": "[Crude OR, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Family history of pancreatic cancer",
                        "Subgroup": "Yes",
                        "Cases (n)": "11",
                        "Cases (%)": "\u22123.4",
                        "Controls (n)": "3",
                        "Controls (%)": "\u22120.9",
                        "Crude OR (95% CI)": "3.67 (1.02\u201313.14)",
                        "Adjusted OR1 (95% CI)": "4.04 (1.08\u201315.07)",
                        "Adjusted OR2 (95% CI)": "1.23 (1.11\u20133.70)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[3.67, 4.04, 1.23]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "family history of pancreatic cancer",
                        "group": "no",
                        "cases_n": "312",
                        "cases_percentage": "96.6",
                        "controls_n": "320",
                        "controls_percentage": "99.1",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted  OR1, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Family history of pancreatic cancer",
                        "Subgroup": "Yes",
                        "Cases (n)": "11",
                        "Cases (%)": "\u22123.4",
                        "Controls (n)": "3",
                        "Controls (%)": "\u22120.9",
                        "Crude OR (95% CI)": "3.67 (1.02\u201313.14)",
                        "Adjusted OR1 (95% CI)": "4.04 (1.08\u201315.07)",
                        "Adjusted OR2 (95% CI)": "1.23 (1.11\u20133.70)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[3.67, 4.04, 1.23]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "family history of pancreatic cancer",
                        "group": "no",
                        "cases_n": "312",
                        "cases_percentage": "96.6",
                        "controls_n": "320",
                        "controls_percentage": "99.1",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Family history of pancreatic cancer",
                        "Subgroup": "Yes",
                        "Cases (n)": "11",
                        "Cases (%)": "\u22123.4",
                        "Controls (n)": "3",
                        "Controls (%)": "\u22120.9",
                        "Crude OR (95% CI)": "3.67 (1.02\u201313.14)",
                        "Adjusted OR1 (95% CI)": "4.04 (1.08\u201315.07)",
                        "Adjusted OR2 (95% CI)": "1.23 (1.11\u20133.70)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[3.67, 4.04, 1.23]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "family history of pancreatic cancer",
                        "group": "yes",
                        "cases_n": "11",
                        "cases_percentage": "3.4",
                        "controls_n": "3",
                        "controls_percentage": "0.9"
                    },
                    "measures": "[Crude OR, 95% CI]",
                    "outcomes": "[3.67, (1.02\u201313.14)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Family history of pancreatic cancer",
                        "Subgroup": "Yes",
                        "Cases (n)": "11",
                        "Cases (%)": "\u22123.4",
                        "Controls (n)": "3",
                        "Controls (%)": "\u22120.9",
                        "Crude OR (95% CI)": "3.67 (1.02\u201313.14)",
                        "Adjusted OR1 (95% CI)": "4.04 (1.08\u201315.07)",
                        "Adjusted OR2 (95% CI)": "1.23 (1.11\u20133.70)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[3.67, 4.04, 1.23]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "family history of pancreatic cancer",
                        "group": "yes",
                        "cases_n": "11",
                        "cases_percentage": "3.4",
                        "controls_n": "3",
                        "controls_percentage": "0.9",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted OR1, 95% CI]",
                    "outcomes": "[4.04, (1.08\u201315.07)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Family history of pancreatic cancer",
                        "Subgroup": "Yes",
                        "Cases (n)": "11",
                        "Cases (%)": "\u22123.4",
                        "Controls (n)": "3",
                        "Controls (%)": "\u22120.9",
                        "Crude OR (95% CI)": "3.67 (1.02\u201313.14)",
                        "Adjusted OR1 (95% CI)": "4.04 (1.08\u201315.07)",
                        "Adjusted OR2 (95% CI)": "1.23 (1.11\u20133.70)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[3.67, 4.04, 1.23]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "family history of pancreatic cancer",
                        "group": "yes",
                        "cases_n": "11",
                        "cases_percentage": "3.4",
                        "controls_n": "3",
                        "controls_percentage": "0.9",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[1.23, (1.11\u20133.70)]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "BMI",
                        "Subgroup": "<24.0",
                        "Cases (n)": "197",
                        "Cases (%)": "\u221261.0",
                        "Controls (n)": "230",
                        "Controls (%)": "\u221271.2",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "family history of pancreatic cancer",
                        "group": "no",
                        "cases_n": "312",
                        "cases_percentage": "96.6",
                        "controls_n": "320",
                        "controls_percentage": "99.1",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted  OR1, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "BMI",
                        "Subgroup": "<24.0",
                        "Cases (n)": "197",
                        "Cases (%)": "\u221261.0",
                        "Controls (n)": "230",
                        "Controls (%)": "\u221271.2",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "family history of pancreatic cancer",
                        "group": "no",
                        "cases_n": "312",
                        "cases_percentage": "96.6",
                        "controls_n": "320",
                        "controls_percentage": "99.1",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "BMI",
                        "Subgroup": "<24.0",
                        "Cases (n)": "197",
                        "Cases (%)": "\u221261.0",
                        "Controls (n)": "230",
                        "Controls (%)": "\u221271.2",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "family history of pancreatic cancer",
                        "group": "yes",
                        "cases_n": "11",
                        "cases_percentage": "3.4",
                        "controls_n": "3",
                        "controls_percentage": "0.9"
                    },
                    "measures": "[Crude OR, 95% CI]",
                    "outcomes": "[3.67, (1.02\u201313.14)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "BMI",
                        "Subgroup": "<24.0",
                        "Cases (n)": "197",
                        "Cases (%)": "\u221261.0",
                        "Controls (n)": "230",
                        "Controls (%)": "\u221271.2",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "family history of pancreatic cancer",
                        "group": "yes",
                        "cases_n": "11",
                        "cases_percentage": "3.4",
                        "controls_n": "3",
                        "controls_percentage": "0.9",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted OR1, 95% CI]",
                    "outcomes": "[4.04, (1.08\u201315.07)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "BMI",
                        "Subgroup": "<24.0",
                        "Cases (n)": "197",
                        "Cases (%)": "\u221261.0",
                        "Controls (n)": "230",
                        "Controls (%)": "\u221271.2",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "BMI",
                        "group": "<24.0",
                        "cases_n": "197",
                        "cases_percentage": "61.0",
                        "controls_n": "230",
                        "controls_percentage": "71.2"
                    },
                    "measures": "[Crude OR, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "BMI",
                        "Subgroup": "\u226524.0",
                        "Cases (n)": "126",
                        "Cases (%)": "\u221239.0",
                        "Controls (n)": "93",
                        "Controls (%)": "\u221228.8",
                        "Crude OR (95% CI)": "1.67 (1.18\u20132.38)",
                        "Adjusted OR1 (95% CI)": "1.78 (1.23\u20132.58)",
                        "Adjusted OR2 (95% CI)": "1.77 (1.22\u20132.57)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[1.67, 1.78, 1.77]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "family history of pancreatic cancer",
                        "group": "no",
                        "cases_n": "312",
                        "cases_percentage": "96.6",
                        "controls_n": "320",
                        "controls_percentage": "99.1",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted  OR1, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "BMI",
                        "Subgroup": "\u226524.0",
                        "Cases (n)": "126",
                        "Cases (%)": "\u221239.0",
                        "Controls (n)": "93",
                        "Controls (%)": "\u221228.8",
                        "Crude OR (95% CI)": "1.67 (1.18\u20132.38)",
                        "Adjusted OR1 (95% CI)": "1.78 (1.23\u20132.58)",
                        "Adjusted OR2 (95% CI)": "1.77 (1.22\u20132.57)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[1.67, 1.78, 1.77]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "family history of pancreatic cancer",
                        "group": "no",
                        "cases_n": "312",
                        "cases_percentage": "96.6",
                        "controls_n": "320",
                        "controls_percentage": "99.1",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "BMI",
                        "Subgroup": "\u226524.0",
                        "Cases (n)": "126",
                        "Cases (%)": "\u221239.0",
                        "Controls (n)": "93",
                        "Controls (%)": "\u221228.8",
                        "Crude OR (95% CI)": "1.67 (1.18\u20132.38)",
                        "Adjusted OR1 (95% CI)": "1.78 (1.23\u20132.58)",
                        "Adjusted OR2 (95% CI)": "1.77 (1.22\u20132.57)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[1.67, 1.78, 1.77]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "family history of pancreatic cancer",
                        "group": "yes",
                        "cases_n": "11",
                        "cases_percentage": "3.4",
                        "controls_n": "3",
                        "controls_percentage": "0.9"
                    },
                    "measures": "[Crude OR, 95% CI]",
                    "outcomes": "[3.67, (1.02\u201313.14)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "BMI",
                        "Subgroup": "\u226524.0",
                        "Cases (n)": "126",
                        "Cases (%)": "\u221239.0",
                        "Controls (n)": "93",
                        "Controls (%)": "\u221228.8",
                        "Crude OR (95% CI)": "1.67 (1.18\u20132.38)",
                        "Adjusted OR1 (95% CI)": "1.78 (1.23\u20132.58)",
                        "Adjusted OR2 (95% CI)": "1.77 (1.22\u20132.57)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[1.67, 1.78, 1.77]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "family history of pancreatic cancer",
                        "group": "yes",
                        "cases_n": "11",
                        "cases_percentage": "3.4",
                        "controls_n": "3",
                        "controls_percentage": "0.9",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted OR1, 95% CI]",
                    "outcomes": "[4.04, (1.08\u201315.07)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "BMI",
                        "Subgroup": "\u226524.0",
                        "Cases (n)": "126",
                        "Cases (%)": "\u221239.0",
                        "Controls (n)": "93",
                        "Controls (%)": "\u221228.8",
                        "Crude OR (95% CI)": "1.67 (1.18\u20132.38)",
                        "Adjusted OR1 (95% CI)": "1.78 (1.23\u20132.58)",
                        "Adjusted OR2 (95% CI)": "1.77 (1.22\u20132.57)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[1.67, 1.78, 1.77]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "BMI",
                        "group": "<24.0",
                        "cases_n": "197",
                        "cases_percentage": "61.0",
                        "controls_n": "230",
                        "controls_percentage": "71.2",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted OR1, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "BMI",
                        "Subgroup": "\u226524.0",
                        "Cases (n)": "126",
                        "Cases (%)": "\u221239.0",
                        "Controls (n)": "93",
                        "Controls (%)": "\u221228.8",
                        "Crude OR (95% CI)": "1.67 (1.18\u20132.38)",
                        "Adjusted OR1 (95% CI)": "1.78 (1.23\u20132.58)",
                        "Adjusted OR2 (95% CI)": "1.77 (1.22\u20132.57)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[1.67, 1.78, 1.77]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "BMI",
                        "group": "<24.0",
                        "cases_n": "197",
                        "cases_percentage": "61.0",
                        "controls_n": "230",
                        "controls_percentage": "71.2",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "BMI",
                        "Subgroup": "\u226524.0",
                        "Cases (n)": "126",
                        "Cases (%)": "\u221239.0",
                        "Controls (n)": "93",
                        "Controls (%)": "\u221228.8",
                        "Crude OR (95% CI)": "1.67 (1.18\u20132.38)",
                        "Adjusted OR1 (95% CI)": "1.78 (1.23\u20132.58)",
                        "Adjusted OR2 (95% CI)": "1.77 (1.22\u20132.57)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[1.67, 1.78, 1.77]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "BMI",
                        "group": "\u226524.0",
                        "cases_n": "126",
                        "cases_percentage": "39.0",
                        "controls_n": "93",
                        "controls_percentage": "28.8"
                    },
                    "measures": "[Crude OR, 95% CI]",
                    "outcomes": "[1.67, (1.18\u20132.38)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "BMI",
                        "Subgroup": "\u226524.0",
                        "Cases (n)": "126",
                        "Cases (%)": "\u221239.0",
                        "Controls (n)": "93",
                        "Controls (%)": "\u221228.8",
                        "Crude OR (95% CI)": "1.67 (1.18\u20132.38)",
                        "Adjusted OR1 (95% CI)": "1.78 (1.23\u20132.58)",
                        "Adjusted OR2 (95% CI)": "1.77 (1.22\u20132.57)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[1.67, 1.78, 1.77]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "BMI",
                        "group": "\u226524.0",
                        "cases_n": "126",
                        "cases_percentage": "39.0",
                        "controls_n": "93",
                        "controls_percentage": "28.8",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted OR1, 95% CI]",
                    "outcomes": "[1.78, (1.23\u20132.58)]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Diabetes",
                        "Subgroup": "No",
                        "Cases (n)": "174",
                        "Cases (%)": "\u221278.0",
                        "Controls (n)": "255",
                        "Controls (%)": "\u221290.7",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "family history of pancreatic cancer",
                        "group": "no",
                        "cases_n": "312",
                        "cases_percentage": "96.6",
                        "controls_n": "320",
                        "controls_percentage": "99.1",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted  OR1, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Diabetes",
                        "Subgroup": "No",
                        "Cases (n)": "174",
                        "Cases (%)": "\u221278.0",
                        "Controls (n)": "255",
                        "Controls (%)": "\u221290.7",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "family history of pancreatic cancer",
                        "group": "no",
                        "cases_n": "312",
                        "cases_percentage": "96.6",
                        "controls_n": "320",
                        "controls_percentage": "99.1",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Diabetes",
                        "Subgroup": "No",
                        "Cases (n)": "174",
                        "Cases (%)": "\u221278.0",
                        "Controls (n)": "255",
                        "Controls (%)": "\u221290.7",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "family history of pancreatic cancer",
                        "group": "yes",
                        "cases_n": "11",
                        "cases_percentage": "3.4",
                        "controls_n": "3",
                        "controls_percentage": "0.9"
                    },
                    "measures": "[Crude OR, 95% CI]",
                    "outcomes": "[3.67, (1.02\u201313.14)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Diabetes",
                        "Subgroup": "No",
                        "Cases (n)": "174",
                        "Cases (%)": "\u221278.0",
                        "Controls (n)": "255",
                        "Controls (%)": "\u221290.7",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "family history of pancreatic cancer",
                        "group": "yes",
                        "cases_n": "11",
                        "cases_percentage": "3.4",
                        "controls_n": "3",
                        "controls_percentage": "0.9",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted OR1, 95% CI]",
                    "outcomes": "[4.04, (1.08\u201315.07)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Diabetes",
                        "Subgroup": "No",
                        "Cases (n)": "174",
                        "Cases (%)": "\u221278.0",
                        "Controls (n)": "255",
                        "Controls (%)": "\u221290.7",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "BMI",
                        "group": "<24.0",
                        "cases_n": "197",
                        "cases_percentage": "61.0",
                        "controls_n": "230",
                        "controls_percentage": "71.2",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted OR1, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Diabetes",
                        "Subgroup": "No",
                        "Cases (n)": "174",
                        "Cases (%)": "\u221278.0",
                        "Controls (n)": "255",
                        "Controls (%)": "\u221290.7",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "BMI",
                        "group": "<24.0",
                        "cases_n": "197",
                        "cases_percentage": "61.0",
                        "controls_n": "230",
                        "controls_percentage": "71.2",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Diabetes",
                        "Subgroup": "No",
                        "Cases (n)": "174",
                        "Cases (%)": "\u221278.0",
                        "Controls (n)": "255",
                        "Controls (%)": "\u221290.7",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "BMI",
                        "group": "\u226524.0",
                        "cases_n": "126",
                        "cases_percentage": "39.0",
                        "controls_n": "93",
                        "controls_percentage": "28.8"
                    },
                    "measures": "[Crude OR, 95% CI]",
                    "outcomes": "[1.67, (1.18\u20132.38)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Diabetes",
                        "Subgroup": "No",
                        "Cases (n)": "174",
                        "Cases (%)": "\u221278.0",
                        "Controls (n)": "255",
                        "Controls (%)": "\u221290.7",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "BMI",
                        "group": "\u226524.0",
                        "cases_n": "126",
                        "cases_percentage": "39.0",
                        "controls_n": "93",
                        "controls_percentage": "28.8",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[1.77, (1.22\u20132.57)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Diabetes",
                        "Subgroup": "No",
                        "Cases (n)": "174",
                        "Cases (%)": "\u221278.0",
                        "Controls (n)": "255",
                        "Controls (%)": "\u221290.7",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Diabetes",
                        "group": "No",
                        "cases_n": "174",
                        "cases_percentage": "78.0",
                        "controls_n": "255",
                        "controls_percentage": "90.7"
                    },
                    "measures": "[Crude OR, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Diabetes",
                        "Subgroup": "Yes",
                        "Cases (n)": "49",
                        "Cases (%)": "\u221222.0",
                        "Controls (n)": "26",
                        "Controls (%)": "\u22129.3",
                        "Crude OR (95% CI)": "2.69 (1.51\u20134.77)",
                        "Adjusted OR1 (95% CI)": "2.60 (1.41\u20134.79)",
                        "Adjusted OR2 (95% CI)": "2.96 (1.48\u20135.92)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.69, 2.60, 2.96]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "family history of pancreatic cancer",
                        "group": "no",
                        "cases_n": "312",
                        "cases_percentage": "96.6",
                        "controls_n": "320",
                        "controls_percentage": "99.1",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted  OR1, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Diabetes",
                        "Subgroup": "Yes",
                        "Cases (n)": "49",
                        "Cases (%)": "\u221222.0",
                        "Controls (n)": "26",
                        "Controls (%)": "\u22129.3",
                        "Crude OR (95% CI)": "2.69 (1.51\u20134.77)",
                        "Adjusted OR1 (95% CI)": "2.60 (1.41\u20134.79)",
                        "Adjusted OR2 (95% CI)": "2.96 (1.48\u20135.92)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.69, 2.60, 2.96]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "family history of pancreatic cancer",
                        "group": "no",
                        "cases_n": "312",
                        "cases_percentage": "96.6",
                        "controls_n": "320",
                        "controls_percentage": "99.1",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Diabetes",
                        "Subgroup": "Yes",
                        "Cases (n)": "49",
                        "Cases (%)": "\u221222.0",
                        "Controls (n)": "26",
                        "Controls (%)": "\u22129.3",
                        "Crude OR (95% CI)": "2.69 (1.51\u20134.77)",
                        "Adjusted OR1 (95% CI)": "2.60 (1.41\u20134.79)",
                        "Adjusted OR2 (95% CI)": "2.96 (1.48\u20135.92)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.69, 2.60, 2.96]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "family history of pancreatic cancer",
                        "group": "yes",
                        "cases_n": "11",
                        "cases_percentage": "3.4",
                        "controls_n": "3",
                        "controls_percentage": "0.9"
                    },
                    "measures": "[Crude OR, 95% CI]",
                    "outcomes": "[3.67, (1.02\u201313.14)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Diabetes",
                        "Subgroup": "Yes",
                        "Cases (n)": "49",
                        "Cases (%)": "\u221222.0",
                        "Controls (n)": "26",
                        "Controls (%)": "\u22129.3",
                        "Crude OR (95% CI)": "2.69 (1.51\u20134.77)",
                        "Adjusted OR1 (95% CI)": "2.60 (1.41\u20134.79)",
                        "Adjusted OR2 (95% CI)": "2.96 (1.48\u20135.92)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.69, 2.60, 2.96]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "family history of pancreatic cancer",
                        "group": "yes",
                        "cases_n": "11",
                        "cases_percentage": "3.4",
                        "controls_n": "3",
                        "controls_percentage": "0.9",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted OR1, 95% CI]",
                    "outcomes": "[4.04, (1.08\u201315.07)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Diabetes",
                        "Subgroup": "Yes",
                        "Cases (n)": "49",
                        "Cases (%)": "\u221222.0",
                        "Controls (n)": "26",
                        "Controls (%)": "\u22129.3",
                        "Crude OR (95% CI)": "2.69 (1.51\u20134.77)",
                        "Adjusted OR1 (95% CI)": "2.60 (1.41\u20134.79)",
                        "Adjusted OR2 (95% CI)": "2.96 (1.48\u20135.92)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.69, 2.60, 2.96]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "BMI",
                        "group": "<24.0",
                        "cases_n": "197",
                        "cases_percentage": "61.0",
                        "controls_n": "230",
                        "controls_percentage": "71.2",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted OR1, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Diabetes",
                        "Subgroup": "Yes",
                        "Cases (n)": "49",
                        "Cases (%)": "\u221222.0",
                        "Controls (n)": "26",
                        "Controls (%)": "\u22129.3",
                        "Crude OR (95% CI)": "2.69 (1.51\u20134.77)",
                        "Adjusted OR1 (95% CI)": "2.60 (1.41\u20134.79)",
                        "Adjusted OR2 (95% CI)": "2.96 (1.48\u20135.92)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.69, 2.60, 2.96]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "BMI",
                        "group": "<24.0",
                        "cases_n": "197",
                        "cases_percentage": "61.0",
                        "controls_n": "230",
                        "controls_percentage": "71.2",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Diabetes",
                        "Subgroup": "Yes",
                        "Cases (n)": "49",
                        "Cases (%)": "\u221222.0",
                        "Controls (n)": "26",
                        "Controls (%)": "\u22129.3",
                        "Crude OR (95% CI)": "2.69 (1.51\u20134.77)",
                        "Adjusted OR1 (95% CI)": "2.60 (1.41\u20134.79)",
                        "Adjusted OR2 (95% CI)": "2.96 (1.48\u20135.92)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.69, 2.60, 2.96]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "BMI",
                        "group": "\u226524.0",
                        "cases_n": "126",
                        "cases_percentage": "39.0",
                        "controls_n": "93",
                        "controls_percentage": "28.8"
                    },
                    "measures": "[Crude OR, 95% CI]",
                    "outcomes": "[1.67, (1.18\u20132.38)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Diabetes",
                        "Subgroup": "Yes",
                        "Cases (n)": "49",
                        "Cases (%)": "\u221222.0",
                        "Controls (n)": "26",
                        "Controls (%)": "\u22129.3",
                        "Crude OR (95% CI)": "2.69 (1.51\u20134.77)",
                        "Adjusted OR1 (95% CI)": "2.60 (1.41\u20134.79)",
                        "Adjusted OR2 (95% CI)": "2.96 (1.48\u20135.92)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.69, 2.60, 2.96]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "BMI",
                        "group": "\u226524.0",
                        "cases_n": "126",
                        "cases_percentage": "39.0",
                        "controls_n": "93",
                        "controls_percentage": "28.8",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[1.77, (1.22\u20132.57)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Diabetes",
                        "Subgroup": "Yes",
                        "Cases (n)": "49",
                        "Cases (%)": "\u221222.0",
                        "Controls (n)": "26",
                        "Controls (%)": "\u22129.3",
                        "Crude OR (95% CI)": "2.69 (1.51\u20134.77)",
                        "Adjusted OR1 (95% CI)": "2.60 (1.41\u20134.79)",
                        "Adjusted OR2 (95% CI)": "2.96 (1.48\u20135.92)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.69, 2.60, 2.96]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Diabetes",
                        "group": "No",
                        "cases_n": "174",
                        "cases_percentage": "78.0",
                        "controls_n": "255",
                        "controls_percentage": "90.7",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted OR1, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Diabetes",
                        "Subgroup": "Yes",
                        "Cases (n)": "49",
                        "Cases (%)": "\u221222.0",
                        "Controls (n)": "26",
                        "Controls (%)": "\u22129.3",
                        "Crude OR (95% CI)": "2.69 (1.51\u20134.77)",
                        "Adjusted OR1 (95% CI)": "2.60 (1.41\u20134.79)",
                        "Adjusted OR2 (95% CI)": "2.96 (1.48\u20135.92)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.69, 2.60, 2.96]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Diabetes",
                        "group": "No",
                        "cases_n": "174",
                        "cases_percentage": "78.0",
                        "controls_n": "255",
                        "controls_percentage": "90.7",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Diabetes",
                        "Subgroup": "Yes",
                        "Cases (n)": "49",
                        "Cases (%)": "\u221222.0",
                        "Controls (n)": "26",
                        "Controls (%)": "\u22129.3",
                        "Crude OR (95% CI)": "2.69 (1.51\u20134.77)",
                        "Adjusted OR1 (95% CI)": "2.60 (1.41\u20134.79)",
                        "Adjusted OR2 (95% CI)": "2.96 (1.48\u20135.92)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.69, 2.60, 2.96]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Diabetes",
                        "group": "Yes",
                        "cases_n": "49",
                        "cases_percentage": "22.0",
                        "controls_n": "26",
                        "controls_percentage": "9.3"
                    },
                    "measures": "[Crude OR, 95% CI]",
                    "outcomes": "[2.69, (1.51\u20134.77)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Diabetes",
                        "Subgroup": "Yes",
                        "Cases (n)": "49",
                        "Cases (%)": "\u221222.0",
                        "Controls (n)": "26",
                        "Controls (%)": "\u22129.3",
                        "Crude OR (95% CI)": "2.69 (1.51\u20134.77)",
                        "Adjusted OR1 (95% CI)": "2.60 (1.41\u20134.79)",
                        "Adjusted OR2 (95% CI)": "2.96 (1.48\u20135.92)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.69, 2.60, 2.96]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Diabetes",
                        "group": "Yes",
                        "cases_n": "49",
                        "cases_percentage": "22.0",
                        "controls_n": "26",
                        "controls_percentage": "9.3",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted OR1, 95% CI]",
                    "outcomes": "[2.60, (1.41\u20134.79)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Diabetes",
                        "Subgroup": "Yes",
                        "Cases (n)": "49",
                        "Cases (%)": "\u221222.0",
                        "Controls (n)": "26",
                        "Controls (%)": "\u22129.3",
                        "Crude OR (95% CI)": "2.69 (1.51\u20134.77)",
                        "Adjusted OR1 (95% CI)": "2.60 (1.41\u20134.79)",
                        "Adjusted OR2 (95% CI)": "2.96 (1.48\u20135.92)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.69, 2.60, 2.96]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Diabetes",
                        "group": "Yes",
                        "cases_n": "49",
                        "cases_percentage": "22.0",
                        "controls_n": "26",
                        "controls_percentage": "9.3",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[2.96, (1.48\u20135.92)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Diabetes",
                        "Subgroup": "Yes",
                        "Cases (n)": "49",
                        "Cases (%)": "\u221222.0",
                        "Controls (n)": "26",
                        "Controls (%)": "\u22129.3",
                        "Crude OR (95% CI)": "2.69 (1.51\u20134.77)",
                        "Adjusted OR1 (95% CI)": "2.60 (1.41\u20134.79)",
                        "Adjusted OR2 (95% CI)": "2.96 (1.48\u20135.92)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.69, 2.60, 2.96]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Cholecystitis",
                        "group": "No",
                        "cases_n": "272",
                        "cases_percentage": "94.1",
                        "controls_n": "195",
                        "controls_percentage": "96.7"
                    },
                    "measures": "[Crude OR, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Diabetes",
                        "Subgroup": "Yes",
                        "Cases (n)": "49",
                        "Cases (%)": "\u221222.0",
                        "Controls (n)": "26",
                        "Controls (%)": "\u22129.3",
                        "Crude OR (95% CI)": "2.69 (1.51\u20134.77)",
                        "Adjusted OR1 (95% CI)": "2.60 (1.41\u20134.79)",
                        "Adjusted OR2 (95% CI)": "2.96 (1.48\u20135.92)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.69, 2.60, 2.96]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Cholecystitis",
                        "group": "No",
                        "cases_n": "272",
                        "cases_percentage": "94.1",
                        "controls_n": "195",
                        "controls_percentage": "96.7",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted OR1, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Diabetes",
                        "Subgroup": "Yes",
                        "Cases (n)": "49",
                        "Cases (%)": "\u221222.0",
                        "Controls (n)": "26",
                        "Controls (%)": "\u22129.3",
                        "Crude OR (95% CI)": "2.69 (1.51\u20134.77)",
                        "Adjusted OR1 (95% CI)": "2.60 (1.41\u20134.79)",
                        "Adjusted OR2 (95% CI)": "2.96 (1.48\u20135.92)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.69, 2.60, 2.96]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Cholecystitis",
                        "group": "No",
                        "cases_n": "272",
                        "cases_percentage": "94.1",
                        "controls_n": "195",
                        "controls_percentage": "96.7",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Diabetes",
                        "Subgroup": "Yes",
                        "Cases (n)": "49",
                        "Cases (%)": "\u221222.0",
                        "Controls (n)": "26",
                        "Controls (%)": "\u22129.3",
                        "Crude OR (95% CI)": "2.69 (1.51\u20134.77)",
                        "Adjusted OR1 (95% CI)": "2.60 (1.41\u20134.79)",
                        "Adjusted OR2 (95% CI)": "2.96 (1.48\u20135.92)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.69, 2.60, 2.96]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Cholecystitis",
                        "group": "Yes",
                        "cases_n": "17",
                        "cases_percentage": "5.9",
                        "controls_n": "10",
                        "controls_percentage": "3.3"
                    },
                    "measures": "[Crude OR, 95% CI]",
                    "outcomes": "[1.89, (0.84\u20134.24)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Diabetes",
                        "Subgroup": "Yes",
                        "Cases (n)": "49",
                        "Cases (%)": "\u221222.0",
                        "Controls (n)": "26",
                        "Controls (%)": "\u22129.3",
                        "Crude OR (95% CI)": "2.69 (1.51\u20134.77)",
                        "Adjusted OR1 (95% CI)": "2.60 (1.41\u20134.79)",
                        "Adjusted OR2 (95% CI)": "2.96 (1.48\u20135.92)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.69, 2.60, 2.96]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Cholecystitis",
                        "group": "Yes",
                        "cases_n": "17",
                        "cases_percentage": "5.9",
                        "controls_n": "10",
                        "controls_percentage": "3.3",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted OR1, 95% CI]",
                    "outcomes": "[1.91, (0.83\u20134.38)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Diabetes",
                        "Subgroup": "Yes",
                        "Cases (n)": "49",
                        "Cases (%)": "\u221222.0",
                        "Controls (n)": "26",
                        "Controls (%)": "\u22129.3",
                        "Crude OR (95% CI)": "2.69 (1.51\u20134.77)",
                        "Adjusted OR1 (95% CI)": "2.60 (1.41\u20134.79)",
                        "Adjusted OR2 (95% CI)": "2.96 (1.48\u20135.92)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.69, 2.60, 2.96]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Cholecystitis",
                        "group": "Yes",
                        "cases_n": "17",
                        "cases_percentage": "5.9",
                        "controls_n": "10",
                        "controls_percentage": "3.3",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[1.35, (0.50\u20133.68)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Diabetes",
                        "Subgroup": "Yes",
                        "Cases (n)": "49",
                        "Cases (%)": "\u221222.0",
                        "Controls (n)": "26",
                        "Controls (%)": "\u22129.3",
                        "Crude OR (95% CI)": "2.69 (1.51\u20134.77)",
                        "Adjusted OR1 (95% CI)": "2.60 (1.41\u20134.79)",
                        "Adjusted OR2 (95% CI)": "2.96 (1.48\u20135.92)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.69, 2.60, 2.96]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Gallstone",
                        "group": "No",
                        "cases_n": "274",
                        "cases_percentage": "95.1",
                        "controls_n": "300",
                        "controls_percentage": "98.4"
                    },
                    "measures": "[Crude OR, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Diabetes",
                        "Subgroup": "Yes",
                        "Cases (n)": "49",
                        "Cases (%)": "\u221222.0",
                        "Controls (n)": "26",
                        "Controls (%)": "\u22129.3",
                        "Crude OR (95% CI)": "2.69 (1.51\u20134.77)",
                        "Adjusted OR1 (95% CI)": "2.60 (1.41\u20134.79)",
                        "Adjusted OR2 (95% CI)": "2.96 (1.48\u20135.92)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.69, 2.60, 2.96]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Gallstone",
                        "group": "No",
                        "cases_n": "274",
                        "cases_percentage": "95.1",
                        "controls_n": "300",
                        "controls_percentage": "98.4",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted OR1, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Diabetes",
                        "Subgroup": "Yes",
                        "Cases (n)": "49",
                        "Cases (%)": "\u221222.0",
                        "Controls (n)": "26",
                        "Controls (%)": "\u22129.3",
                        "Crude OR (95% CI)": "2.69 (1.51\u20134.77)",
                        "Adjusted OR1 (95% CI)": "2.60 (1.41\u20134.79)",
                        "Adjusted OR2 (95% CI)": "2.96 (1.48\u20135.92)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.69, 2.60, 2.96]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Gallstone",
                        "group": "No",
                        "cases_n": "274",
                        "cases_percentage": "95.1",
                        "controls_n": "300",
                        "controls_percentage": "98.4",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Diabetes",
                        "Subgroup": "Yes",
                        "Cases (n)": "49",
                        "Cases (%)": "\u221222.0",
                        "Controls (n)": "26",
                        "Controls (%)": "\u22129.3",
                        "Crude OR (95% CI)": "2.69 (1.51\u20134.77)",
                        "Adjusted OR1 (95% CI)": "2.60 (1.41\u20134.79)",
                        "Adjusted OR2 (95% CI)": "2.96 (1.48\u20135.92)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.69, 2.60, 2.96]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Gallstone",
                        "group": "Yes",
                        "cases_n": "14",
                        "cases_percentage": "4.9",
                        "controls_n": "5",
                        "controls_percentage": "1.6"
                    },
                    "measures": "[Crude OR, 95% CI]",
                    "outcomes": "[2.80, (1.01\u20137.77)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Diabetes",
                        "Subgroup": "Yes",
                        "Cases (n)": "49",
                        "Cases (%)": "\u221222.0",
                        "Controls (n)": "26",
                        "Controls (%)": "\u22129.3",
                        "Crude OR (95% CI)": "2.69 (1.51\u20134.77)",
                        "Adjusted OR1 (95% CI)": "2.60 (1.41\u20134.79)",
                        "Adjusted OR2 (95% CI)": "2.96 (1.48\u20135.92)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.69, 2.60, 2.96]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Gallstone",
                        "group": "Yes",
                        "cases_n": "14",
                        "cases_percentage": "4.9",
                        "controls_n": "5",
                        "controls_percentage": "1.6",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted OR1, 95% CI]",
                    "outcomes": "[2.58, (0.89\u20137.44)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Diabetes",
                        "Subgroup": "Yes",
                        "Cases (n)": "49",
                        "Cases (%)": "\u221222.0",
                        "Controls (n)": "26",
                        "Controls (%)": "\u22129.3",
                        "Crude OR (95% CI)": "2.69 (1.51\u20134.77)",
                        "Adjusted OR1 (95% CI)": "2.60 (1.41\u20134.79)",
                        "Adjusted OR2 (95% CI)": "2.96 (1.48\u20135.92)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.69, 2.60, 2.96]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Gallstone",
                        "group": "Yes",
                        "cases_n": "14",
                        "cases_percentage": "4.9",
                        "controls_n": "5",
                        "controls_percentage": "1.6",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[2.68, (0.65\u201311.07)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Cholecystitis",
                        "Subgroup": "No",
                        "Cases (n)": "272",
                        "Cases (%)": "\u221294.1",
                        "Controls (n)": "195",
                        "Controls (%)": "\u221296.7",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "family history of pancreatic cancer",
                        "group": "no",
                        "cases_n": "312",
                        "cases_percentage": "96.6",
                        "controls_n": "320",
                        "controls_percentage": "99.1",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted  OR1, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Cholecystitis",
                        "Subgroup": "No",
                        "Cases (n)": "272",
                        "Cases (%)": "\u221294.1",
                        "Controls (n)": "195",
                        "Controls (%)": "\u221296.7",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "family history of pancreatic cancer",
                        "group": "no",
                        "cases_n": "312",
                        "cases_percentage": "96.6",
                        "controls_n": "320",
                        "controls_percentage": "99.1",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Cholecystitis",
                        "Subgroup": "No",
                        "Cases (n)": "272",
                        "Cases (%)": "\u221294.1",
                        "Controls (n)": "195",
                        "Controls (%)": "\u221296.7",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "family history of pancreatic cancer",
                        "group": "yes",
                        "cases_n": "11",
                        "cases_percentage": "3.4",
                        "controls_n": "3",
                        "controls_percentage": "0.9"
                    },
                    "measures": "[Crude OR, 95% CI]",
                    "outcomes": "[3.67, (1.02\u201313.14)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Cholecystitis",
                        "Subgroup": "No",
                        "Cases (n)": "272",
                        "Cases (%)": "\u221294.1",
                        "Controls (n)": "195",
                        "Controls (%)": "\u221296.7",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "family history of pancreatic cancer",
                        "group": "yes",
                        "cases_n": "11",
                        "cases_percentage": "3.4",
                        "controls_n": "3",
                        "controls_percentage": "0.9",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted OR1, 95% CI]",
                    "outcomes": "[4.04, (1.08\u201315.07)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Cholecystitis",
                        "Subgroup": "No",
                        "Cases (n)": "272",
                        "Cases (%)": "\u221294.1",
                        "Controls (n)": "195",
                        "Controls (%)": "\u221296.7",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "BMI",
                        "group": "<24.0",
                        "cases_n": "197",
                        "cases_percentage": "61.0",
                        "controls_n": "230",
                        "controls_percentage": "71.2",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted OR1, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Cholecystitis",
                        "Subgroup": "No",
                        "Cases (n)": "272",
                        "Cases (%)": "\u221294.1",
                        "Controls (n)": "195",
                        "Controls (%)": "\u221296.7",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "BMI",
                        "group": "<24.0",
                        "cases_n": "197",
                        "cases_percentage": "61.0",
                        "controls_n": "230",
                        "controls_percentage": "71.2",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Cholecystitis",
                        "Subgroup": "No",
                        "Cases (n)": "272",
                        "Cases (%)": "\u221294.1",
                        "Controls (n)": "195",
                        "Controls (%)": "\u221296.7",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "BMI",
                        "group": "\u226524.0",
                        "cases_n": "126",
                        "cases_percentage": "39.0",
                        "controls_n": "93",
                        "controls_percentage": "28.8"
                    },
                    "measures": "[Crude OR, 95% CI]",
                    "outcomes": "[1.67, (1.18\u20132.38)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Cholecystitis",
                        "Subgroup": "No",
                        "Cases (n)": "272",
                        "Cases (%)": "\u221294.1",
                        "Controls (n)": "195",
                        "Controls (%)": "\u221296.7",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "BMI",
                        "group": "\u226524.0",
                        "cases_n": "126",
                        "cases_percentage": "39.0",
                        "controls_n": "93",
                        "controls_percentage": "28.8",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[1.77, (1.22\u20132.57)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Cholecystitis",
                        "Subgroup": "No",
                        "Cases (n)": "272",
                        "Cases (%)": "\u221294.1",
                        "Controls (n)": "195",
                        "Controls (%)": "\u221296.7",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Diabetes",
                        "group": "No",
                        "cases_n": "174",
                        "cases_percentage": "78.0",
                        "controls_n": "255",
                        "controls_percentage": "90.7",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted OR1, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Cholecystitis",
                        "Subgroup": "No",
                        "Cases (n)": "272",
                        "Cases (%)": "\u221294.1",
                        "Controls (n)": "195",
                        "Controls (%)": "\u221296.7",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Diabetes",
                        "group": "No",
                        "cases_n": "174",
                        "cases_percentage": "78.0",
                        "controls_n": "255",
                        "controls_percentage": "90.7",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Cholecystitis",
                        "Subgroup": "No",
                        "Cases (n)": "272",
                        "Cases (%)": "\u221294.1",
                        "Controls (n)": "195",
                        "Controls (%)": "\u221296.7",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Diabetes",
                        "group": "Yes",
                        "cases_n": "49",
                        "cases_percentage": "22.0",
                        "controls_n": "26",
                        "controls_percentage": "9.3"
                    },
                    "measures": "[Crude OR, 95% CI]",
                    "outcomes": "[2.69, (1.51\u20134.77)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Cholecystitis",
                        "Subgroup": "No",
                        "Cases (n)": "272",
                        "Cases (%)": "\u221294.1",
                        "Controls (n)": "195",
                        "Controls (%)": "\u221296.7",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Diabetes",
                        "group": "Yes",
                        "cases_n": "49",
                        "cases_percentage": "22.0",
                        "controls_n": "26",
                        "controls_percentage": "9.3",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted OR1, 95% CI]",
                    "outcomes": "[2.60, (1.41\u20134.79)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Cholecystitis",
                        "Subgroup": "No",
                        "Cases (n)": "272",
                        "Cases (%)": "\u221294.1",
                        "Controls (n)": "195",
                        "Controls (%)": "\u221296.7",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Diabetes",
                        "group": "Yes",
                        "cases_n": "49",
                        "cases_percentage": "22.0",
                        "controls_n": "26",
                        "controls_percentage": "9.3",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[2.96, (1.48\u20135.92)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Cholecystitis",
                        "Subgroup": "No",
                        "Cases (n)": "272",
                        "Cases (%)": "\u221294.1",
                        "Controls (n)": "195",
                        "Controls (%)": "\u221296.7",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Cholecystitis",
                        "group": "No",
                        "cases_n": "272",
                        "cases_percentage": "94.1",
                        "controls_n": "195",
                        "controls_percentage": "96.7"
                    },
                    "measures": "[Crude OR, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Cholecystitis",
                        "Subgroup": "Yes",
                        "Cases (n)": "17",
                        "Cases (%)": "\u22125.9",
                        "Controls (n)": "10",
                        "Controls (%)": "\u22123.3",
                        "Crude OR (95% CI)": "1.89 (0.84\u20134.24)",
                        "Adjusted OR1 (95% CI)": "1.91 (0.83\u20134.38)",
                        "Adjusted OR2 (95% CI)": "1.35 (0.50\u20133.68)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[1.89, 1.91, 1.35]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "family history of pancreatic cancer",
                        "group": "no",
                        "cases_n": "312",
                        "cases_percentage": "96.6",
                        "controls_n": "320",
                        "controls_percentage": "99.1",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted  OR1, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Cholecystitis",
                        "Subgroup": "Yes",
                        "Cases (n)": "17",
                        "Cases (%)": "\u22125.9",
                        "Controls (n)": "10",
                        "Controls (%)": "\u22123.3",
                        "Crude OR (95% CI)": "1.89 (0.84\u20134.24)",
                        "Adjusted OR1 (95% CI)": "1.91 (0.83\u20134.38)",
                        "Adjusted OR2 (95% CI)": "1.35 (0.50\u20133.68)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[1.89, 1.91, 1.35]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "family history of pancreatic cancer",
                        "group": "no",
                        "cases_n": "312",
                        "cases_percentage": "96.6",
                        "controls_n": "320",
                        "controls_percentage": "99.1",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Cholecystitis",
                        "Subgroup": "Yes",
                        "Cases (n)": "17",
                        "Cases (%)": "\u22125.9",
                        "Controls (n)": "10",
                        "Controls (%)": "\u22123.3",
                        "Crude OR (95% CI)": "1.89 (0.84\u20134.24)",
                        "Adjusted OR1 (95% CI)": "1.91 (0.83\u20134.38)",
                        "Adjusted OR2 (95% CI)": "1.35 (0.50\u20133.68)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[1.89, 1.91, 1.35]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "family history of pancreatic cancer",
                        "group": "yes",
                        "cases_n": "11",
                        "cases_percentage": "3.4",
                        "controls_n": "3",
                        "controls_percentage": "0.9"
                    },
                    "measures": "[Crude OR, 95% CI]",
                    "outcomes": "[3.67, (1.02\u201313.14)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Cholecystitis",
                        "Subgroup": "Yes",
                        "Cases (n)": "17",
                        "Cases (%)": "\u22125.9",
                        "Controls (n)": "10",
                        "Controls (%)": "\u22123.3",
                        "Crude OR (95% CI)": "1.89 (0.84\u20134.24)",
                        "Adjusted OR1 (95% CI)": "1.91 (0.83\u20134.38)",
                        "Adjusted OR2 (95% CI)": "1.35 (0.50\u20133.68)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[1.89, 1.91, 1.35]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "family history of pancreatic cancer",
                        "group": "yes",
                        "cases_n": "11",
                        "cases_percentage": "3.4",
                        "controls_n": "3",
                        "controls_percentage": "0.9",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted OR1, 95% CI]",
                    "outcomes": "[4.04, (1.08\u201315.07)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Cholecystitis",
                        "Subgroup": "Yes",
                        "Cases (n)": "17",
                        "Cases (%)": "\u22125.9",
                        "Controls (n)": "10",
                        "Controls (%)": "\u22123.3",
                        "Crude OR (95% CI)": "1.89 (0.84\u20134.24)",
                        "Adjusted OR1 (95% CI)": "1.91 (0.83\u20134.38)",
                        "Adjusted OR2 (95% CI)": "1.35 (0.50\u20133.68)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[1.89, 1.91, 1.35]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "BMI",
                        "group": "<24.0",
                        "cases_n": "197",
                        "cases_percentage": "61.0",
                        "controls_n": "230",
                        "controls_percentage": "71.2",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted OR1, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Cholecystitis",
                        "Subgroup": "Yes",
                        "Cases (n)": "17",
                        "Cases (%)": "\u22125.9",
                        "Controls (n)": "10",
                        "Controls (%)": "\u22123.3",
                        "Crude OR (95% CI)": "1.89 (0.84\u20134.24)",
                        "Adjusted OR1 (95% CI)": "1.91 (0.83\u20134.38)",
                        "Adjusted OR2 (95% CI)": "1.35 (0.50\u20133.68)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[1.89, 1.91, 1.35]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "BMI",
                        "group": "<24.0",
                        "cases_n": "197",
                        "cases_percentage": "61.0",
                        "controls_n": "230",
                        "controls_percentage": "71.2",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Cholecystitis",
                        "Subgroup": "Yes",
                        "Cases (n)": "17",
                        "Cases (%)": "\u22125.9",
                        "Controls (n)": "10",
                        "Controls (%)": "\u22123.3",
                        "Crude OR (95% CI)": "1.89 (0.84\u20134.24)",
                        "Adjusted OR1 (95% CI)": "1.91 (0.83\u20134.38)",
                        "Adjusted OR2 (95% CI)": "1.35 (0.50\u20133.68)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[1.89, 1.91, 1.35]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "BMI",
                        "group": "\u226524.0",
                        "cases_n": "126",
                        "cases_percentage": "39.0",
                        "controls_n": "93",
                        "controls_percentage": "28.8"
                    },
                    "measures": "[Crude OR, 95% CI]",
                    "outcomes": "[1.67, (1.18\u20132.38)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Cholecystitis",
                        "Subgroup": "Yes",
                        "Cases (n)": "17",
                        "Cases (%)": "\u22125.9",
                        "Controls (n)": "10",
                        "Controls (%)": "\u22123.3",
                        "Crude OR (95% CI)": "1.89 (0.84\u20134.24)",
                        "Adjusted OR1 (95% CI)": "1.91 (0.83\u20134.38)",
                        "Adjusted OR2 (95% CI)": "1.35 (0.50\u20133.68)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[1.89, 1.91, 1.35]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "BMI",
                        "group": "\u226524.0",
                        "cases_n": "126",
                        "cases_percentage": "39.0",
                        "controls_n": "93",
                        "controls_percentage": "28.8",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[1.77, (1.22\u20132.57)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Cholecystitis",
                        "Subgroup": "Yes",
                        "Cases (n)": "17",
                        "Cases (%)": "\u22125.9",
                        "Controls (n)": "10",
                        "Controls (%)": "\u22123.3",
                        "Crude OR (95% CI)": "1.89 (0.84\u20134.24)",
                        "Adjusted OR1 (95% CI)": "1.91 (0.83\u20134.38)",
                        "Adjusted OR2 (95% CI)": "1.35 (0.50\u20133.68)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[1.89, 1.91, 1.35]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Diabetes",
                        "group": "No",
                        "cases_n": "174",
                        "cases_percentage": "78.0",
                        "controls_n": "255",
                        "controls_percentage": "90.7",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted OR1, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Cholecystitis",
                        "Subgroup": "Yes",
                        "Cases (n)": "17",
                        "Cases (%)": "\u22125.9",
                        "Controls (n)": "10",
                        "Controls (%)": "\u22123.3",
                        "Crude OR (95% CI)": "1.89 (0.84\u20134.24)",
                        "Adjusted OR1 (95% CI)": "1.91 (0.83\u20134.38)",
                        "Adjusted OR2 (95% CI)": "1.35 (0.50\u20133.68)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[1.89, 1.91, 1.35]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Diabetes",
                        "group": "No",
                        "cases_n": "174",
                        "cases_percentage": "78.0",
                        "controls_n": "255",
                        "controls_percentage": "90.7",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Cholecystitis",
                        "Subgroup": "Yes",
                        "Cases (n)": "17",
                        "Cases (%)": "\u22125.9",
                        "Controls (n)": "10",
                        "Controls (%)": "\u22123.3",
                        "Crude OR (95% CI)": "1.89 (0.84\u20134.24)",
                        "Adjusted OR1 (95% CI)": "1.91 (0.83\u20134.38)",
                        "Adjusted OR2 (95% CI)": "1.35 (0.50\u20133.68)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[1.89, 1.91, 1.35]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Diabetes",
                        "group": "Yes",
                        "cases_n": "49",
                        "cases_percentage": "22.0",
                        "controls_n": "26",
                        "controls_percentage": "9.3"
                    },
                    "measures": "[Crude OR, 95% CI]",
                    "outcomes": "[2.69, (1.51\u20134.77)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Cholecystitis",
                        "Subgroup": "Yes",
                        "Cases (n)": "17",
                        "Cases (%)": "\u22125.9",
                        "Controls (n)": "10",
                        "Controls (%)": "\u22123.3",
                        "Crude OR (95% CI)": "1.89 (0.84\u20134.24)",
                        "Adjusted OR1 (95% CI)": "1.91 (0.83\u20134.38)",
                        "Adjusted OR2 (95% CI)": "1.35 (0.50\u20133.68)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[1.89, 1.91, 1.35]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Diabetes",
                        "group": "Yes",
                        "cases_n": "49",
                        "cases_percentage": "22.0",
                        "controls_n": "26",
                        "controls_percentage": "9.3",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted OR1, 95% CI]",
                    "outcomes": "[2.60, (1.41\u20134.79)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Cholecystitis",
                        "Subgroup": "Yes",
                        "Cases (n)": "17",
                        "Cases (%)": "\u22125.9",
                        "Controls (n)": "10",
                        "Controls (%)": "\u22123.3",
                        "Crude OR (95% CI)": "1.89 (0.84\u20134.24)",
                        "Adjusted OR1 (95% CI)": "1.91 (0.83\u20134.38)",
                        "Adjusted OR2 (95% CI)": "1.35 (0.50\u20133.68)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[1.89, 1.91, 1.35]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Diabetes",
                        "group": "Yes",
                        "cases_n": "49",
                        "cases_percentage": "22.0",
                        "controls_n": "26",
                        "controls_percentage": "9.3",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[2.96, (1.48\u20135.92)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Cholecystitis",
                        "Subgroup": "Yes",
                        "Cases (n)": "17",
                        "Cases (%)": "\u22125.9",
                        "Controls (n)": "10",
                        "Controls (%)": "\u22123.3",
                        "Crude OR (95% CI)": "1.89 (0.84\u20134.24)",
                        "Adjusted OR1 (95% CI)": "1.91 (0.83\u20134.38)",
                        "Adjusted OR2 (95% CI)": "1.35 (0.50\u20133.68)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[1.89, 1.91, 1.35]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Cholecystitis",
                        "group": "No",
                        "cases_n": "272",
                        "cases_percentage": "94.1",
                        "controls_n": "195",
                        "controls_percentage": "96.7",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted OR1, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Cholecystitis",
                        "Subgroup": "Yes",
                        "Cases (n)": "17",
                        "Cases (%)": "\u22125.9",
                        "Controls (n)": "10",
                        "Controls (%)": "\u22123.3",
                        "Crude OR (95% CI)": "1.89 (0.84\u20134.24)",
                        "Adjusted OR1 (95% CI)": "1.91 (0.83\u20134.38)",
                        "Adjusted OR2 (95% CI)": "1.35 (0.50\u20133.68)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[1.89, 1.91, 1.35]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Cholecystitis",
                        "group": "No",
                        "cases_n": "272",
                        "cases_percentage": "94.1",
                        "controls_n": "195",
                        "controls_percentage": "96.7",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Cholecystitis",
                        "Subgroup": "Yes",
                        "Cases (n)": "17",
                        "Cases (%)": "\u22125.9",
                        "Controls (n)": "10",
                        "Controls (%)": "\u22123.3",
                        "Crude OR (95% CI)": "1.89 (0.84\u20134.24)",
                        "Adjusted OR1 (95% CI)": "1.91 (0.83\u20134.38)",
                        "Adjusted OR2 (95% CI)": "1.35 (0.50\u20133.68)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[1.89, 1.91, 1.35]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Cholecystitis",
                        "group": "Yes",
                        "cases_n": "17",
                        "cases_percentage": "5.9",
                        "controls_n": "10",
                        "controls_percentage": "3.3"
                    },
                    "measures": "[Crude OR, 95% CI]",
                    "outcomes": "[1.89, (0.84\u20134.24)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Cholecystitis",
                        "Subgroup": "Yes",
                        "Cases (n)": "17",
                        "Cases (%)": "\u22125.9",
                        "Controls (n)": "10",
                        "Controls (%)": "\u22123.3",
                        "Crude OR (95% CI)": "1.89 (0.84\u20134.24)",
                        "Adjusted OR1 (95% CI)": "1.91 (0.83\u20134.38)",
                        "Adjusted OR2 (95% CI)": "1.35 (0.50\u20133.68)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[1.89, 1.91, 1.35]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Cholecystitis",
                        "group": "Yes",
                        "cases_n": "17",
                        "cases_percentage": "5.9",
                        "controls_n": "10",
                        "controls_percentage": "3.3",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted OR1, 95% CI]",
                    "outcomes": "[1.91, (0.83\u20134.38)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Cholecystitis",
                        "Subgroup": "Yes",
                        "Cases (n)": "17",
                        "Cases (%)": "\u22125.9",
                        "Controls (n)": "10",
                        "Controls (%)": "\u22123.3",
                        "Crude OR (95% CI)": "1.89 (0.84\u20134.24)",
                        "Adjusted OR1 (95% CI)": "1.91 (0.83\u20134.38)",
                        "Adjusted OR2 (95% CI)": "1.35 (0.50\u20133.68)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[1.89, 1.91, 1.35]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Cholecystitis",
                        "group": "Yes",
                        "cases_n": "17",
                        "cases_percentage": "5.9",
                        "controls_n": "10",
                        "controls_percentage": "3.3",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[1.35, (0.50\u20133.68)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Cholecystitis",
                        "Subgroup": "Yes",
                        "Cases (n)": "17",
                        "Cases (%)": "\u22125.9",
                        "Controls (n)": "10",
                        "Controls (%)": "\u22123.3",
                        "Crude OR (95% CI)": "1.89 (0.84\u20134.24)",
                        "Adjusted OR1 (95% CI)": "1.91 (0.83\u20134.38)",
                        "Adjusted OR2 (95% CI)": "1.35 (0.50\u20133.68)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[1.89, 1.91, 1.35]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Gallstone",
                        "group": "No",
                        "cases_n": "274",
                        "cases_percentage": "95.1",
                        "controls_n": "300",
                        "controls_percentage": "98.4"
                    },
                    "measures": "[Crude OR, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Cholecystitis",
                        "Subgroup": "Yes",
                        "Cases (n)": "17",
                        "Cases (%)": "\u22125.9",
                        "Controls (n)": "10",
                        "Controls (%)": "\u22123.3",
                        "Crude OR (95% CI)": "1.89 (0.84\u20134.24)",
                        "Adjusted OR1 (95% CI)": "1.91 (0.83\u20134.38)",
                        "Adjusted OR2 (95% CI)": "1.35 (0.50\u20133.68)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[1.89, 1.91, 1.35]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Gallstone",
                        "group": "No",
                        "cases_n": "274",
                        "cases_percentage": "95.1",
                        "controls_n": "300",
                        "controls_percentage": "98.4",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted OR1, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Cholecystitis",
                        "Subgroup": "Yes",
                        "Cases (n)": "17",
                        "Cases (%)": "\u22125.9",
                        "Controls (n)": "10",
                        "Controls (%)": "\u22123.3",
                        "Crude OR (95% CI)": "1.89 (0.84\u20134.24)",
                        "Adjusted OR1 (95% CI)": "1.91 (0.83\u20134.38)",
                        "Adjusted OR2 (95% CI)": "1.35 (0.50\u20133.68)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[1.89, 1.91, 1.35]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Gallstone",
                        "group": "No",
                        "cases_n": "274",
                        "cases_percentage": "95.1",
                        "controls_n": "300",
                        "controls_percentage": "98.4",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Cholecystitis",
                        "Subgroup": "Yes",
                        "Cases (n)": "17",
                        "Cases (%)": "\u22125.9",
                        "Controls (n)": "10",
                        "Controls (%)": "\u22123.3",
                        "Crude OR (95% CI)": "1.89 (0.84\u20134.24)",
                        "Adjusted OR1 (95% CI)": "1.91 (0.83\u20134.38)",
                        "Adjusted OR2 (95% CI)": "1.35 (0.50\u20133.68)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[1.89, 1.91, 1.35]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Gallstone",
                        "group": "Yes",
                        "cases_n": "14",
                        "cases_percentage": "4.9",
                        "controls_n": "5",
                        "controls_percentage": "1.6"
                    },
                    "measures": "[Crude OR, 95% CI]",
                    "outcomes": "[2.80, (1.01\u20137.77)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Cholecystitis",
                        "Subgroup": "Yes",
                        "Cases (n)": "17",
                        "Cases (%)": "\u22125.9",
                        "Controls (n)": "10",
                        "Controls (%)": "\u22123.3",
                        "Crude OR (95% CI)": "1.89 (0.84\u20134.24)",
                        "Adjusted OR1 (95% CI)": "1.91 (0.83\u20134.38)",
                        "Adjusted OR2 (95% CI)": "1.35 (0.50\u20133.68)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[1.89, 1.91, 1.35]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Gallstone",
                        "group": "Yes",
                        "cases_n": "14",
                        "cases_percentage": "4.9",
                        "controls_n": "5",
                        "controls_percentage": "1.6",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted OR1, 95% CI]",
                    "outcomes": "[2.58, (0.89\u20137.44)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Cholecystitis",
                        "Subgroup": "Yes",
                        "Cases (n)": "17",
                        "Cases (%)": "\u22125.9",
                        "Controls (n)": "10",
                        "Controls (%)": "\u22123.3",
                        "Crude OR (95% CI)": "1.89 (0.84\u20134.24)",
                        "Adjusted OR1 (95% CI)": "1.91 (0.83\u20134.38)",
                        "Adjusted OR2 (95% CI)": "1.35 (0.50\u20133.68)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[1.89, 1.91, 1.35]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Gallstone",
                        "group": "Yes",
                        "cases_n": "14",
                        "cases_percentage": "4.9",
                        "controls_n": "5",
                        "controls_percentage": "1.6",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[2.68, (0.65\u201311.07)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Gallstone",
                        "Subgroup": "No",
                        "Cases (n)": "274",
                        "Cases (%)": "\u221295.1",
                        "Controls (n)": "300",
                        "Controls (%)": "\u221298.4",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "family history of pancreatic cancer",
                        "group": "no",
                        "cases_n": "312",
                        "cases_percentage": "96.6",
                        "controls_n": "320",
                        "controls_percentage": "99.1",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted  OR1, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Gallstone",
                        "Subgroup": "No",
                        "Cases (n)": "274",
                        "Cases (%)": "\u221295.1",
                        "Controls (n)": "300",
                        "Controls (%)": "\u221298.4",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "family history of pancreatic cancer",
                        "group": "no",
                        "cases_n": "312",
                        "cases_percentage": "96.6",
                        "controls_n": "320",
                        "controls_percentage": "99.1",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Gallstone",
                        "Subgroup": "No",
                        "Cases (n)": "274",
                        "Cases (%)": "\u221295.1",
                        "Controls (n)": "300",
                        "Controls (%)": "\u221298.4",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "family history of pancreatic cancer",
                        "group": "yes",
                        "cases_n": "11",
                        "cases_percentage": "3.4",
                        "controls_n": "3",
                        "controls_percentage": "0.9"
                    },
                    "measures": "[Crude OR, 95% CI]",
                    "outcomes": "[3.67, (1.02\u201313.14)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Gallstone",
                        "Subgroup": "No",
                        "Cases (n)": "274",
                        "Cases (%)": "\u221295.1",
                        "Controls (n)": "300",
                        "Controls (%)": "\u221298.4",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "family history of pancreatic cancer",
                        "group": "yes",
                        "cases_n": "11",
                        "cases_percentage": "3.4",
                        "controls_n": "3",
                        "controls_percentage": "0.9",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted OR1, 95% CI]",
                    "outcomes": "[4.04, (1.08\u201315.07)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Gallstone",
                        "Subgroup": "No",
                        "Cases (n)": "274",
                        "Cases (%)": "\u221295.1",
                        "Controls (n)": "300",
                        "Controls (%)": "\u221298.4",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "BMI",
                        "group": "<24.0",
                        "cases_n": "197",
                        "cases_percentage": "61.0",
                        "controls_n": "230",
                        "controls_percentage": "71.2",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted OR1, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Gallstone",
                        "Subgroup": "No",
                        "Cases (n)": "274",
                        "Cases (%)": "\u221295.1",
                        "Controls (n)": "300",
                        "Controls (%)": "\u221298.4",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "BMI",
                        "group": "<24.0",
                        "cases_n": "197",
                        "cases_percentage": "61.0",
                        "controls_n": "230",
                        "controls_percentage": "71.2",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Gallstone",
                        "Subgroup": "No",
                        "Cases (n)": "274",
                        "Cases (%)": "\u221295.1",
                        "Controls (n)": "300",
                        "Controls (%)": "\u221298.4",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "BMI",
                        "group": "\u226524.0",
                        "cases_n": "126",
                        "cases_percentage": "39.0",
                        "controls_n": "93",
                        "controls_percentage": "28.8"
                    },
                    "measures": "[Crude OR, 95% CI]",
                    "outcomes": "[1.67, (1.18\u20132.38)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Gallstone",
                        "Subgroup": "No",
                        "Cases (n)": "274",
                        "Cases (%)": "\u221295.1",
                        "Controls (n)": "300",
                        "Controls (%)": "\u221298.4",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "BMI",
                        "group": "\u226524.0",
                        "cases_n": "126",
                        "cases_percentage": "39.0",
                        "controls_n": "93",
                        "controls_percentage": "28.8",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[1.77, (1.22\u20132.57)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Gallstone",
                        "Subgroup": "No",
                        "Cases (n)": "274",
                        "Cases (%)": "\u221295.1",
                        "Controls (n)": "300",
                        "Controls (%)": "\u221298.4",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Diabetes",
                        "group": "No",
                        "cases_n": "174",
                        "cases_percentage": "78.0",
                        "controls_n": "255",
                        "controls_percentage": "90.7",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted OR1, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Gallstone",
                        "Subgroup": "No",
                        "Cases (n)": "274",
                        "Cases (%)": "\u221295.1",
                        "Controls (n)": "300",
                        "Controls (%)": "\u221298.4",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Diabetes",
                        "group": "No",
                        "cases_n": "174",
                        "cases_percentage": "78.0",
                        "controls_n": "255",
                        "controls_percentage": "90.7",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Gallstone",
                        "Subgroup": "No",
                        "Cases (n)": "274",
                        "Cases (%)": "\u221295.1",
                        "Controls (n)": "300",
                        "Controls (%)": "\u221298.4",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Diabetes",
                        "group": "Yes",
                        "cases_n": "49",
                        "cases_percentage": "22.0",
                        "controls_n": "26",
                        "controls_percentage": "9.3"
                    },
                    "measures": "[Crude OR, 95% CI]",
                    "outcomes": "[2.69, (1.51\u20134.77)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Gallstone",
                        "Subgroup": "No",
                        "Cases (n)": "274",
                        "Cases (%)": "\u221295.1",
                        "Controls (n)": "300",
                        "Controls (%)": "\u221298.4",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Diabetes",
                        "group": "Yes",
                        "cases_n": "49",
                        "cases_percentage": "22.0",
                        "controls_n": "26",
                        "controls_percentage": "9.3",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted OR1, 95% CI]",
                    "outcomes": "[2.60, (1.41\u20134.79)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Gallstone",
                        "Subgroup": "No",
                        "Cases (n)": "274",
                        "Cases (%)": "\u221295.1",
                        "Controls (n)": "300",
                        "Controls (%)": "\u221298.4",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Diabetes",
                        "group": "Yes",
                        "cases_n": "49",
                        "cases_percentage": "22.0",
                        "controls_n": "26",
                        "controls_percentage": "9.3",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[2.96, (1.48\u20135.92)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Gallstone",
                        "Subgroup": "No",
                        "Cases (n)": "274",
                        "Cases (%)": "\u221295.1",
                        "Controls (n)": "300",
                        "Controls (%)": "\u221298.4",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Cholecystitis",
                        "group": "No",
                        "cases_n": "272",
                        "cases_percentage": "94.1",
                        "controls_n": "195",
                        "controls_percentage": "96.7",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted OR1, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Gallstone",
                        "Subgroup": "No",
                        "Cases (n)": "274",
                        "Cases (%)": "\u221295.1",
                        "Controls (n)": "300",
                        "Controls (%)": "\u221298.4",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Cholecystitis",
                        "group": "No",
                        "cases_n": "272",
                        "cases_percentage": "94.1",
                        "controls_n": "195",
                        "controls_percentage": "96.7",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Gallstone",
                        "Subgroup": "No",
                        "Cases (n)": "274",
                        "Cases (%)": "\u221295.1",
                        "Controls (n)": "300",
                        "Controls (%)": "\u221298.4",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Cholecystitis",
                        "group": "Yes",
                        "cases_n": "17",
                        "cases_percentage": "5.9",
                        "controls_n": "10",
                        "controls_percentage": "3.3"
                    },
                    "measures": "[Crude OR, 95% CI]",
                    "outcomes": "[1.89, (0.84\u20134.24)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Gallstone",
                        "Subgroup": "No",
                        "Cases (n)": "274",
                        "Cases (%)": "\u221295.1",
                        "Controls (n)": "300",
                        "Controls (%)": "\u221298.4",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Cholecystitis",
                        "group": "Yes",
                        "cases_n": "17",
                        "cases_percentage": "5.9",
                        "controls_n": "10",
                        "controls_percentage": "3.3",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted OR1, 95% CI]",
                    "outcomes": "[1.91, (0.83\u20134.38)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Gallstone",
                        "Subgroup": "No",
                        "Cases (n)": "274",
                        "Cases (%)": "\u221295.1",
                        "Controls (n)": "300",
                        "Controls (%)": "\u221298.4",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Cholecystitis",
                        "group": "Yes",
                        "cases_n": "17",
                        "cases_percentage": "5.9",
                        "controls_n": "10",
                        "controls_percentage": "3.3",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[1.35, (0.50\u20133.68)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Gallstone",
                        "Subgroup": "No",
                        "Cases (n)": "274",
                        "Cases (%)": "\u221295.1",
                        "Controls (n)": "300",
                        "Controls (%)": "\u221298.4",
                        "Crude OR (95% CI)": "1.00 (reference)",
                        "Adjusted OR1 (95% CI)": "1.00 (reference)",
                        "Adjusted OR2 (95% CI)": "1.00 (reference)"
                    },
                    "measures": "[]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Gallstone",
                        "group": "No",
                        "cases_n": "274",
                        "cases_percentage": "95.1",
                        "controls_n": "300",
                        "controls_percentage": "98.4"
                    },
                    "measures": "[Crude OR, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Gallstone",
                        "Subgroup": "Yes",
                        "Cases (n)": "14",
                        "Cases (%)": "\u22124.9",
                        "Controls (n)": "5",
                        "Controls (%)": "\u22121.6",
                        "Crude OR (95% CI)": "2.80 (1.01\u20137.77)",
                        "Adjusted OR1 (95% CI)": "2.58 (0.89\u20137.44)",
                        "Adjusted OR2 (95% CI)": "2.68 (0.65\u201311.07)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.80, 2.58, 2.68]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "family history of pancreatic cancer",
                        "group": "no",
                        "cases_n": "312",
                        "cases_percentage": "96.6",
                        "controls_n": "320",
                        "controls_percentage": "99.1",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted  OR1, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Gallstone",
                        "Subgroup": "Yes",
                        "Cases (n)": "14",
                        "Cases (%)": "\u22124.9",
                        "Controls (n)": "5",
                        "Controls (%)": "\u22121.6",
                        "Crude OR (95% CI)": "2.80 (1.01\u20137.77)",
                        "Adjusted OR1 (95% CI)": "2.58 (0.89\u20137.44)",
                        "Adjusted OR2 (95% CI)": "2.68 (0.65\u201311.07)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.80, 2.58, 2.68]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "family history of pancreatic cancer",
                        "group": "no",
                        "cases_n": "312",
                        "cases_percentage": "96.6",
                        "controls_n": "320",
                        "controls_percentage": "99.1",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Gallstone",
                        "Subgroup": "Yes",
                        "Cases (n)": "14",
                        "Cases (%)": "\u22124.9",
                        "Controls (n)": "5",
                        "Controls (%)": "\u22121.6",
                        "Crude OR (95% CI)": "2.80 (1.01\u20137.77)",
                        "Adjusted OR1 (95% CI)": "2.58 (0.89\u20137.44)",
                        "Adjusted OR2 (95% CI)": "2.68 (0.65\u201311.07)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.80, 2.58, 2.68]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "family history of pancreatic cancer",
                        "group": "yes",
                        "cases_n": "11",
                        "cases_percentage": "3.4",
                        "controls_n": "3",
                        "controls_percentage": "0.9"
                    },
                    "measures": "[Crude OR, 95% CI]",
                    "outcomes": "[3.67, (1.02\u201313.14)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Gallstone",
                        "Subgroup": "Yes",
                        "Cases (n)": "14",
                        "Cases (%)": "\u22124.9",
                        "Controls (n)": "5",
                        "Controls (%)": "\u22121.6",
                        "Crude OR (95% CI)": "2.80 (1.01\u20137.77)",
                        "Adjusted OR1 (95% CI)": "2.58 (0.89\u20137.44)",
                        "Adjusted OR2 (95% CI)": "2.68 (0.65\u201311.07)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.80, 2.58, 2.68]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "family history of pancreatic cancer",
                        "group": "yes",
                        "cases_n": "11",
                        "cases_percentage": "3.4",
                        "controls_n": "3",
                        "controls_percentage": "0.9",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted OR1, 95% CI]",
                    "outcomes": "[4.04, (1.08\u201315.07)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Gallstone",
                        "Subgroup": "Yes",
                        "Cases (n)": "14",
                        "Cases (%)": "\u22124.9",
                        "Controls (n)": "5",
                        "Controls (%)": "\u22121.6",
                        "Crude OR (95% CI)": "2.80 (1.01\u20137.77)",
                        "Adjusted OR1 (95% CI)": "2.58 (0.89\u20137.44)",
                        "Adjusted OR2 (95% CI)": "2.68 (0.65\u201311.07)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.80, 2.58, 2.68]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "BMI",
                        "group": "<24.0",
                        "cases_n": "197",
                        "cases_percentage": "61.0",
                        "controls_n": "230",
                        "controls_percentage": "71.2",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted OR1, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Gallstone",
                        "Subgroup": "Yes",
                        "Cases (n)": "14",
                        "Cases (%)": "\u22124.9",
                        "Controls (n)": "5",
                        "Controls (%)": "\u22121.6",
                        "Crude OR (95% CI)": "2.80 (1.01\u20137.77)",
                        "Adjusted OR1 (95% CI)": "2.58 (0.89\u20137.44)",
                        "Adjusted OR2 (95% CI)": "2.68 (0.65\u201311.07)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.80, 2.58, 2.68]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "BMI",
                        "group": "<24.0",
                        "cases_n": "197",
                        "cases_percentage": "61.0",
                        "controls_n": "230",
                        "controls_percentage": "71.2",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Gallstone",
                        "Subgroup": "Yes",
                        "Cases (n)": "14",
                        "Cases (%)": "\u22124.9",
                        "Controls (n)": "5",
                        "Controls (%)": "\u22121.6",
                        "Crude OR (95% CI)": "2.80 (1.01\u20137.77)",
                        "Adjusted OR1 (95% CI)": "2.58 (0.89\u20137.44)",
                        "Adjusted OR2 (95% CI)": "2.68 (0.65\u201311.07)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.80, 2.58, 2.68]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "BMI",
                        "group": "\u226524.0",
                        "cases_n": "126",
                        "cases_percentage": "39.0",
                        "controls_n": "93",
                        "controls_percentage": "28.8"
                    },
                    "measures": "[Crude OR, 95% CI]",
                    "outcomes": "[1.67, (1.18\u20132.38)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Gallstone",
                        "Subgroup": "Yes",
                        "Cases (n)": "14",
                        "Cases (%)": "\u22124.9",
                        "Controls (n)": "5",
                        "Controls (%)": "\u22121.6",
                        "Crude OR (95% CI)": "2.80 (1.01\u20137.77)",
                        "Adjusted OR1 (95% CI)": "2.58 (0.89\u20137.44)",
                        "Adjusted OR2 (95% CI)": "2.68 (0.65\u201311.07)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.80, 2.58, 2.68]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "BMI",
                        "group": "\u226524.0",
                        "cases_n": "126",
                        "cases_percentage": "39.0",
                        "controls_n": "93",
                        "controls_percentage": "28.8",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[1.77, (1.22\u20132.57)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Gallstone",
                        "Subgroup": "Yes",
                        "Cases (n)": "14",
                        "Cases (%)": "\u22124.9",
                        "Controls (n)": "5",
                        "Controls (%)": "\u22121.6",
                        "Crude OR (95% CI)": "2.80 (1.01\u20137.77)",
                        "Adjusted OR1 (95% CI)": "2.58 (0.89\u20137.44)",
                        "Adjusted OR2 (95% CI)": "2.68 (0.65\u201311.07)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.80, 2.58, 2.68]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Diabetes",
                        "group": "No",
                        "cases_n": "174",
                        "cases_percentage": "78.0",
                        "controls_n": "255",
                        "controls_percentage": "90.7",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted OR1, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Gallstone",
                        "Subgroup": "Yes",
                        "Cases (n)": "14",
                        "Cases (%)": "\u22124.9",
                        "Controls (n)": "5",
                        "Controls (%)": "\u22121.6",
                        "Crude OR (95% CI)": "2.80 (1.01\u20137.77)",
                        "Adjusted OR1 (95% CI)": "2.58 (0.89\u20137.44)",
                        "Adjusted OR2 (95% CI)": "2.68 (0.65\u201311.07)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.80, 2.58, 2.68]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Diabetes",
                        "group": "No",
                        "cases_n": "174",
                        "cases_percentage": "78.0",
                        "controls_n": "255",
                        "controls_percentage": "90.7",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Gallstone",
                        "Subgroup": "Yes",
                        "Cases (n)": "14",
                        "Cases (%)": "\u22124.9",
                        "Controls (n)": "5",
                        "Controls (%)": "\u22121.6",
                        "Crude OR (95% CI)": "2.80 (1.01\u20137.77)",
                        "Adjusted OR1 (95% CI)": "2.58 (0.89\u20137.44)",
                        "Adjusted OR2 (95% CI)": "2.68 (0.65\u201311.07)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.80, 2.58, 2.68]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Diabetes",
                        "group": "Yes",
                        "cases_n": "49",
                        "cases_percentage": "22.0",
                        "controls_n": "26",
                        "controls_percentage": "9.3"
                    },
                    "measures": "[Crude OR, 95% CI]",
                    "outcomes": "[2.69, (1.51\u20134.77)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Gallstone",
                        "Subgroup": "Yes",
                        "Cases (n)": "14",
                        "Cases (%)": "\u22124.9",
                        "Controls (n)": "5",
                        "Controls (%)": "\u22121.6",
                        "Crude OR (95% CI)": "2.80 (1.01\u20137.77)",
                        "Adjusted OR1 (95% CI)": "2.58 (0.89\u20137.44)",
                        "Adjusted OR2 (95% CI)": "2.68 (0.65\u201311.07)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.80, 2.58, 2.68]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Diabetes",
                        "group": "Yes",
                        "cases_n": "49",
                        "cases_percentage": "22.0",
                        "controls_n": "26",
                        "controls_percentage": "9.3",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted OR1, 95% CI]",
                    "outcomes": "[2.60, (1.41\u20134.79)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Gallstone",
                        "Subgroup": "Yes",
                        "Cases (n)": "14",
                        "Cases (%)": "\u22124.9",
                        "Controls (n)": "5",
                        "Controls (%)": "\u22121.6",
                        "Crude OR (95% CI)": "2.80 (1.01\u20137.77)",
                        "Adjusted OR1 (95% CI)": "2.58 (0.89\u20137.44)",
                        "Adjusted OR2 (95% CI)": "2.68 (0.65\u201311.07)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.80, 2.58, 2.68]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Diabetes",
                        "group": "Yes",
                        "cases_n": "49",
                        "cases_percentage": "22.0",
                        "controls_n": "26",
                        "controls_percentage": "9.3",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[2.96, (1.48\u20135.92)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Gallstone",
                        "Subgroup": "Yes",
                        "Cases (n)": "14",
                        "Cases (%)": "\u22124.9",
                        "Controls (n)": "5",
                        "Controls (%)": "\u22121.6",
                        "Crude OR (95% CI)": "2.80 (1.01\u20137.77)",
                        "Adjusted OR1 (95% CI)": "2.58 (0.89\u20137.44)",
                        "Adjusted OR2 (95% CI)": "2.68 (0.65\u201311.07)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.80, 2.58, 2.68]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Cholecystitis",
                        "group": "No",
                        "cases_n": "272",
                        "cases_percentage": "94.1",
                        "controls_n": "195",
                        "controls_percentage": "96.7",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted OR1, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Gallstone",
                        "Subgroup": "Yes",
                        "Cases (n)": "14",
                        "Cases (%)": "\u22124.9",
                        "Controls (n)": "5",
                        "Controls (%)": "\u22121.6",
                        "Crude OR (95% CI)": "2.80 (1.01\u20137.77)",
                        "Adjusted OR1 (95% CI)": "2.58 (0.89\u20137.44)",
                        "Adjusted OR2 (95% CI)": "2.68 (0.65\u201311.07)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.80, 2.58, 2.68]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Cholecystitis",
                        "group": "No",
                        "cases_n": "272",
                        "cases_percentage": "94.1",
                        "controls_n": "195",
                        "controls_percentage": "96.7",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Gallstone",
                        "Subgroup": "Yes",
                        "Cases (n)": "14",
                        "Cases (%)": "\u22124.9",
                        "Controls (n)": "5",
                        "Controls (%)": "\u22121.6",
                        "Crude OR (95% CI)": "2.80 (1.01\u20137.77)",
                        "Adjusted OR1 (95% CI)": "2.58 (0.89\u20137.44)",
                        "Adjusted OR2 (95% CI)": "2.68 (0.65\u201311.07)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.80, 2.58, 2.68]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Cholecystitis",
                        "group": "Yes",
                        "cases_n": "17",
                        "cases_percentage": "5.9",
                        "controls_n": "10",
                        "controls_percentage": "3.3"
                    },
                    "measures": "[Crude OR, 95% CI]",
                    "outcomes": "[1.89, (0.84\u20134.24)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Gallstone",
                        "Subgroup": "Yes",
                        "Cases (n)": "14",
                        "Cases (%)": "\u22124.9",
                        "Controls (n)": "5",
                        "Controls (%)": "\u22121.6",
                        "Crude OR (95% CI)": "2.80 (1.01\u20137.77)",
                        "Adjusted OR1 (95% CI)": "2.58 (0.89\u20137.44)",
                        "Adjusted OR2 (95% CI)": "2.68 (0.65\u201311.07)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.80, 2.58, 2.68]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Cholecystitis",
                        "group": "Yes",
                        "cases_n": "17",
                        "cases_percentage": "5.9",
                        "controls_n": "10",
                        "controls_percentage": "3.3",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted OR1, 95% CI]",
                    "outcomes": "[1.91, (0.83\u20134.38)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Gallstone",
                        "Subgroup": "Yes",
                        "Cases (n)": "14",
                        "Cases (%)": "\u22124.9",
                        "Controls (n)": "5",
                        "Controls (%)": "\u22121.6",
                        "Crude OR (95% CI)": "2.80 (1.01\u20137.77)",
                        "Adjusted OR1 (95% CI)": "2.58 (0.89\u20137.44)",
                        "Adjusted OR2 (95% CI)": "2.68 (0.65\u201311.07)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.80, 2.58, 2.68]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Cholecystitis",
                        "group": "Yes",
                        "cases_n": "17",
                        "cases_percentage": "5.9",
                        "controls_n": "10",
                        "controls_percentage": "3.3",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[1.35, (0.50\u20133.68)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Gallstone",
                        "Subgroup": "Yes",
                        "Cases (n)": "14",
                        "Cases (%)": "\u22124.9",
                        "Controls (n)": "5",
                        "Controls (%)": "\u22121.6",
                        "Crude OR (95% CI)": "2.80 (1.01\u20137.77)",
                        "Adjusted OR1 (95% CI)": "2.58 (0.89\u20137.44)",
                        "Adjusted OR2 (95% CI)": "2.68 (0.65\u201311.07)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.80, 2.58, 2.68]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Gallstone",
                        "group": "No",
                        "cases_n": "274",
                        "cases_percentage": "95.1",
                        "controls_n": "300",
                        "controls_percentage": "98.4",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted OR1, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Gallstone",
                        "Subgroup": "Yes",
                        "Cases (n)": "14",
                        "Cases (%)": "\u22124.9",
                        "Controls (n)": "5",
                        "Controls (%)": "\u22121.6",
                        "Crude OR (95% CI)": "2.80 (1.01\u20137.77)",
                        "Adjusted OR1 (95% CI)": "2.58 (0.89\u20137.44)",
                        "Adjusted OR2 (95% CI)": "2.68 (0.65\u201311.07)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.80, 2.58, 2.68]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Gallstone",
                        "group": "No",
                        "cases_n": "274",
                        "cases_percentage": "95.1",
                        "controls_n": "300",
                        "controls_percentage": "98.4",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[1.00 (reference), NA]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Gallstone",
                        "Subgroup": "Yes",
                        "Cases (n)": "14",
                        "Cases (%)": "\u22124.9",
                        "Controls (n)": "5",
                        "Controls (%)": "\u22121.6",
                        "Crude OR (95% CI)": "2.80 (1.01\u20137.77)",
                        "Adjusted OR1 (95% CI)": "2.58 (0.89\u20137.44)",
                        "Adjusted OR2 (95% CI)": "2.68 (0.65\u201311.07)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.80, 2.58, 2.68]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Gallstone",
                        "group": "Yes",
                        "cases_n": "14",
                        "cases_percentage": "4.9",
                        "controls_n": "5",
                        "controls_percentage": "1.6"
                    },
                    "measures": "[Crude OR, 95% CI]",
                    "outcomes": "[2.80, (1.01\u20137.77)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Gallstone",
                        "Subgroup": "Yes",
                        "Cases (n)": "14",
                        "Cases (%)": "\u22124.9",
                        "Controls (n)": "5",
                        "Controls (%)": "\u22121.6",
                        "Crude OR (95% CI)": "2.80 (1.01\u20137.77)",
                        "Adjusted OR1 (95% CI)": "2.58 (0.89\u20137.44)",
                        "Adjusted OR2 (95% CI)": "2.68 (0.65\u201311.07)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.80, 2.58, 2.68]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Gallstone",
                        "group": "Yes",
                        "cases_n": "14",
                        "cases_percentage": "4.9",
                        "controls_n": "5",
                        "controls_percentage": "1.6",
                        "adjustment": "Adjusted for age, sex, race, and residential areas."
                    },
                    "measures": "[Adjusted OR1, 95% CI]",
                    "outcomes": "[2.58, (0.89\u20137.44)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Characteristic": "Gallstone",
                        "Subgroup": "Yes",
                        "Cases (n)": "14",
                        "Cases (%)": "\u22124.9",
                        "Controls (n)": "5",
                        "Controls (%)": "\u22121.6",
                        "Crude OR (95% CI)": "2.80 (1.01\u20137.77)",
                        "Adjusted OR1 (95% CI)": "2.58 (0.89\u20137.44)",
                        "Adjusted OR2 (95% CI)": "2.68 (0.65\u201311.07)"
                    },
                    "measures": "[Crude OR, Adjusted OR1, Adjusted OR2]",
                    "outcomes": "[2.80, 2.58, 2.68]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "characteristic": "Gallstone",
                        "group": "Yes",
                        "cases_n": "14",
                        "cases_percentage": "4.9",
                        "controls_n": "5",
                        "controls_percentage": "1.6",
                        "adjustment": "Adjusted for age, sex, race, residential areas, smoking, tea drinking, mental pressure, family history of pancreatic cancer, BMI, diabetes, gallstone, pickles and vegetables."
                    },
                    "measures": "[Adjusted OR2, 95% CI]",
                    "outcomes": "[2.68, (0.65\u201311.07)]"
                },
                "match": "no"
            }
        ],
        "total_extracted_claims": 10,
        "total_ground_truth_claims": 30,
        "number_of_matches": 7
    },
    "PMC5522086_3": {
        "matches": [
            {
                "Extracted_claim": {
                    "subject": {
                        "Table": "Top 15 significant upstream transcription regulators",
                        "Upstream Regulator": "TP53",
                        "Activation z-score": "\u22122.353",
                        "P-value of overlap": "3.34\u00d710^\u221232"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[\u22122.353, 3.34\u00d710^\u221232]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Upstream Regulator": "TP53",
                        "Regulation Type": "Inhibition",
                        "Statistical significant overlap": "Fisher's Exact Test"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[-2.353, 3.34E-32]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table": "Top 15 significant upstream transcription regulators",
                        "Upstream Regulator": "NUPR1",
                        "Log Ratio": "\u22122.52",
                        "Activation z-score": "\u22123.977",
                        "P-value of overlap": "4.62\u00d710^\u221213"
                    },
                    "measures": "[Log Ratio, Activation z-score, P-value of overlap]",
                    "outcomes": "[\u22122.52, \u22123.977, 4.62\u00d710^\u221213]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Upstream Regulator": "NUPR1",
                        "Regulation Type": "Inhibition",
                        "Log Ratio": "-2.52",
                        "Statistical significant overlap": "Fisher's Exact Test"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[-3.977, 4.62E-13]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table": "Top 15 significant upstream transcription regulators",
                        "Upstream Regulator": "NKX2-3",
                        "Activation z-score": "\u22123.455",
                        "P-value of overlap": "5.88\u00d710^\u221212"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[\u22123.455, 5.88\u00d710^\u221212]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Upstream Regulator": "NKX2-3",
                        "Regulation Type": "Inhibition",
                        "Statistical significant overlap": "Fisher's Exact Test"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[-3.455, 5.88E-12]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table": "Top 15 significant upstream transcription regulators",
                        "Upstream Regulator": "HNF1A",
                        "Activation z-score": "\u22122.359",
                        "P-value of overlap": "8.82\u00d710^\u221212"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[\u22122.359, 8.82\u00d710^\u221212]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Upstream Regulator": "HNF1A",
                        "Regulation Type": "Inhibition",
                        "Statistical significant overlap": "Fisher's Exact Test"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[-2.359, 8.82E-12]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table": "Top 15 significant upstream transcription regulators",
                        "Upstream Regulator": "CDKN2A",
                        "Log Ratio": "1.737",
                        "Activation z-score": "\u22123.219",
                        "P-value of overlap": "1.34\u00d710^\u221211"
                    },
                    "measures": "[Log Ratio, Activation z-score, P-value of overlap]",
                    "outcomes": "[1.737, \u22123.219, 1.34\u00d710^\u221211]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Upstream Regulator": "CDKN2A",
                        "Regulation Type": "Inhibition",
                        "Log Ratio": "1.737",
                        "Statistical significant overlap": "Fisher's Exact Test"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[-3.219, 1.34E-11]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table": "Top 15 significant upstream transcription regulators",
                        "Upstream Regulator": "estrogen receptor",
                        "Activation z-score": "\u22122.299",
                        "P-value of overlap": "9.57\u00d710^\u221210"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[\u22122.299, 9.57\u00d710^\u221210]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Upstream Regulator": "estrogen receptor",
                        "Regulation Type": "Inhibition",
                        "Statistical significant overlap": "Fisher's Exact Test"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[-2.299, 9.57E-10]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table": "Top 15 significant upstream transcription regulators",
                        "Upstream Regulator": "RB1",
                        "Activation z-score": "\u22124.286",
                        "P-value of overlap": "3.74\u00d710^\u221208"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[\u22124.286, 3.74\u00d710^\u221208]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Upstream Regulator": "RB1",
                        "Regulation Type": "Inhibition",
                        "Statistical significant overlap": "Fisher's Exact Test"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[-4.286, 3.74E-08]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table": "Top 15 significant upstream transcription regulators",
                        "Upstream Regulator": "TCF3",
                        "Activation z-score": "\u22123.116",
                        "P-value of overlap": "4.32\u00d710^\u221208"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[\u22123.116, 4.32\u00d710^\u221208]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Upstream Regulator": "TCF3",
                        "Regulation Type": "Inhibition",
                        "Statistical significant overlap": "Fisher's Exact Test"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[-3.116, 4.32E-08]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table": "Top 15 significant upstream transcription regulators",
                        "Upstream Regulator": "TRIM24",
                        "Activation z-score": "\u22123.714",
                        "P-value of overlap": "6.26\u00d710^\u221207"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[\u22123.714, 6.26\u00d710^\u221207]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Upstream Regulator": "TRIM24",
                        "Regulation Type": "Inhibition",
                        "Statistical significant overlap": "Fisher's Exact Test"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[-3.714, 6.26E-07]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table": "Top 15 significant upstream transcription regulators",
                        "Upstream Regulator": "BCL6",
                        "Activation z-score": "\u22122.313",
                        "P-value of overlap": "1.60\u00d710^\u221206"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[\u22122.313, 1.60\u00d710^\u221206]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Upstream Regulator": "BCL6",
                        "Regulation Type": "Inhibition",
                        "Statistical significant overlap": "Fisher's Exact Test"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[-2.313, 1.60E-06]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table": "Top 15 significant upstream transcription regulators",
                        "Upstream Regulator": "NR5A2",
                        "Log Ratio": "\u22122.876",
                        "Activation z-score": "\u22122.7",
                        "P-value of overlap": "7.26\u00d710^\u221206"
                    },
                    "measures": "[Log Ratio, Activation z-score, P-value of overlap]",
                    "outcomes": "[\u22122.876, \u22122.7, 7.26\u00d710^\u221206]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Upstream Regulator": "NR5A2",
                        "Regulation Type": "Inhibition",
                        "Log Ratio": "-2.876",
                        "Statistical significant overlap": "Fisher's Exact Test"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[-2.7, 7.26E-06]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table": "Top 15 significant upstream transcription regulators",
                        "Upstream Regulator": "SATB1",
                        "Log Ratio": "\u22120.814",
                        "Activation z-score": "\u22122.003",
                        "P-value of overlap": "1.09\u00d710^\u221205"
                    },
                    "measures": "[Log Ratio, Activation z-score, P-value of overlap]",
                    "outcomes": "[\u22120.814, \u22122.003, 1.09\u00d710^\u221205]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Upstream Regulator": "SATB1",
                        "Regulation Type": "Inhibition",
                        "Log Ratio": "-0814",
                        "Statistical significant overlap": "Fisher's Exact Test"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[-2.003, 1.09E-05]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table": "Top 15 significant upstream transcription regulators",
                        "Upstream Regulator": "IRF4",
                        "Log Ratio": "2.115",
                        "Activation z-score": "\u22122.41",
                        "P-value of overlap": "4.24\u00d710^\u221205"
                    },
                    "measures": "[Log Ratio, Activation z-score, P-value of overlap]",
                    "outcomes": "[2.115, \u22122.41, 4.24\u00d710^\u221205]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Upstream Regulator": "IRF4",
                        "Regulation Type": "Inhibition",
                        "Log Ratio": "2.115",
                        "Statistical significant overlap": "Fisher's Exact Test"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[-2.41, 4.24E-05]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table": "Top 15 significant upstream transcription regulators",
                        "Upstream Regulator": "RBL1",
                        "Activation z-score": "\u22123.124",
                        "P-value of overlap": "1.72\u00d710^\u221204"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[\u22123.124, 1.72\u00d710^\u221204]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Upstream Regulator": "RBL1",
                        "Regulation Type": "Inhibition",
                        "Statistical significant overlap": "Fisher's Exact Test"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[-3.124, 1.72E-04]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table": "Top 15 significant upstream transcription regulators",
                        "Upstream Regulator": "SPDEF",
                        "Activation z-score": "\u22122.887",
                        "P-value of overlap": "2.39\u00d710^\u221204"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[\u22122.887, 2.39\u00d710^\u221204]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Upstream Regulator": "SPDEF",
                        "Regulation Type": "Inhibition",
                        "Statistical significant overlap": "Fisher's Exact Test"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[-2.887, 2.39E-04]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table": "Top 15 significant upstream transcription regulators",
                        "Upstream Regulator": "STAT3",
                        "Activation z-score": "2.924",
                        "P-value of overlap": "5.78\u00d710^\u221219"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[2.924, 5.78\u00d710^\u221219]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Upstream Regulator": "STAT3",
                        "Regulation Type": "Activation",
                        "Statistical significant overlap": "Fisher's Exact Test"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[2.924, 5.78E-19]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table": "Top 15 significant upstream transcription regulators",
                        "Upstream Regulator": "CTNNB1",
                        "Activation z-score": "3.359",
                        "P-value of overlap": "1.99\u00d710^\u221215"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[3.359, 1.99\u00d710^\u221215]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Upstream Regulator": "CTNNB1",
                        "Regulation Type": "Activation",
                        "Statistical significant overlap": "Fisher's Exact Test"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[3.359, 1.99E-15]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table": "Top 15 significant upstream transcription regulators",
                        "Upstream Regulator": "SP1",
                        "Activation z-score": "2.06",
                        "P-value of overlap": "4.79\u00d710^\u221213"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[2.06, 4.79\u00d710^\u221213]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Upstream Regulator": "SP1",
                        "Regulation Type": "Activation",
                        "Statistical significant overlap": "Fisher's Exact Test"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[2.06, 4.79E-13]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table": "Top 15 significant upstream transcription regulators",
                        "Upstream Regulator": "CEBPB",
                        "Activation z-score": "2.866",
                        "P-value of overlap": "2.62\u00d710^\u221212"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[2.866, 2.62\u00d710^\u221212]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Upstream Regulator": "CEBPB",
                        "Regulation Type": "Activation",
                        "Statistical significant overlap": "Fisher's Exact Test"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[2.866, 2.62E-12]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table": "Top 15 significant upstream transcription regulators",
                        "Upstream Regulator": "NFkB (complex)",
                        "Activation z-score": "6.314",
                        "P-value of overlap": "1.43\u00d710^\u221211"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[6.314, 1.43\u00d710^\u221211]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Upstream Regulator": "NFkB (complex)",
                        "Regulation Type": "Activation",
                        "Statistical significant overlap": "Fisher's Exact Test"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[6.314, 1.43E-11]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table": "Top 15 significant upstream transcription regulators",
                        "Upstream Regulator": "TBX2",
                        "Activation z-score": "4.99",
                        "P-value of overlap": "1.62\u00d710^\u221211"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[4.99, 1.62\u00d710^\u221211]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Upstream Regulator": "TBX2",
                        "Regulation Type": "Activation",
                        "Statistical significant overlap": "Fisher's Exact Test"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[4.99, 1.62E-11]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table": "Top 15 significant upstream transcription regulators",
                        "Upstream Regulator": "IRF1",
                        "Activation z-score": "3.759",
                        "P-value of overlap": "2.76\u00d710^\u221211"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[3.759, 2.76\u00d710^\u221211]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Upstream Regulator": "IRF1",
                        "Regulation Type": "Activation",
                        "Statistical significant overlap": "Fisher's Exact Test"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[3.759, 2.76E-11]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table": "Top 15 significant upstream transcription regulators",
                        "Upstream Regulator": "IRF7",
                        "Log Ratio": "1.504",
                        "Activation z-score": "5.591",
                        "P-value of overlap": "2.88\u00d710^\u221210"
                    },
                    "measures": "[Log Ratio, Activation z-score, P-value of overlap]",
                    "outcomes": "[1.504, 5.591, 2.88\u00d710^\u221210]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Upstream Regulator": "IRF7",
                        "Regulation Type": "Activation",
                        "Log Ratio": "1.504",
                        "Statistical significant overlap": "Fisher's Exact Test"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[5.591, 2.88E-10]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table": "Top 15 significant upstream transcription regulators",
                        "Upstream Regulator": "FOXM1",
                        "Log Ratio": "2.152",
                        "Activation z-score": "4.395",
                        "P-value of overlap": "5.12\u00d710^\u221210"
                    },
                    "measures": "[Log Ratio, Activation z-score, P-value of overlap]",
                    "outcomes": "[2.152, 4.395, 5.12\u00d710^\u221210]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Upstream Regulator": "FOXM1",
                        "Regulation Type": "Activation",
                        "Log Ratio": "2.152",
                        "Statistical significant overlap": "Fisher's Exact Test"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[4.395, 5.12E-10]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table": "Top 15 significant upstream transcription regulators",
                        "Upstream Regulator": "STAT1",
                        "Activation z-score": "4.576",
                        "P-value of overlap": "2.05\u00d710^\u221208"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[4.576, 2.05\u00d710^\u221208]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Upstream Regulator": "STAT1",
                        "Regulation Type": "Activation",
                        "Statistical significant overlap": "Fisher's Exact Test"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[4.576, 2.05E-08]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table": "Top 15 significant upstream transcription regulators",
                        "Upstream Regulator": "ETS1",
                        "Log Ratio": "0.863",
                        "Activation z-score": "2.575",
                        "P-value of overlap": "5.06\u00d710^\u221208"
                    },
                    "measures": "[Log Ratio, Activation z-score, P-value of overlap]",
                    "outcomes": "[0.863, 2.575, 5.06\u00d710^\u221208]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Upstream Regulator": "ETS1",
                        "Regulation Type": "Activation",
                        "Log Ratio": "0.863",
                        "Statistical significant overlap": "Fisher's Exact Test"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[2.575, 5.06E-08]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table": "Top 15 significant upstream transcription regulators",
                        "Upstream Regulator": "JUN",
                        "Activation z-score": "2.045",
                        "P-value of overlap": "5.57\u00d710^\u221208"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[2.045, 5.57\u00d710^\u221208]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Upstream Regulator": "JUN",
                        "Regulation Type": "Activation",
                        "Statistical significant overlap": "Fisher's Exact Test"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[2.045, 5.57E-08]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table": "Top 15 significant upstream transcription regulators",
                        "Upstream Regulator": "FOXO1",
                        "Activation z-score": "3.242",
                        "P-value of overlap": "9.35\u00d710^\u221208"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[3.242, 9.35\u00d710^\u221208]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Upstream Regulator": "FOXO1",
                        "Regulation Type": "Activation",
                        "Statistical significant overlap": "Fisher's Exact Test"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[3.242, 9.35E-08]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table": "Top 15 significant upstream transcription regulators",
                        "Upstream Regulator": "E2F3",
                        "Log Ratio": "1.137",
                        "Activation z-score": "2.394",
                        "P-value of overlap": "1.16\u00d710^\u221206"
                    },
                    "measures": "[Log Ratio, Activation z-score, P-value of overlap]",
                    "outcomes": "[1.137, 2.394, 1.16\u00d710^\u221206]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Upstream Regulator": "E2F3",
                        "Regulation Type": "Activation",
                        "Log Ratio": "1.137",
                        "Statistical significant overlap": "Fisher's Exact Test"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[2.394, 1.16E-06]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table": "Top 15 significant upstream transcription regulators",
                        "Upstream Regulator": "MBD2",
                        "Activation z-score": "2.549",
                        "P-value of overlap": "5.41\u00d710^\u221206"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[2.549, 5.41\u00d710^\u221206]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Upstream Regulator": "MBD2",
                        "Regulation Type": "Activation",
                        "Statistical significant overlap": "Fisher's Exact Test"
                    },
                    "measures": "[Activation z-score, P-value of overlap]",
                    "outcomes": "[2.549, 5.41E-06]"
                },
                "match": "yes"
            }
        ],
        "total_extracted_claims": 30,
        "total_ground_truth_claims": 30,
        "number_of_matches": 30
    },
    "PMC6062623_3": {
        "matches": [
            {
                "Extracted_claim": {
                    "subject": {
                        "Hypothesis": "State transition",
                        "Graph metric": "Local efficiency",
                        "Hemisphere": "Right",
                        "Density": "0.1"
                    },
                    "measures": "[t-statistic, p-value]",
                    "outcomes": "[-3.76, 0.002]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Hypothesis": "State transition",
                        "Graph metric": "Local efficiency",
                        "Hemisphere": "Right",
                        "Density (k)": "0.1"
                    },
                    "measures": "[t-statistic, p-value]",
                    "outcomes": "[-3.76, 0.002]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Hypothesis": "State transition",
                        "Graph metric": "Local efficiency",
                        "Hemisphere": "Right",
                        "Density": "0.15"
                    },
                    "measures": "[t-statistic, p-value]",
                    "outcomes": "[-3.15, 0.008]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Hypothesis": "State transition",
                        "Graph metric": "Local efficiency",
                        "Hemisphere": "Right",
                        "Density (k)": "0.15"
                    },
                    "measures": "[t-statistic, p-value]",
                    "outcomes": "[-3.15, 0.008]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Hypothesis": "State transition",
                        "Graph metric": "Local efficiency",
                        "Hemisphere": "Right",
                        "Density": "0.2"
                    },
                    "measures": "[t-statistic, p-value]",
                    "outcomes": "[-3.25, 0.006]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Hypothesis": "State transition",
                        "Graph metric": "Local efficiency",
                        "Hemisphere": "Right",
                        "Density (k)": "0.2"
                    },
                    "measures": "[t-statistic, p-value]",
                    "outcomes": "[-3.25, 0.006]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Hypothesis": "State transition",
                        "Graph metric": "Local efficiency",
                        "Hemisphere": "Right",
                        "Density": "0.25"
                    },
                    "measures": "[t-statistic, p-value]",
                    "outcomes": "[-3.08, 0.009]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Hypothesis": "State transition",
                        "Graph metric": "Local efficiency",
                        "Hemisphere": "Right",
                        "Density (k)": "0.25"
                    },
                    "measures": "[t-statistic, p-value]",
                    "outcomes": "[-3.08, 0.009]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Hypothesis": "State transition",
                        "Graph metric": "Local efficiency",
                        "Hemisphere": "Left",
                        "Density": "0.1"
                    },
                    "measures": "[t-statistic, p-value]",
                    "outcomes": "[-1.04, 0.32]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Hypothesis": "State transition",
                        "Graph metric": "Local efficiency",
                        "Hemisphere": "Right",
                        "Density (k)": "0.1"
                    },
                    "measures": "[t-statistic, p-value]",
                    "outcomes": "[-1.04, 0.32]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Hypothesis": "State transition",
                        "Graph metric": "Local efficiency",
                        "Hemisphere": "Left",
                        "Density": "0.15"
                    },
                    "measures": "[t-statistic, p-value]",
                    "outcomes": "[-2.58, 0.022]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Hypothesis": "State transition",
                        "Graph metric": "Local efficiency",
                        "Hemisphere": "Right",
                        "Density (k)": "0.15"
                    },
                    "measures": "[t-statistic, p-value]",
                    "outcomes": "[-2.58, 0.022]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Hypothesis": "State transition",
                        "Graph metric": "Local efficiency",
                        "Hemisphere": "Left",
                        "Density": "0.2"
                    },
                    "measures": "[t-statistic, p-value]",
                    "outcomes": "[-3.36, 0.005]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Hypothesis": "State transition",
                        "Graph metric": "Local efficiency",
                        "Hemisphere": "Right",
                        "Density (k)": "0.2"
                    },
                    "measures": "[t-statistic, p-value]",
                    "outcomes": "[-3.36, 0.005]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Hypothesis": "State transition",
                        "Graph metric": "Local efficiency",
                        "Hemisphere": "Left",
                        "Density": "0.25"
                    },
                    "measures": "[t-statistic, p-value]",
                    "outcomes": "[-3.04, 0.01]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Hypothesis": "State transition",
                        "Graph metric": "Local efficiency",
                        "Hemisphere": "Right",
                        "Density (k)": "0.25"
                    },
                    "measures": "[t-statistic, p-value]",
                    "outcomes": "[-3.04, 0.01]"
                },
                "match": "yes"
            }
        ],
        "total_extracted_claims": 8,
        "total_ground_truth_claims": 8,
        "number_of_matches": 8
    },
    "PMC5687650_6": {
        "matches": [
            {
                "Extracted_claim": {
                    "subject": {
                        "Analysis type": "Univariate analysis",
                        "Risk factor": "Gender (Women or Men)",
                        "OR (95% CI)": "0.770 (0.528-1.124)",
                        "P value": "0.175"
                    },
                    "measures": "[OR, P value]",
                    "outcomes": "[0.770, 0.175]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis_type": "univariate",
                        "risk_factor": "gender",
                        "risk_factor_categories": "women or men"
                    },
                    "measures": "[OR, 95% CI, P value]",
                    "outcomes": "[0.770, 0.528-1.124, 0.175]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Analysis type": "Univariate analysis",
                        "Risk factor": "Age (>65 years or \u226465 years)",
                        "OR (95% CI)": "0.773 (0.537-1.110)",
                        "P value": "0.163"
                    },
                    "measures": "[OR, P value]",
                    "outcomes": "[0.773, 0.163]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis_type": "univariate",
                        "risk_factor": "age",
                        "risk_factor_categories": ">65 years or \u226465years"
                    },
                    "measures": "[OR, 95% CI, P value]",
                    "outcomes": "[0.773, 0.537-1.110, 0.163]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Analysis type": "Univariate analysis",
                        "Risk factor": "PLR (high or low)",
                        "OR (95% CI)": "0.922 (0.641-1.325)",
                        "P value": "0.660"
                    },
                    "measures": "[OR, P value]",
                    "outcomes": "[0.922, 0.660]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis_type": "univariate",
                        "risk_factor": "PLR",
                        "risk_factor_categories": "high or low"
                    },
                    "measures": "[OR, 95% CI, P value]",
                    "outcomes": "[0.922, 0.641-1.325, 0.660]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Analysis type": "Univariate analysis",
                        "Risk factor": "NLR (high or low)",
                        "OR (95% CI)": "1.007 (0.701-1.448)",
                        "P value": "0.969"
                    },
                    "measures": "[OR, P value]",
                    "outcomes": "[1.007, 0.969]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis_type": "univariate",
                        "risk_factor": "NLR",
                        "risk_factor_categories": "high or low"
                    },
                    "measures": "[OR, 95% CI, P value]",
                    "outcomes": "[1.007, 0.701-1.448, 0.969]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Analysis type": "Univariate analysis",
                        "Risk factor": "Post/pre-chemotherapy PLR ratio (>1 or \u22641)",
                        "OR (95% CI)": "1.272 (0.881-1.837)",
                        "P value": "0.199"
                    },
                    "measures": "[OR, P value]",
                    "outcomes": "[1.272, 0.199]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis_type": "univariate",
                        "risk_factor": "post/pre-chemotherapy PLR ratio",
                        "risk_factor_categories": ">1 or \u22641"
                    },
                    "measures": "[OR, 95% CI, P value]",
                    "outcomes": "[1.272, 0.881-1.837, 0.199]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Analysis type": "Univariate analysis",
                        "Risk factor": "Post/pre-chemotherapy NLR ratio (>1 or \u22641)",
                        "OR (95% CI)": "1.902 (1.290-2.803)",
                        "P value": "0.001**"
                    },
                    "measures": "[OR, P value]",
                    "outcomes": "[1.902, 0.001]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis_type": "univariate",
                        "risk_factor": "post/pre-chemotherapy NLR ratio",
                        "risk_factor_categories": ">1 or \u22641"
                    },
                    "measures": "[OR, 95% CI, P value]",
                    "outcomes": "[1.902, 1.290-2.803, 0.001]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Analysis type": "Multivariate analysis",
                        "Risk factor": "Post/pre-chemotherapy NLR ratio (>1 or \u22641)",
                        "OR (95% CI)": "1.902 (1.290-2.803)",
                        "P value": "0.001**"
                    },
                    "measures": "[OR, P value]",
                    "outcomes": "[1.902, 0.001]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis_type": "multivariate",
                        "risk_factor": "post/pre-chemotherapy NLR ratio",
                        "risk_factor_categories": ">1 or \u22641"
                    },
                    "measures": "[OR, 95% CI, P value]",
                    "outcomes": "[1.902, 1.290-2.803, 0.001]"
                },
                "match": "yes"
            }
        ],
        "total_extracted_claims": 7,
        "total_ground_truth_claims": 7,
        "number_of_matches": 7
    },
    "PMC5464866_1": {
        "matches": [
            {
                "Extracted_claim": {
                    "subject": {
                        "Study focus": "Pancreatic cancer",
                        "FXR expression": "Low",
                        "Year": "0",
                        "Number at risk": "87",
                        "Percentage": "49.7%"
                    },
                    "measures": "[Number at risk]",
                    "outcomes": "[87]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Cancer Type": "pancreatic cancer",
                        "Factor": "FXR expression",
                        "Expression Level": "Low",
                        "Year": "0",
                        "Number at risk": "87",
                        "Percentage at risk": "49.7%"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Study focus": "Pancreatic cancer",
                        "FXR expression": "Low",
                        "Year": "2",
                        "Number at risk": "16",
                        "Percentage": "9.1%"
                    },
                    "measures": "[Number at risk]",
                    "outcomes": "[16]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Cancer Type": "pancreatic cancer",
                        "Factor": "FXR expression",
                        "Expression Level": "Low",
                        "Year": "2",
                        "Number at risk": "16",
                        "Percentage at risk": "9.1%"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Study focus": "Pancreatic cancer",
                        "FXR expression": "Low",
                        "Year": "4",
                        "Number at risk": "6",
                        "Percentage": "3.4%"
                    },
                    "measures": "[Number at risk]",
                    "outcomes": "[6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Cancer Type": "pancreatic cancer",
                        "Factor": "FXR expression",
                        "Expression Level": "Low",
                        "Year": "4",
                        "Number at risk": "6",
                        "Percentage at risk": "3.4%"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Study focus": "Pancreatic cancer",
                        "FXR expression": "Low",
                        "Year": "6",
                        "Number at risk": "1",
                        "Percentage": "0.6%"
                    },
                    "measures": "[Number at risk]",
                    "outcomes": "[1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Cancer Type": "pancreatic cancer",
                        "Factor": "FXR expression",
                        "Expression Level": "Low",
                        "Year": "6",
                        "Number at risk": "1",
                        "Percentage at risk": "0.6%"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Study focus": "Pancreatic cancer",
                        "FXR expression": "High",
                        "Year": "0",
                        "Number at risk": "88",
                        "Percentage": "50.3%"
                    },
                    "measures": "[Number at risk]",
                    "outcomes": "[88]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Cancer Type": "pancreatic cancer",
                        "Factor": "FXR expression",
                        "Expression Level": "High",
                        "Year": "0",
                        "Number at risk": "88",
                        "Percentage at risk": "50.3%"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Study focus": "Pancreatic cancer",
                        "FXR expression": "High",
                        "Year": "2",
                        "Number at risk": "9",
                        "Percentage": "5.1%"
                    },
                    "measures": "[Number at risk]",
                    "outcomes": "[9]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Cancer Type": "pancreatic cancer",
                        "Factor": "FXR expression",
                        "Expression Level": "High",
                        "Year": "2",
                        "Number at risk": "9",
                        "Percentage at risk": "5.1%"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Study focus": "Pancreatic cancer",
                        "FXR expression": "High",
                        "Year": "4",
                        "Number at risk": "3",
                        "Percentage": "1.7%"
                    },
                    "measures": "[Number at risk]",
                    "outcomes": "[3]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Cancer Type": "pancreatic cancer",
                        "Factor": "FXR expression",
                        "Expression Level": "High",
                        "Year": "4",
                        "Number at risk": "3",
                        "Percentage at risk": "1.7%"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Study focus": "Pancreatic cancer",
                        "FXR expression": "High",
                        "Year": "6",
                        "Number at risk": "0",
                        "Percentage": "0.0%"
                    },
                    "measures": "[Number at risk]",
                    "outcomes": "[0]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Cancer Type": "pancreatic cancer",
                        "Factor": "FXR expression",
                        "Expression Level": "High",
                        "Year": "6",
                        "Number at risk": "0",
                        "Percentage at risk": "0.0%"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Study focus": "Pancreatic cancer",
                        "FXR expression": "Low",
                        "Median survival time": "1.83 years"
                    },
                    "measures": "[Median survival time]",
                    "outcomes": "[1.83]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Cancer Type": "pancreatic cancer",
                        "Factor": "FXR expression",
                        "Expression Level": "Low",
                        "Unit": "year"
                    },
                    "measures": "['Median survival time']",
                    "outcomes": "['1.83']"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Study focus": "Pancreatic cancer",
                        "FXR expression": "High",
                        "Median survival time": "1.78 years"
                    },
                    "measures": "[Median survival time]",
                    "outcomes": "[1.78]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Cancer Type": "pancreatic cancer",
                        "Factor": "FXR expression",
                        "Expression Level": "High",
                        "Unit": "year"
                    },
                    "measures": "['Median survival time']",
                    "outcomes": "['1.78']"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Study focus": "Pancreatic cancer",
                        "FXR expression": "Low",
                        "Survival rate type": "Three year survival rate",
                        "Survival rate (95% CI)": "0.4288 (0.3020~0.6089)"
                    },
                    "measures": "[Survival rate]",
                    "outcomes": "[0.4288]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Cancer Type": "pancreatic cancer",
                        "Factor": "FXR expression",
                        "Expression Level": "Low",
                        "Confidence Interval": "0.3020~0.6089"
                    },
                    "measures": "['Three year survival rate']",
                    "outcomes": "['0.4288']"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Study focus": "Pancreatic cancer",
                        "FXR expression": "Low",
                        "Survival rate type": "Five year survival rate",
                        "Survival rate (95% CI)": "0.3127 (0.1776~0.5503)"
                    },
                    "measures": "[Survival rate]",
                    "outcomes": "[0.3127]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Cancer Type": "pancreatic cancer",
                        "Factor": "FXR expression",
                        "Expression Level": "Low",
                        "Confidence Interval": "0.1776~0.5503"
                    },
                    "measures": "['Five year survival rate']",
                    "outcomes": "['0.3127']"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Study focus": "Pancreatic cancer",
                        "FXR expression": "High",
                        "Survival rate type": "Three year survival rate",
                        "Survival rate (95% CI)": "0.3036 (0.1646~0.5600)"
                    },
                    "measures": "[Survival rate]",
                    "outcomes": "[0.3036]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Cancer Type": "pancreatic cancer",
                        "Factor": "FXR expression",
                        "Expression Level": "High",
                        "Confidence Interval": "0.1646~0.5600"
                    },
                    "measures": "['Three year survival rate']",
                    "outcomes": "['0.3036']"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Study focus": "Pancreatic cancer",
                        "FXR expression": "High",
                        "Survival rate type": "Five year survival rate",
                        "Survival rate (95% CI)": "0.2277 (0.0989~0.5241)"
                    },
                    "measures": "[Survival rate]",
                    "outcomes": "[0.2277]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Cancer Type": "pancreatic cancer",
                        "Factor": "FXR expression",
                        "Expression Level": "High",
                        "Confidence Interval": "0.0989~0.5241"
                    },
                    "measures": "['Five year survival rate']",
                    "outcomes": "['0.2277']"
                },
                "match": "yes"
            }
        ],
        "total_extracted_claims": 14,
        "total_ground_truth_claims": 14,
        "number_of_matches": 14
    },
    "PMC5641200_3": {
        "matches": [
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[5 (83), 1 (17), -, 2 (50), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['83']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[5 (83), 1 (17), -, 2 (50), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['5']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[5 (83), 1 (17), -, 2 (50), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[5 (83), 1 (17), -, 2 (50), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[5 (83), 1 (17), -, 2 (50), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[5 (83), 1 (17), -, 2 (50), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[5 (83), 1 (17), -, 2 (50), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[5 (83), 1 (17), -, 2 (50), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[5 (83), 1 (17), -, 2 (50), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[5 (83), 1 (17), -, 2 (50), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[5 (83), 1 (17), -, 2 (50), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[5 (83), 1 (17), -, 2 (50), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), 1 (17), -, 2 (50), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['83']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), 1 (17), -, 2 (50), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['5']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), 1 (17), -, 2 (50), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), 1 (17), -, 2 (50), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), 1 (17), -, 2 (50), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), 1 (17), -, 2 (50), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), 1 (17), -, 2 (50), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), 1 (17), -, 2 (50), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), 1 (17), -, 2 (50), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), 1 (17), -, 2 (50), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), 1 (17), -, 2 (50), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), 1 (17), -, 2 (50), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), 1 (17), -, 2 (50), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), 1 (17), -, 2 (50), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), 1 (17), -, 2 (50), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), 1 (17), -, 2 (50), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), 1 (17), -, 2 (50), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), 1 (17), -, 2 (50), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), 1 (17), -, 2 (50), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), 1 (17), -, 2 (50), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), 1 (17), -, 2 (50), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), 1 (17), -, 2 (50), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), -, -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['83']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), -, -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['5']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), -, -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), -, -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), -, -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), -, -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), -, -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), -, -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), -, -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), -, -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), -, -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), -, -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), -, -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), -, -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), -, -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), -, -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), -, -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), -, -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), -, -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), -, -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), -, -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), -, -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), -, -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['67']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), -, -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), -, -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), -, -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), -, -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), -, -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), -, -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), -, -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), -, -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), -, -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), -, -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), 4 (100), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['83']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), 4 (100), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['5']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), 4 (100), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), 4 (100), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), 4 (100), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), 4 (100), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), 4 (100), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), 4 (100), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), 4 (100), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), 4 (100), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), 4 (100), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), 4 (100), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), 4 (100), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), 4 (100), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), 4 (100), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), 4 (100), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), 4 (100), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), 4 (100), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), 4 (100), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), 4 (100), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), 4 (100), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), 4 (100), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), 4 (100), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['67']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), 4 (100), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), 4 (100), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), 4 (100), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), 4 (100), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), 4 (100), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), 4 (100), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), 4 (100), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), 4 (100), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), 4 (100), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), 4 (100), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), 4 (100), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), 4 (100), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), 4 (100), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), 4 (100), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), 4 (100), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), 4 (100), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), 4 (100), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['100']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), 4 (100), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), 4 (100), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), 4 (100), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), 4 (100), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), 4 (100), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['83']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['5']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['67']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['100']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['67']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['75']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[4 (67), 1 (17), 1 (17), 3 (75), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['83']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['5']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['67']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['100']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['67']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['75']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['83']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['5']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['67']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['100']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['67']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['75']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 2 (33), -, 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['83']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['5']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['67']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['100']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['67']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['75']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, 1 (17), -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['25']"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['83']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['5']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['67']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['100']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['67']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['75']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['25']"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['83']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['5']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['67']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['100']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['67']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['75']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['25']"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['83']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['5']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['67']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['100']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['67']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['75']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 2 (33), 2 (33), 1 (25), 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['83']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['5']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['67']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['100']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['67']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['75']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Abdominal pain",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['83']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['5']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['67']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['100']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['67']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['75']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Oral mucositis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['83']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['5']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['67']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['100']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['67']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['75']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dyspepsia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), -, -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['83']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['5']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['67']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['100']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['67']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['75']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Dysgeusia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['83']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['5']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['67']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['100']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['67']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['75']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Anorexia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, -, 2 (50), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['83']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['5']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['67']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['100']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['67']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['75']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Alopecia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 4 (67), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['83']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['5']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['67']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['100']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['67']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['75']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Fatigue",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, 1 (17), -, 3 (75), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['83']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['5']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['67']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['100']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['67']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['75']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pneumonitis",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, -, 1 (25)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['83']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['5']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['67']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['100']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['67']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['75']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Peripheral sensory neuropathy",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[3 (50), -, -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['83']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['5']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['67']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['100']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['67']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['75']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Arthralgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[2 (33), 1 (17), -, 1 (25), -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['83']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['5']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['67']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['100']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['67']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['75']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Myalgia",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[1 (17), 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['83']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['5']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['67']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['100']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['67']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['75']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "LVEF decrease",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, 1 (17), -, -, -, -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['83']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['5']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Red blood cells count decreased",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Leukopenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['67']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Neutropenia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['100']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "AST increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['67']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['4']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['75']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "ALT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "GGT increase",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['25']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hypocalcemia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['17']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Hyponatremia",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['3']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['50']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Nausea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Vomiting",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 2",
                        "Sample Size": "4",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['1']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 incidence']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G1 count']",
                    "outcomes": "['0']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G2 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 incidence']",
                    "outcomes": "['33']"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "AE": "Pericardial effusion",
                        "Dasatinib Dose Level": "Level 2",
                        "n (Level 1)": "6",
                        "n (Level 2)": "4",
                        "Grade": "G3"
                    },
                    "measures": "[n (%) (Level 1, G1), n (%) (Level 1, G2), n (%) (Level 1, G3), n (%) (Level 2, G1), n (%) (Level 2, G2), n (%) (Level 2, G3)]",
                    "outcomes": "[-, -, -, -, 1 (25), -]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "AE": "Diarrhea",
                        "Treatment": "Dasatinib",
                        "Dose Level": "Level 1",
                        "Sample Size": "6",
                        "Grading System": "NCI-CTCAE v4.03"
                    },
                    "measures": "['G3 count']",
                    "outcomes": "['2']"
                },
                "match": "no"
            }
        ],
        "total_extracted_claims": 24,
        "total_ground_truth_claims": 126,
        "number_of_matches": 9
    },
    "PMC5716794_2": {
        "matches": [
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.694 \u00b1 0.077, 0.582\u20130.791]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[90.6, 80.7\u201396.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[50.0, 26.0\u201374.0]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Positive predictive value (PPV)]",
                    "outcomes": "[86.6%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Negative predictive value (NPV)]",
                    "outcomes": "[59.9%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Accuracy (ACC)]",
                    "outcomes": "[81.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "99 mm^2",
                        "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.707 \u00b1 0.074, 0.596\u20130.802]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "99 mm^2",
                        "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[90.6, 80.7\u201396.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "99 mm^2",
                        "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[50.0, 26.0\u201374.0]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "99 mm^2",
                        "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Positive predictive value (PPV)]",
                    "outcomes": "[86.6%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "99 mm^2",
                        "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Negative predictive value (NPV)]",
                    "outcomes": "[59.9%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "99 mm^2",
                        "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Accuracy (ACC)]",
                    "outcomes": "[81.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "134 mm^2",
                        "optimal cutoff value": "1.74 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.731 \u00b1 0.070, 0.622\u20130.823]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "134 mm^2",
                        "optimal cutoff value": "1.74 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[90.6, 80.7\u201396.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "134 mm^2",
                        "optimal cutoff value": "1.74 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[50.0, 26.0\u201374.0]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "134 mm^2",
                        "optimal cutoff value": "1.74 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Positive predictive value (PPV)]",
                    "outcomes": "[86.6%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "134 mm^2",
                        "optimal cutoff value": "1.74 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Negative predictive value (NPV)]",
                    "outcomes": "[59.9%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "134 mm^2",
                        "optimal cutoff value": "1.74 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Accuracy (ACC)]",
                    "outcomes": "[81.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "152 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.751 \u00b1 0.067, 0.643\u20130.840]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "152 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[89.1, 78.8\u201395.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "152 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[55.6, 30.8\u201378.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "152 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Positive predictive value (PPV)]",
                    "outcomes": "[87.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "152 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Negative predictive value (NPV)]",
                    "outcomes": "[58.9%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "152 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Accuracy (ACC)]",
                    "outcomes": "[81.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "161 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.756 \u00b1 0.065, 0.649\u20130.844]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "161 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[89.1, 78.8\u201395.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "161 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[55.6, 30.8\u201378.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "161 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Positive predictive value (PPV)]",
                    "outcomes": "[87.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "161 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Negative predictive value (NPV)]",
                    "outcomes": "[58.9%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "161 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Accuracy (ACC)]",
                    "outcomes": "[81.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "189 mm^2",
                        "optimal cutoff value": "1.75 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.770 \u00b1 0.062, 0.664\u20130.856]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "189 mm^2",
                        "optimal cutoff value": "1.75 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[90.6, 80.7\u201396.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "189 mm^2",
                        "optimal cutoff value": "1.75 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[55.6, 30.8\u201378.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "189 mm^2",
                        "optimal cutoff value": "1.75 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Positive predictive value (PPV)]",
                    "outcomes": "[87.9%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "189 mm^2",
                        "optimal cutoff value": "1.75 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Negative predictive value (NPV)]",
                    "outcomes": "[62.5%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "189 mm^2",
                        "optimal cutoff value": "1.75 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Accuracy (ACC)]",
                    "outcomes": "[82.9%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "214 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.788 \u00b1 0.059, 0.684\u20130.871]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "214 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[92.2, 82.7\u201397.4]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "214 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[55.6, 30.8\u201378.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "214 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Positive predictive value (PPV)]",
                    "outcomes": "[88.1%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "214 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Negative predictive value (NPV)]",
                    "outcomes": "[66.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "214 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Accuracy (ACC)]",
                    "outcomes": "[84.2%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "223 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.793 \u00b1 0.058, 0.689\u20130.874]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "223 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[93.8, 84.8\u201398.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "223 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[55.6, 30.8\u201378.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "223 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Positive predictive value (PPV)]",
                    "outcomes": "[88.3%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "223 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Negative predictive value (NPV)]",
                    "outcomes": "[71.6%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "223 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Accuracy (ACC)]",
                    "outcomes": "[85.4%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "245 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.800 \u00b1 0.056, 0.697\u20130.881]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "245 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[95.3, 86.9\u201399.0]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "245 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[55.6, 30.8\u201378.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "245 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Positive predictive value (PPV)]",
                    "outcomes": "[88.4%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "245 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Negative predictive value (NPV)]",
                    "outcomes": "[76.9%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "55 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.687 \u00b1 0.079",
                        "AUC CI": "0.575\u22120.785",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.4%",
                        "NPV": "56.3%",
                        "ACC": "80.5%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "245 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Accuracy (ACC)]",
                    "outcomes": "[86.6%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "82 mm\u00b2",
                        "Optimal cutoff value": "1.72 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.694 \u00b1 0.077",
                        "AUC CI": "0.582\u22120.791",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.6%",
                        "NPV": "59.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.694, 90.6, 50.0, 86.6, 59.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.694 \u00b1 0.077, 0.582\u20130.791]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "82 mm\u00b2",
                        "Optimal cutoff value": "1.72 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.694 \u00b1 0.077",
                        "AUC CI": "0.582\u22120.791",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.6%",
                        "NPV": "59.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.694, 90.6, 50.0, 86.6, 59.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[90.6, 80.7\u201396.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "82 mm\u00b2",
                        "Optimal cutoff value": "1.72 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.694 \u00b1 0.077",
                        "AUC CI": "0.582\u22120.791",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.6%",
                        "NPV": "59.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.694, 90.6, 50.0, 86.6, 59.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[50.0, 26.0\u201374.0]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "82 mm\u00b2",
                        "Optimal cutoff value": "1.72 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.694 \u00b1 0.077",
                        "AUC CI": "0.582\u22120.791",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.6%",
                        "NPV": "59.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.694, 90.6, 50.0, 86.6, 59.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Positive predictive value (PPV)]",
                    "outcomes": "[86.6%]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "99 mm\u00b2",
                        "Optimal cutoff value": "1.73 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.707 \u00b1 0.074",
                        "AUC CI": "0.596\u22120.802",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.6%",
                        "NPV": "59.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.707, 90.6, 50.0, 86.6, 59.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.694 \u00b1 0.077, 0.582\u20130.791]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "99 mm\u00b2",
                        "Optimal cutoff value": "1.73 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.707 \u00b1 0.074",
                        "AUC CI": "0.596\u22120.802",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.6%",
                        "NPV": "59.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.707, 90.6, 50.0, 86.6, 59.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[90.6, 80.7\u201396.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "99 mm\u00b2",
                        "Optimal cutoff value": "1.73 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.707 \u00b1 0.074",
                        "AUC CI": "0.596\u22120.802",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.6%",
                        "NPV": "59.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.707, 90.6, 50.0, 86.6, 59.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[50.0, 26.0\u201374.0]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "99 mm\u00b2",
                        "Optimal cutoff value": "1.73 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.707 \u00b1 0.074",
                        "AUC CI": "0.596\u22120.802",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.6%",
                        "NPV": "59.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.707, 90.6, 50.0, 86.6, 59.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Negative predictive value (NPV)]",
                    "outcomes": "[59.9%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "99 mm\u00b2",
                        "Optimal cutoff value": "1.73 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.707 \u00b1 0.074",
                        "AUC CI": "0.596\u22120.802",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.6%",
                        "NPV": "59.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.707, 90.6, 50.0, 86.6, 59.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Accuracy (ACC)]",
                    "outcomes": "[81.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "99 mm\u00b2",
                        "Optimal cutoff value": "1.73 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.707 \u00b1 0.074",
                        "AUC CI": "0.596\u22120.802",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.6%",
                        "NPV": "59.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.707, 90.6, 50.0, 86.6, 59.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "99 mm^2",
                        "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.707 \u00b1 0.074, 0.596\u20130.802]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "99 mm\u00b2",
                        "Optimal cutoff value": "1.73 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.707 \u00b1 0.074",
                        "AUC CI": "0.596\u22120.802",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.6%",
                        "NPV": "59.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.707, 90.6, 50.0, 86.6, 59.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "99 mm^2",
                        "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[90.6, 80.7\u201396.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "99 mm\u00b2",
                        "Optimal cutoff value": "1.73 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.707 \u00b1 0.074",
                        "AUC CI": "0.596\u22120.802",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.6%",
                        "NPV": "59.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.707, 90.6, 50.0, 86.6, 59.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "99 mm^2",
                        "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[50.0, 26.0\u201374.0]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "99 mm\u00b2",
                        "Optimal cutoff value": "1.73 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.707 \u00b1 0.074",
                        "AUC CI": "0.596\u22120.802",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.6%",
                        "NPV": "59.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.707, 90.6, 50.0, 86.6, 59.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "99 mm^2",
                        "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Positive predictive value (PPV)]",
                    "outcomes": "[86.6%]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "134 mm\u00b2",
                        "Optimal cutoff value": "1.74 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.731 \u00b1 0.070",
                        "AUC CI": "0.622\u22120.823",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.6%",
                        "NPV": "59.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.731, 90.6, 50.0, 86.6, 59.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.694 \u00b1 0.077, 0.582\u20130.791]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "134 mm\u00b2",
                        "Optimal cutoff value": "1.74 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.731 \u00b1 0.070",
                        "AUC CI": "0.622\u22120.823",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.6%",
                        "NPV": "59.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.731, 90.6, 50.0, 86.6, 59.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[90.6, 80.7\u201396.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "134 mm\u00b2",
                        "Optimal cutoff value": "1.74 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.731 \u00b1 0.070",
                        "AUC CI": "0.622\u22120.823",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.6%",
                        "NPV": "59.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.731, 90.6, 50.0, 86.6, 59.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[50.0, 26.0\u201374.0]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "134 mm\u00b2",
                        "Optimal cutoff value": "1.74 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.731 \u00b1 0.070",
                        "AUC CI": "0.622\u22120.823",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.6%",
                        "NPV": "59.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.731, 90.6, 50.0, 86.6, 59.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Negative predictive value (NPV)]",
                    "outcomes": "[59.9%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "134 mm\u00b2",
                        "Optimal cutoff value": "1.74 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.731 \u00b1 0.070",
                        "AUC CI": "0.622\u22120.823",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.6%",
                        "NPV": "59.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.731, 90.6, 50.0, 86.6, 59.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Accuracy (ACC)]",
                    "outcomes": "[81.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "134 mm\u00b2",
                        "Optimal cutoff value": "1.74 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.731 \u00b1 0.070",
                        "AUC CI": "0.622\u22120.823",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.6%",
                        "NPV": "59.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.731, 90.6, 50.0, 86.6, 59.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "99 mm^2",
                        "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.707 \u00b1 0.074, 0.596\u20130.802]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "134 mm\u00b2",
                        "Optimal cutoff value": "1.74 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.731 \u00b1 0.070",
                        "AUC CI": "0.622\u22120.823",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.6%",
                        "NPV": "59.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.731, 90.6, 50.0, 86.6, 59.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "99 mm^2",
                        "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[90.6, 80.7\u201396.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "134 mm\u00b2",
                        "Optimal cutoff value": "1.74 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.731 \u00b1 0.070",
                        "AUC CI": "0.622\u22120.823",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.6%",
                        "NPV": "59.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.731, 90.6, 50.0, 86.6, 59.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "99 mm^2",
                        "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[50.0, 26.0\u201374.0]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "134 mm\u00b2",
                        "Optimal cutoff value": "1.74 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.731 \u00b1 0.070",
                        "AUC CI": "0.622\u22120.823",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.6%",
                        "NPV": "59.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.731, 90.6, 50.0, 86.6, 59.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "99 mm^2",
                        "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Negative predictive value (NPV)]",
                    "outcomes": "[59.9%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "134 mm\u00b2",
                        "Optimal cutoff value": "1.74 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.731 \u00b1 0.070",
                        "AUC CI": "0.622\u22120.823",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.6%",
                        "NPV": "59.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.731, 90.6, 50.0, 86.6, 59.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "99 mm^2",
                        "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Accuracy (ACC)]",
                    "outcomes": "[81.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "134 mm\u00b2",
                        "Optimal cutoff value": "1.74 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.731 \u00b1 0.070",
                        "AUC CI": "0.622\u22120.823",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.6%",
                        "NPV": "59.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.731, 90.6, 50.0, 86.6, 59.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "134 mm^2",
                        "optimal cutoff value": "1.74 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.731 \u00b1 0.070, 0.622\u20130.823]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "134 mm\u00b2",
                        "Optimal cutoff value": "1.74 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.731 \u00b1 0.070",
                        "AUC CI": "0.622\u22120.823",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.6%",
                        "NPV": "59.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.731, 90.6, 50.0, 86.6, 59.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "134 mm^2",
                        "optimal cutoff value": "1.74 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[90.6, 80.7\u201396.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "134 mm\u00b2",
                        "Optimal cutoff value": "1.74 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.731 \u00b1 0.070",
                        "AUC CI": "0.622\u22120.823",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.6%",
                        "NPV": "59.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.731, 90.6, 50.0, 86.6, 59.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "134 mm^2",
                        "optimal cutoff value": "1.74 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[50.0, 26.0\u201374.0]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "134 mm\u00b2",
                        "Optimal cutoff value": "1.74 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.731 \u00b1 0.070",
                        "AUC CI": "0.622\u22120.823",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "50.0 (26.0\u221274.0)",
                        "PPV": "86.6%",
                        "NPV": "59.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.731, 90.6, 50.0, 86.6, 59.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "134 mm^2",
                        "optimal cutoff value": "1.74 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Positive predictive value (PPV)]",
                    "outcomes": "[86.6%]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "152 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.751 \u00b1 0.067",
                        "AUC CI": "0.643\u22120.840",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.7%",
                        "NPV": "58.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.751, 89.1, 55.6, 87.7, 58.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.694 \u00b1 0.077, 0.582\u20130.791]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "152 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.751 \u00b1 0.067",
                        "AUC CI": "0.643\u22120.840",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.7%",
                        "NPV": "58.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.751, 89.1, 55.6, 87.7, 58.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[90.6, 80.7\u201396.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "152 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.751 \u00b1 0.067",
                        "AUC CI": "0.643\u22120.840",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.7%",
                        "NPV": "58.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.751, 89.1, 55.6, 87.7, 58.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[50.0, 26.0\u201374.0]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "152 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.751 \u00b1 0.067",
                        "AUC CI": "0.643\u22120.840",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.7%",
                        "NPV": "58.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.751, 89.1, 55.6, 87.7, 58.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Negative predictive value (NPV)]",
                    "outcomes": "[59.9%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "152 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.751 \u00b1 0.067",
                        "AUC CI": "0.643\u22120.840",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.7%",
                        "NPV": "58.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.751, 89.1, 55.6, 87.7, 58.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Accuracy (ACC)]",
                    "outcomes": "[81.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "152 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.751 \u00b1 0.067",
                        "AUC CI": "0.643\u22120.840",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.7%",
                        "NPV": "58.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.751, 89.1, 55.6, 87.7, 58.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "99 mm^2",
                        "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.707 \u00b1 0.074, 0.596\u20130.802]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "152 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.751 \u00b1 0.067",
                        "AUC CI": "0.643\u22120.840",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.7%",
                        "NPV": "58.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.751, 89.1, 55.6, 87.7, 58.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "99 mm^2",
                        "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[90.6, 80.7\u201396.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "152 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.751 \u00b1 0.067",
                        "AUC CI": "0.643\u22120.840",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.7%",
                        "NPV": "58.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.751, 89.1, 55.6, 87.7, 58.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "99 mm^2",
                        "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[50.0, 26.0\u201374.0]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "152 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.751 \u00b1 0.067",
                        "AUC CI": "0.643\u22120.840",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.7%",
                        "NPV": "58.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.751, 89.1, 55.6, 87.7, 58.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "99 mm^2",
                        "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Negative predictive value (NPV)]",
                    "outcomes": "[59.9%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "152 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.751 \u00b1 0.067",
                        "AUC CI": "0.643\u22120.840",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.7%",
                        "NPV": "58.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.751, 89.1, 55.6, 87.7, 58.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "99 mm^2",
                        "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Accuracy (ACC)]",
                    "outcomes": "[81.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "152 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.751 \u00b1 0.067",
                        "AUC CI": "0.643\u22120.840",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.7%",
                        "NPV": "58.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.751, 89.1, 55.6, 87.7, 58.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "134 mm^2",
                        "optimal cutoff value": "1.74 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.731 \u00b1 0.070, 0.622\u20130.823]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "152 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.751 \u00b1 0.067",
                        "AUC CI": "0.643\u22120.840",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.7%",
                        "NPV": "58.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.751, 89.1, 55.6, 87.7, 58.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "134 mm^2",
                        "optimal cutoff value": "1.74 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[90.6, 80.7\u201396.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "152 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.751 \u00b1 0.067",
                        "AUC CI": "0.643\u22120.840",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.7%",
                        "NPV": "58.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.751, 89.1, 55.6, 87.7, 58.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "134 mm^2",
                        "optimal cutoff value": "1.74 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[50.0, 26.0\u201374.0]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "152 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.751 \u00b1 0.067",
                        "AUC CI": "0.643\u22120.840",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.7%",
                        "NPV": "58.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.751, 89.1, 55.6, 87.7, 58.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "134 mm^2",
                        "optimal cutoff value": "1.74 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Negative predictive value (NPV)]",
                    "outcomes": "[59.9%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "152 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.751 \u00b1 0.067",
                        "AUC CI": "0.643\u22120.840",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.7%",
                        "NPV": "58.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.751, 89.1, 55.6, 87.7, 58.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "134 mm^2",
                        "optimal cutoff value": "1.74 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Accuracy (ACC)]",
                    "outcomes": "[81.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "152 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.751 \u00b1 0.067",
                        "AUC CI": "0.643\u22120.840",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.7%",
                        "NPV": "58.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.751, 89.1, 55.6, 87.7, 58.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "152 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.751 \u00b1 0.067, 0.643\u20130.840]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "152 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.751 \u00b1 0.067",
                        "AUC CI": "0.643\u22120.840",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.7%",
                        "NPV": "58.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.751, 89.1, 55.6, 87.7, 58.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "152 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[89.1, 78.8\u201395.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "152 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.751 \u00b1 0.067",
                        "AUC CI": "0.643\u22120.840",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.7%",
                        "NPV": "58.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.751, 89.1, 55.6, 87.7, 58.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "152 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[55.6, 30.8\u201378.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "152 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.751 \u00b1 0.067",
                        "AUC CI": "0.643\u22120.840",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.7%",
                        "NPV": "58.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.751, 89.1, 55.6, 87.7, 58.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "152 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Positive predictive value (PPV)]",
                    "outcomes": "[87.7%]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "161 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.756 \u00b1 0.065",
                        "AUC CI": "0.649\u22120.844",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.7%",
                        "NPV": "58.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.756, 89.1, 55.6, 87.7, 58.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.694 \u00b1 0.077, 0.582\u20130.791]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "161 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.756 \u00b1 0.065",
                        "AUC CI": "0.649\u22120.844",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.7%",
                        "NPV": "58.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.756, 89.1, 55.6, 87.7, 58.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[90.6, 80.7\u201396.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "161 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.756 \u00b1 0.065",
                        "AUC CI": "0.649\u22120.844",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.7%",
                        "NPV": "58.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.756, 89.1, 55.6, 87.7, 58.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[50.0, 26.0\u201374.0]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "161 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.756 \u00b1 0.065",
                        "AUC CI": "0.649\u22120.844",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.7%",
                        "NPV": "58.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.756, 89.1, 55.6, 87.7, 58.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Negative predictive value (NPV)]",
                    "outcomes": "[59.9%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "161 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.756 \u00b1 0.065",
                        "AUC CI": "0.649\u22120.844",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.7%",
                        "NPV": "58.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.756, 89.1, 55.6, 87.7, 58.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Accuracy (ACC)]",
                    "outcomes": "[81.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "161 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.756 \u00b1 0.065",
                        "AUC CI": "0.649\u22120.844",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.7%",
                        "NPV": "58.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.756, 89.1, 55.6, 87.7, 58.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "99 mm^2",
                        "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.707 \u00b1 0.074, 0.596\u20130.802]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "161 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.756 \u00b1 0.065",
                        "AUC CI": "0.649\u22120.844",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.7%",
                        "NPV": "58.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.756, 89.1, 55.6, 87.7, 58.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "99 mm^2",
                        "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[90.6, 80.7\u201396.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "161 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.756 \u00b1 0.065",
                        "AUC CI": "0.649\u22120.844",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.7%",
                        "NPV": "58.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.756, 89.1, 55.6, 87.7, 58.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "99 mm^2",
                        "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[50.0, 26.0\u201374.0]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "161 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.756 \u00b1 0.065",
                        "AUC CI": "0.649\u22120.844",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.7%",
                        "NPV": "58.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.756, 89.1, 55.6, 87.7, 58.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "99 mm^2",
                        "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Negative predictive value (NPV)]",
                    "outcomes": "[59.9%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "161 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.756 \u00b1 0.065",
                        "AUC CI": "0.649\u22120.844",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.7%",
                        "NPV": "58.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.756, 89.1, 55.6, 87.7, 58.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "99 mm^2",
                        "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Accuracy (ACC)]",
                    "outcomes": "[81.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "161 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.756 \u00b1 0.065",
                        "AUC CI": "0.649\u22120.844",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.7%",
                        "NPV": "58.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.756, 89.1, 55.6, 87.7, 58.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "134 mm^2",
                        "optimal cutoff value": "1.74 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.731 \u00b1 0.070, 0.622\u20130.823]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "161 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.756 \u00b1 0.065",
                        "AUC CI": "0.649\u22120.844",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.7%",
                        "NPV": "58.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.756, 89.1, 55.6, 87.7, 58.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "134 mm^2",
                        "optimal cutoff value": "1.74 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[90.6, 80.7\u201396.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "161 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.756 \u00b1 0.065",
                        "AUC CI": "0.649\u22120.844",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.7%",
                        "NPV": "58.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.756, 89.1, 55.6, 87.7, 58.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "134 mm^2",
                        "optimal cutoff value": "1.74 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[50.0, 26.0\u201374.0]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "161 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.756 \u00b1 0.065",
                        "AUC CI": "0.649\u22120.844",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.7%",
                        "NPV": "58.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.756, 89.1, 55.6, 87.7, 58.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "134 mm^2",
                        "optimal cutoff value": "1.74 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Negative predictive value (NPV)]",
                    "outcomes": "[59.9%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "161 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.756 \u00b1 0.065",
                        "AUC CI": "0.649\u22120.844",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.7%",
                        "NPV": "58.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.756, 89.1, 55.6, 87.7, 58.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "134 mm^2",
                        "optimal cutoff value": "1.74 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Accuracy (ACC)]",
                    "outcomes": "[81.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "161 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.756 \u00b1 0.065",
                        "AUC CI": "0.649\u22120.844",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.7%",
                        "NPV": "58.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.756, 89.1, 55.6, 87.7, 58.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "152 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.751 \u00b1 0.067, 0.643\u20130.840]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "161 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.756 \u00b1 0.065",
                        "AUC CI": "0.649\u22120.844",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.7%",
                        "NPV": "58.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.756, 89.1, 55.6, 87.7, 58.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "152 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[89.1, 78.8\u201395.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "161 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.756 \u00b1 0.065",
                        "AUC CI": "0.649\u22120.844",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.7%",
                        "NPV": "58.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.756, 89.1, 55.6, 87.7, 58.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "152 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[55.6, 30.8\u201378.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "161 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.756 \u00b1 0.065",
                        "AUC CI": "0.649\u22120.844",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.7%",
                        "NPV": "58.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.756, 89.1, 55.6, 87.7, 58.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "152 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Negative predictive value (NPV)]",
                    "outcomes": "[58.9%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "161 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.756 \u00b1 0.065",
                        "AUC CI": "0.649\u22120.844",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.7%",
                        "NPV": "58.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.756, 89.1, 55.6, 87.7, 58.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "152 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Accuracy (ACC)]",
                    "outcomes": "[81.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "161 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.756 \u00b1 0.065",
                        "AUC CI": "0.649\u22120.844",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.7%",
                        "NPV": "58.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.756, 89.1, 55.6, 87.7, 58.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "161 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.756 \u00b1 0.065, 0.649\u20130.844]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "161 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.756 \u00b1 0.065",
                        "AUC CI": "0.649\u22120.844",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.7%",
                        "NPV": "58.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.756, 89.1, 55.6, 87.7, 58.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "161 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[89.1, 78.8\u201395.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "161 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.756 \u00b1 0.065",
                        "AUC CI": "0.649\u22120.844",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.7%",
                        "NPV": "58.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.756, 89.1, 55.6, 87.7, 58.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "161 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[55.6, 30.8\u201378.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "161 mm\u00b2",
                        "Optimal cutoff value": "1.70 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.756 \u00b1 0.065",
                        "AUC CI": "0.649\u22120.844",
                        "Sensitivity": "89.1 (78.8\u221295.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.7%",
                        "NPV": "58.9%",
                        "ACC": "81.7%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.756, 89.1, 55.6, 87.7, 58.9, 81.7]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "161 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Positive predictive value (PPV)]",
                    "outcomes": "[87.7%]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "189 mm\u00b2",
                        "Optimal cutoff value": "1.75 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.770 \u00b1 0.062",
                        "AUC CI": "0.664\u22120.856",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.9%",
                        "NPV": "62.5%",
                        "ACC": "82.9%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.770, 90.6, 55.6, 87.9, 62.5, 82.9]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.694 \u00b1 0.077, 0.582\u20130.791]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "189 mm\u00b2",
                        "Optimal cutoff value": "1.75 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.770 \u00b1 0.062",
                        "AUC CI": "0.664\u22120.856",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.9%",
                        "NPV": "62.5%",
                        "ACC": "82.9%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.770, 90.6, 55.6, 87.9, 62.5, 82.9]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[90.6, 80.7\u201396.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "189 mm\u00b2",
                        "Optimal cutoff value": "1.75 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.770 \u00b1 0.062",
                        "AUC CI": "0.664\u22120.856",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.9%",
                        "NPV": "62.5%",
                        "ACC": "82.9%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.770, 90.6, 55.6, 87.9, 62.5, 82.9]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[50.0, 26.0\u201374.0]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "189 mm\u00b2",
                        "Optimal cutoff value": "1.75 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.770 \u00b1 0.062",
                        "AUC CI": "0.664\u22120.856",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.9%",
                        "NPV": "62.5%",
                        "ACC": "82.9%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.770, 90.6, 55.6, 87.9, 62.5, 82.9]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Negative predictive value (NPV)]",
                    "outcomes": "[59.9%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "189 mm\u00b2",
                        "Optimal cutoff value": "1.75 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.770 \u00b1 0.062",
                        "AUC CI": "0.664\u22120.856",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.9%",
                        "NPV": "62.5%",
                        "ACC": "82.9%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.770, 90.6, 55.6, 87.9, 62.5, 82.9]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Accuracy (ACC)]",
                    "outcomes": "[81.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "189 mm\u00b2",
                        "Optimal cutoff value": "1.75 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.770 \u00b1 0.062",
                        "AUC CI": "0.664\u22120.856",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.9%",
                        "NPV": "62.5%",
                        "ACC": "82.9%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.770, 90.6, 55.6, 87.9, 62.5, 82.9]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "99 mm^2",
                        "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.707 \u00b1 0.074, 0.596\u20130.802]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "189 mm\u00b2",
                        "Optimal cutoff value": "1.75 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.770 \u00b1 0.062",
                        "AUC CI": "0.664\u22120.856",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.9%",
                        "NPV": "62.5%",
                        "ACC": "82.9%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.770, 90.6, 55.6, 87.9, 62.5, 82.9]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "99 mm^2",
                        "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[90.6, 80.7\u201396.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "189 mm\u00b2",
                        "Optimal cutoff value": "1.75 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.770 \u00b1 0.062",
                        "AUC CI": "0.664\u22120.856",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.9%",
                        "NPV": "62.5%",
                        "ACC": "82.9%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.770, 90.6, 55.6, 87.9, 62.5, 82.9]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "99 mm^2",
                        "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[50.0, 26.0\u201374.0]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "189 mm\u00b2",
                        "Optimal cutoff value": "1.75 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.770 \u00b1 0.062",
                        "AUC CI": "0.664\u22120.856",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.9%",
                        "NPV": "62.5%",
                        "ACC": "82.9%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.770, 90.6, 55.6, 87.9, 62.5, 82.9]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "99 mm^2",
                        "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Negative predictive value (NPV)]",
                    "outcomes": "[59.9%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "189 mm\u00b2",
                        "Optimal cutoff value": "1.75 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.770 \u00b1 0.062",
                        "AUC CI": "0.664\u22120.856",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.9%",
                        "NPV": "62.5%",
                        "ACC": "82.9%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.770, 90.6, 55.6, 87.9, 62.5, 82.9]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "99 mm^2",
                        "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Accuracy (ACC)]",
                    "outcomes": "[81.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "189 mm\u00b2",
                        "Optimal cutoff value": "1.75 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.770 \u00b1 0.062",
                        "AUC CI": "0.664\u22120.856",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.9%",
                        "NPV": "62.5%",
                        "ACC": "82.9%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.770, 90.6, 55.6, 87.9, 62.5, 82.9]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "134 mm^2",
                        "optimal cutoff value": "1.74 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.731 \u00b1 0.070, 0.622\u20130.823]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "189 mm\u00b2",
                        "Optimal cutoff value": "1.75 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.770 \u00b1 0.062",
                        "AUC CI": "0.664\u22120.856",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.9%",
                        "NPV": "62.5%",
                        "ACC": "82.9%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.770, 90.6, 55.6, 87.9, 62.5, 82.9]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "134 mm^2",
                        "optimal cutoff value": "1.74 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[90.6, 80.7\u201396.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "189 mm\u00b2",
                        "Optimal cutoff value": "1.75 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.770 \u00b1 0.062",
                        "AUC CI": "0.664\u22120.856",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.9%",
                        "NPV": "62.5%",
                        "ACC": "82.9%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.770, 90.6, 55.6, 87.9, 62.5, 82.9]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "134 mm^2",
                        "optimal cutoff value": "1.74 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[50.0, 26.0\u201374.0]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "189 mm\u00b2",
                        "Optimal cutoff value": "1.75 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.770 \u00b1 0.062",
                        "AUC CI": "0.664\u22120.856",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.9%",
                        "NPV": "62.5%",
                        "ACC": "82.9%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.770, 90.6, 55.6, 87.9, 62.5, 82.9]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "134 mm^2",
                        "optimal cutoff value": "1.74 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Negative predictive value (NPV)]",
                    "outcomes": "[59.9%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "189 mm\u00b2",
                        "Optimal cutoff value": "1.75 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.770 \u00b1 0.062",
                        "AUC CI": "0.664\u22120.856",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.9%",
                        "NPV": "62.5%",
                        "ACC": "82.9%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.770, 90.6, 55.6, 87.9, 62.5, 82.9]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "134 mm^2",
                        "optimal cutoff value": "1.74 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Accuracy (ACC)]",
                    "outcomes": "[81.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "189 mm\u00b2",
                        "Optimal cutoff value": "1.75 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.770 \u00b1 0.062",
                        "AUC CI": "0.664\u22120.856",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.9%",
                        "NPV": "62.5%",
                        "ACC": "82.9%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.770, 90.6, 55.6, 87.9, 62.5, 82.9]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "152 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.751 \u00b1 0.067, 0.643\u20130.840]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "189 mm\u00b2",
                        "Optimal cutoff value": "1.75 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.770 \u00b1 0.062",
                        "AUC CI": "0.664\u22120.856",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.9%",
                        "NPV": "62.5%",
                        "ACC": "82.9%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.770, 90.6, 55.6, 87.9, 62.5, 82.9]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "152 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[89.1, 78.8\u201395.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "189 mm\u00b2",
                        "Optimal cutoff value": "1.75 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.770 \u00b1 0.062",
                        "AUC CI": "0.664\u22120.856",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.9%",
                        "NPV": "62.5%",
                        "ACC": "82.9%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.770, 90.6, 55.6, 87.9, 62.5, 82.9]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "152 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[55.6, 30.8\u201378.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "189 mm\u00b2",
                        "Optimal cutoff value": "1.75 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.770 \u00b1 0.062",
                        "AUC CI": "0.664\u22120.856",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.9%",
                        "NPV": "62.5%",
                        "ACC": "82.9%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.770, 90.6, 55.6, 87.9, 62.5, 82.9]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "152 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Negative predictive value (NPV)]",
                    "outcomes": "[58.9%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "189 mm\u00b2",
                        "Optimal cutoff value": "1.75 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.770 \u00b1 0.062",
                        "AUC CI": "0.664\u22120.856",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.9%",
                        "NPV": "62.5%",
                        "ACC": "82.9%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.770, 90.6, 55.6, 87.9, 62.5, 82.9]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "152 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Accuracy (ACC)]",
                    "outcomes": "[81.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "189 mm\u00b2",
                        "Optimal cutoff value": "1.75 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.770 \u00b1 0.062",
                        "AUC CI": "0.664\u22120.856",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.9%",
                        "NPV": "62.5%",
                        "ACC": "82.9%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.770, 90.6, 55.6, 87.9, 62.5, 82.9]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "161 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.756 \u00b1 0.065, 0.649\u20130.844]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "189 mm\u00b2",
                        "Optimal cutoff value": "1.75 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.770 \u00b1 0.062",
                        "AUC CI": "0.664\u22120.856",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.9%",
                        "NPV": "62.5%",
                        "ACC": "82.9%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.770, 90.6, 55.6, 87.9, 62.5, 82.9]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "161 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[89.1, 78.8\u201395.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "189 mm\u00b2",
                        "Optimal cutoff value": "1.75 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.770 \u00b1 0.062",
                        "AUC CI": "0.664\u22120.856",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.9%",
                        "NPV": "62.5%",
                        "ACC": "82.9%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.770, 90.6, 55.6, 87.9, 62.5, 82.9]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "161 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[55.6, 30.8\u201378.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "189 mm\u00b2",
                        "Optimal cutoff value": "1.75 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.770 \u00b1 0.062",
                        "AUC CI": "0.664\u22120.856",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.9%",
                        "NPV": "62.5%",
                        "ACC": "82.9%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.770, 90.6, 55.6, 87.9, 62.5, 82.9]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "161 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Negative predictive value (NPV)]",
                    "outcomes": "[58.9%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "189 mm\u00b2",
                        "Optimal cutoff value": "1.75 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.770 \u00b1 0.062",
                        "AUC CI": "0.664\u22120.856",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.9%",
                        "NPV": "62.5%",
                        "ACC": "82.9%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.770, 90.6, 55.6, 87.9, 62.5, 82.9]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "161 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Accuracy (ACC)]",
                    "outcomes": "[81.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "189 mm\u00b2",
                        "Optimal cutoff value": "1.75 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.770 \u00b1 0.062",
                        "AUC CI": "0.664\u22120.856",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.9%",
                        "NPV": "62.5%",
                        "ACC": "82.9%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.770, 90.6, 55.6, 87.9, 62.5, 82.9]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "189 mm^2",
                        "optimal cutoff value": "1.75 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.770 \u00b1 0.062, 0.664\u20130.856]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "189 mm\u00b2",
                        "Optimal cutoff value": "1.75 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.770 \u00b1 0.062",
                        "AUC CI": "0.664\u22120.856",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.9%",
                        "NPV": "62.5%",
                        "ACC": "82.9%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.770, 90.6, 55.6, 87.9, 62.5, 82.9]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "189 mm^2",
                        "optimal cutoff value": "1.75 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[90.6, 80.7\u201396.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "189 mm\u00b2",
                        "Optimal cutoff value": "1.75 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.770 \u00b1 0.062",
                        "AUC CI": "0.664\u22120.856",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.9%",
                        "NPV": "62.5%",
                        "ACC": "82.9%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.770, 90.6, 55.6, 87.9, 62.5, 82.9]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "189 mm^2",
                        "optimal cutoff value": "1.75 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[55.6, 30.8\u201378.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "189 mm\u00b2",
                        "Optimal cutoff value": "1.75 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.770 \u00b1 0.062",
                        "AUC CI": "0.664\u22120.856",
                        "Sensitivity": "90.6 (80.7\u221296.5)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "87.9%",
                        "NPV": "62.5%",
                        "ACC": "82.9%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.770, 90.6, 55.6, 87.9, 62.5, 82.9]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "189 mm^2",
                        "optimal cutoff value": "1.75 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Positive predictive value (PPV)]",
                    "outcomes": "[87.9%]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "214 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.788 \u00b1 0.059",
                        "AUC CI": "0.684\u22120.871",
                        "Sensitivity": "92.2 (82.7\u221297.4)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.1%",
                        "NPV": "66.7%",
                        "ACC": "84.2%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.788, 92.2, 55.6, 88.1, 66.7, 84.2]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.694 \u00b1 0.077, 0.582\u20130.791]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "214 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.788 \u00b1 0.059",
                        "AUC CI": "0.684\u22120.871",
                        "Sensitivity": "92.2 (82.7\u221297.4)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.1%",
                        "NPV": "66.7%",
                        "ACC": "84.2%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.788, 92.2, 55.6, 88.1, 66.7, 84.2]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[90.6, 80.7\u201396.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "214 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.788 \u00b1 0.059",
                        "AUC CI": "0.684\u22120.871",
                        "Sensitivity": "92.2 (82.7\u221297.4)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.1%",
                        "NPV": "66.7%",
                        "ACC": "84.2%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.788, 92.2, 55.6, 88.1, 66.7, 84.2]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[50.0, 26.0\u201374.0]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "214 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.788 \u00b1 0.059",
                        "AUC CI": "0.684\u22120.871",
                        "Sensitivity": "92.2 (82.7\u221297.4)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.1%",
                        "NPV": "66.7%",
                        "ACC": "84.2%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.788, 92.2, 55.6, 88.1, 66.7, 84.2]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Negative predictive value (NPV)]",
                    "outcomes": "[59.9%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "214 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.788 \u00b1 0.059",
                        "AUC CI": "0.684\u22120.871",
                        "Sensitivity": "92.2 (82.7\u221297.4)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.1%",
                        "NPV": "66.7%",
                        "ACC": "84.2%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.788, 92.2, 55.6, 88.1, 66.7, 84.2]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Accuracy (ACC)]",
                    "outcomes": "[81.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "214 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.788 \u00b1 0.059",
                        "AUC CI": "0.684\u22120.871",
                        "Sensitivity": "92.2 (82.7\u221297.4)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.1%",
                        "NPV": "66.7%",
                        "ACC": "84.2%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.788, 92.2, 55.6, 88.1, 66.7, 84.2]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "99 mm^2",
                        "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.707 \u00b1 0.074, 0.596\u20130.802]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "214 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.788 \u00b1 0.059",
                        "AUC CI": "0.684\u22120.871",
                        "Sensitivity": "92.2 (82.7\u221297.4)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.1%",
                        "NPV": "66.7%",
                        "ACC": "84.2%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.788, 92.2, 55.6, 88.1, 66.7, 84.2]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "99 mm^2",
                        "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[90.6, 80.7\u201396.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "214 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.788 \u00b1 0.059",
                        "AUC CI": "0.684\u22120.871",
                        "Sensitivity": "92.2 (82.7\u221297.4)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.1%",
                        "NPV": "66.7%",
                        "ACC": "84.2%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.788, 92.2, 55.6, 88.1, 66.7, 84.2]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "99 mm^2",
                        "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[50.0, 26.0\u201374.0]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "214 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.788 \u00b1 0.059",
                        "AUC CI": "0.684\u22120.871",
                        "Sensitivity": "92.2 (82.7\u221297.4)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.1%",
                        "NPV": "66.7%",
                        "ACC": "84.2%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.788, 92.2, 55.6, 88.1, 66.7, 84.2]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "99 mm^2",
                        "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Negative predictive value (NPV)]",
                    "outcomes": "[59.9%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "214 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.788 \u00b1 0.059",
                        "AUC CI": "0.684\u22120.871",
                        "Sensitivity": "92.2 (82.7\u221297.4)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.1%",
                        "NPV": "66.7%",
                        "ACC": "84.2%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.788, 92.2, 55.6, 88.1, 66.7, 84.2]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "99 mm^2",
                        "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Accuracy (ACC)]",
                    "outcomes": "[81.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "214 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.788 \u00b1 0.059",
                        "AUC CI": "0.684\u22120.871",
                        "Sensitivity": "92.2 (82.7\u221297.4)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.1%",
                        "NPV": "66.7%",
                        "ACC": "84.2%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.788, 92.2, 55.6, 88.1, 66.7, 84.2]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "134 mm^2",
                        "optimal cutoff value": "1.74 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.731 \u00b1 0.070, 0.622\u20130.823]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "214 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.788 \u00b1 0.059",
                        "AUC CI": "0.684\u22120.871",
                        "Sensitivity": "92.2 (82.7\u221297.4)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.1%",
                        "NPV": "66.7%",
                        "ACC": "84.2%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.788, 92.2, 55.6, 88.1, 66.7, 84.2]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "134 mm^2",
                        "optimal cutoff value": "1.74 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[90.6, 80.7\u201396.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "214 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.788 \u00b1 0.059",
                        "AUC CI": "0.684\u22120.871",
                        "Sensitivity": "92.2 (82.7\u221297.4)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.1%",
                        "NPV": "66.7%",
                        "ACC": "84.2%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.788, 92.2, 55.6, 88.1, 66.7, 84.2]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "134 mm^2",
                        "optimal cutoff value": "1.74 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[50.0, 26.0\u201374.0]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "214 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.788 \u00b1 0.059",
                        "AUC CI": "0.684\u22120.871",
                        "Sensitivity": "92.2 (82.7\u221297.4)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.1%",
                        "NPV": "66.7%",
                        "ACC": "84.2%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.788, 92.2, 55.6, 88.1, 66.7, 84.2]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "134 mm^2",
                        "optimal cutoff value": "1.74 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Negative predictive value (NPV)]",
                    "outcomes": "[59.9%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "214 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.788 \u00b1 0.059",
                        "AUC CI": "0.684\u22120.871",
                        "Sensitivity": "92.2 (82.7\u221297.4)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.1%",
                        "NPV": "66.7%",
                        "ACC": "84.2%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.788, 92.2, 55.6, 88.1, 66.7, 84.2]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "134 mm^2",
                        "optimal cutoff value": "1.74 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Accuracy (ACC)]",
                    "outcomes": "[81.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "214 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.788 \u00b1 0.059",
                        "AUC CI": "0.684\u22120.871",
                        "Sensitivity": "92.2 (82.7\u221297.4)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.1%",
                        "NPV": "66.7%",
                        "ACC": "84.2%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.788, 92.2, 55.6, 88.1, 66.7, 84.2]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "152 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.751 \u00b1 0.067, 0.643\u20130.840]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "214 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.788 \u00b1 0.059",
                        "AUC CI": "0.684\u22120.871",
                        "Sensitivity": "92.2 (82.7\u221297.4)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.1%",
                        "NPV": "66.7%",
                        "ACC": "84.2%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.788, 92.2, 55.6, 88.1, 66.7, 84.2]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "152 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[89.1, 78.8\u201395.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "214 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.788 \u00b1 0.059",
                        "AUC CI": "0.684\u22120.871",
                        "Sensitivity": "92.2 (82.7\u221297.4)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.1%",
                        "NPV": "66.7%",
                        "ACC": "84.2%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.788, 92.2, 55.6, 88.1, 66.7, 84.2]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "152 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[55.6, 30.8\u201378.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "214 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.788 \u00b1 0.059",
                        "AUC CI": "0.684\u22120.871",
                        "Sensitivity": "92.2 (82.7\u221297.4)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.1%",
                        "NPV": "66.7%",
                        "ACC": "84.2%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.788, 92.2, 55.6, 88.1, 66.7, 84.2]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "152 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Negative predictive value (NPV)]",
                    "outcomes": "[58.9%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "214 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.788 \u00b1 0.059",
                        "AUC CI": "0.684\u22120.871",
                        "Sensitivity": "92.2 (82.7\u221297.4)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.1%",
                        "NPV": "66.7%",
                        "ACC": "84.2%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.788, 92.2, 55.6, 88.1, 66.7, 84.2]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "152 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Accuracy (ACC)]",
                    "outcomes": "[81.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "214 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.788 \u00b1 0.059",
                        "AUC CI": "0.684\u22120.871",
                        "Sensitivity": "92.2 (82.7\u221297.4)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.1%",
                        "NPV": "66.7%",
                        "ACC": "84.2%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.788, 92.2, 55.6, 88.1, 66.7, 84.2]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "161 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.756 \u00b1 0.065, 0.649\u20130.844]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "214 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.788 \u00b1 0.059",
                        "AUC CI": "0.684\u22120.871",
                        "Sensitivity": "92.2 (82.7\u221297.4)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.1%",
                        "NPV": "66.7%",
                        "ACC": "84.2%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.788, 92.2, 55.6, 88.1, 66.7, 84.2]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "161 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[89.1, 78.8\u201395.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "214 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.788 \u00b1 0.059",
                        "AUC CI": "0.684\u22120.871",
                        "Sensitivity": "92.2 (82.7\u221297.4)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.1%",
                        "NPV": "66.7%",
                        "ACC": "84.2%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.788, 92.2, 55.6, 88.1, 66.7, 84.2]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "161 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[55.6, 30.8\u201378.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "214 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.788 \u00b1 0.059",
                        "AUC CI": "0.684\u22120.871",
                        "Sensitivity": "92.2 (82.7\u221297.4)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.1%",
                        "NPV": "66.7%",
                        "ACC": "84.2%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.788, 92.2, 55.6, 88.1, 66.7, 84.2]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "161 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Negative predictive value (NPV)]",
                    "outcomes": "[58.9%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "214 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.788 \u00b1 0.059",
                        "AUC CI": "0.684\u22120.871",
                        "Sensitivity": "92.2 (82.7\u221297.4)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.1%",
                        "NPV": "66.7%",
                        "ACC": "84.2%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.788, 92.2, 55.6, 88.1, 66.7, 84.2]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "161 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Accuracy (ACC)]",
                    "outcomes": "[81.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "214 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.788 \u00b1 0.059",
                        "AUC CI": "0.684\u22120.871",
                        "Sensitivity": "92.2 (82.7\u221297.4)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.1%",
                        "NPV": "66.7%",
                        "ACC": "84.2%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.788, 92.2, 55.6, 88.1, 66.7, 84.2]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "189 mm^2",
                        "optimal cutoff value": "1.75 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.770 \u00b1 0.062, 0.664\u20130.856]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "214 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.788 \u00b1 0.059",
                        "AUC CI": "0.684\u22120.871",
                        "Sensitivity": "92.2 (82.7\u221297.4)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.1%",
                        "NPV": "66.7%",
                        "ACC": "84.2%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.788, 92.2, 55.6, 88.1, 66.7, 84.2]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "189 mm^2",
                        "optimal cutoff value": "1.75 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[90.6, 80.7\u201396.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "214 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.788 \u00b1 0.059",
                        "AUC CI": "0.684\u22120.871",
                        "Sensitivity": "92.2 (82.7\u221297.4)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.1%",
                        "NPV": "66.7%",
                        "ACC": "84.2%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.788, 92.2, 55.6, 88.1, 66.7, 84.2]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "189 mm^2",
                        "optimal cutoff value": "1.75 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[55.6, 30.8\u201378.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "214 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.788 \u00b1 0.059",
                        "AUC CI": "0.684\u22120.871",
                        "Sensitivity": "92.2 (82.7\u221297.4)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.1%",
                        "NPV": "66.7%",
                        "ACC": "84.2%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.788, 92.2, 55.6, 88.1, 66.7, 84.2]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "189 mm^2",
                        "optimal cutoff value": "1.75 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Negative predictive value (NPV)]",
                    "outcomes": "[62.5%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "214 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.788 \u00b1 0.059",
                        "AUC CI": "0.684\u22120.871",
                        "Sensitivity": "92.2 (82.7\u221297.4)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.1%",
                        "NPV": "66.7%",
                        "ACC": "84.2%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.788, 92.2, 55.6, 88.1, 66.7, 84.2]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "189 mm^2",
                        "optimal cutoff value": "1.75 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Accuracy (ACC)]",
                    "outcomes": "[82.9%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "214 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.788 \u00b1 0.059",
                        "AUC CI": "0.684\u22120.871",
                        "Sensitivity": "92.2 (82.7\u221297.4)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.1%",
                        "NPV": "66.7%",
                        "ACC": "84.2%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.788, 92.2, 55.6, 88.1, 66.7, 84.2]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "214 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.788 \u00b1 0.059, 0.684\u20130.871]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "214 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.788 \u00b1 0.059",
                        "AUC CI": "0.684\u22120.871",
                        "Sensitivity": "92.2 (82.7\u221297.4)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.1%",
                        "NPV": "66.7%",
                        "ACC": "84.2%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.788, 92.2, 55.6, 88.1, 66.7, 84.2]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "214 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[92.2, 82.7\u201397.4]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "214 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.788 \u00b1 0.059",
                        "AUC CI": "0.684\u22120.871",
                        "Sensitivity": "92.2 (82.7\u221297.4)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.1%",
                        "NPV": "66.7%",
                        "ACC": "84.2%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.788, 92.2, 55.6, 88.1, 66.7, 84.2]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "214 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[55.6, 30.8\u201378.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "214 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.788 \u00b1 0.059",
                        "AUC CI": "0.684\u22120.871",
                        "Sensitivity": "92.2 (82.7\u221297.4)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.1%",
                        "NPV": "66.7%",
                        "ACC": "84.2%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.788, 92.2, 55.6, 88.1, 66.7, 84.2]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "214 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Positive predictive value (PPV)]",
                    "outcomes": "[88.1%]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "223 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.793 \u00b1 0.058",
                        "AUC CI": "0.689\u22120.874",
                        "Sensitivity": "93.8 (84.8\u221298.3)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.3%",
                        "NPV": "71.6%",
                        "ACC": "85.4%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.793, 93.8, 55.6, 88.3, 71.6, 85.4]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.694 \u00b1 0.077, 0.582\u20130.791]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "223 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.793 \u00b1 0.058",
                        "AUC CI": "0.689\u22120.874",
                        "Sensitivity": "93.8 (84.8\u221298.3)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.3%",
                        "NPV": "71.6%",
                        "ACC": "85.4%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.793, 93.8, 55.6, 88.3, 71.6, 85.4]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[90.6, 80.7\u201396.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "223 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.793 \u00b1 0.058",
                        "AUC CI": "0.689\u22120.874",
                        "Sensitivity": "93.8 (84.8\u221298.3)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.3%",
                        "NPV": "71.6%",
                        "ACC": "85.4%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.793, 93.8, 55.6, 88.3, 71.6, 85.4]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[50.0, 26.0\u201374.0]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "223 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.793 \u00b1 0.058",
                        "AUC CI": "0.689\u22120.874",
                        "Sensitivity": "93.8 (84.8\u221298.3)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.3%",
                        "NPV": "71.6%",
                        "ACC": "85.4%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.793, 93.8, 55.6, 88.3, 71.6, 85.4]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Negative predictive value (NPV)]",
                    "outcomes": "[59.9%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "223 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.793 \u00b1 0.058",
                        "AUC CI": "0.689\u22120.874",
                        "Sensitivity": "93.8 (84.8\u221298.3)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.3%",
                        "NPV": "71.6%",
                        "ACC": "85.4%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.793, 93.8, 55.6, 88.3, 71.6, 85.4]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Accuracy (ACC)]",
                    "outcomes": "[81.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "223 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.793 \u00b1 0.058",
                        "AUC CI": "0.689\u22120.874",
                        "Sensitivity": "93.8 (84.8\u221298.3)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.3%",
                        "NPV": "71.6%",
                        "ACC": "85.4%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.793, 93.8, 55.6, 88.3, 71.6, 85.4]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "99 mm^2",
                        "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.707 \u00b1 0.074, 0.596\u20130.802]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "223 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.793 \u00b1 0.058",
                        "AUC CI": "0.689\u22120.874",
                        "Sensitivity": "93.8 (84.8\u221298.3)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.3%",
                        "NPV": "71.6%",
                        "ACC": "85.4%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.793, 93.8, 55.6, 88.3, 71.6, 85.4]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "99 mm^2",
                        "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[90.6, 80.7\u201396.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "223 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.793 \u00b1 0.058",
                        "AUC CI": "0.689\u22120.874",
                        "Sensitivity": "93.8 (84.8\u221298.3)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.3%",
                        "NPV": "71.6%",
                        "ACC": "85.4%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.793, 93.8, 55.6, 88.3, 71.6, 85.4]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "99 mm^2",
                        "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[50.0, 26.0\u201374.0]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "223 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.793 \u00b1 0.058",
                        "AUC CI": "0.689\u22120.874",
                        "Sensitivity": "93.8 (84.8\u221298.3)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.3%",
                        "NPV": "71.6%",
                        "ACC": "85.4%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.793, 93.8, 55.6, 88.3, 71.6, 85.4]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "99 mm^2",
                        "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Negative predictive value (NPV)]",
                    "outcomes": "[59.9%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "223 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.793 \u00b1 0.058",
                        "AUC CI": "0.689\u22120.874",
                        "Sensitivity": "93.8 (84.8\u221298.3)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.3%",
                        "NPV": "71.6%",
                        "ACC": "85.4%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.793, 93.8, 55.6, 88.3, 71.6, 85.4]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "99 mm^2",
                        "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Accuracy (ACC)]",
                    "outcomes": "[81.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "223 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.793 \u00b1 0.058",
                        "AUC CI": "0.689\u22120.874",
                        "Sensitivity": "93.8 (84.8\u221298.3)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.3%",
                        "NPV": "71.6%",
                        "ACC": "85.4%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.793, 93.8, 55.6, 88.3, 71.6, 85.4]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "134 mm^2",
                        "optimal cutoff value": "1.74 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.731 \u00b1 0.070, 0.622\u20130.823]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "223 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.793 \u00b1 0.058",
                        "AUC CI": "0.689\u22120.874",
                        "Sensitivity": "93.8 (84.8\u221298.3)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.3%",
                        "NPV": "71.6%",
                        "ACC": "85.4%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.793, 93.8, 55.6, 88.3, 71.6, 85.4]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "134 mm^2",
                        "optimal cutoff value": "1.74 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[90.6, 80.7\u201396.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "223 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.793 \u00b1 0.058",
                        "AUC CI": "0.689\u22120.874",
                        "Sensitivity": "93.8 (84.8\u221298.3)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.3%",
                        "NPV": "71.6%",
                        "ACC": "85.4%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.793, 93.8, 55.6, 88.3, 71.6, 85.4]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "134 mm^2",
                        "optimal cutoff value": "1.74 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[50.0, 26.0\u201374.0]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "223 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.793 \u00b1 0.058",
                        "AUC CI": "0.689\u22120.874",
                        "Sensitivity": "93.8 (84.8\u221298.3)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.3%",
                        "NPV": "71.6%",
                        "ACC": "85.4%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.793, 93.8, 55.6, 88.3, 71.6, 85.4]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "134 mm^2",
                        "optimal cutoff value": "1.74 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Negative predictive value (NPV)]",
                    "outcomes": "[59.9%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "223 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.793 \u00b1 0.058",
                        "AUC CI": "0.689\u22120.874",
                        "Sensitivity": "93.8 (84.8\u221298.3)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.3%",
                        "NPV": "71.6%",
                        "ACC": "85.4%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.793, 93.8, 55.6, 88.3, 71.6, 85.4]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "134 mm^2",
                        "optimal cutoff value": "1.74 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Accuracy (ACC)]",
                    "outcomes": "[81.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "223 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.793 \u00b1 0.058",
                        "AUC CI": "0.689\u22120.874",
                        "Sensitivity": "93.8 (84.8\u221298.3)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.3%",
                        "NPV": "71.6%",
                        "ACC": "85.4%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.793, 93.8, 55.6, 88.3, 71.6, 85.4]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "152 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.751 \u00b1 0.067, 0.643\u20130.840]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "223 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.793 \u00b1 0.058",
                        "AUC CI": "0.689\u22120.874",
                        "Sensitivity": "93.8 (84.8\u221298.3)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.3%",
                        "NPV": "71.6%",
                        "ACC": "85.4%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.793, 93.8, 55.6, 88.3, 71.6, 85.4]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "152 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[89.1, 78.8\u201395.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "223 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.793 \u00b1 0.058",
                        "AUC CI": "0.689\u22120.874",
                        "Sensitivity": "93.8 (84.8\u221298.3)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.3%",
                        "NPV": "71.6%",
                        "ACC": "85.4%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.793, 93.8, 55.6, 88.3, 71.6, 85.4]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "152 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[55.6, 30.8\u201378.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "223 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.793 \u00b1 0.058",
                        "AUC CI": "0.689\u22120.874",
                        "Sensitivity": "93.8 (84.8\u221298.3)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.3%",
                        "NPV": "71.6%",
                        "ACC": "85.4%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.793, 93.8, 55.6, 88.3, 71.6, 85.4]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "152 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Negative predictive value (NPV)]",
                    "outcomes": "[58.9%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "223 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.793 \u00b1 0.058",
                        "AUC CI": "0.689\u22120.874",
                        "Sensitivity": "93.8 (84.8\u221298.3)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.3%",
                        "NPV": "71.6%",
                        "ACC": "85.4%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.793, 93.8, 55.6, 88.3, 71.6, 85.4]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "152 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Accuracy (ACC)]",
                    "outcomes": "[81.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "223 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.793 \u00b1 0.058",
                        "AUC CI": "0.689\u22120.874",
                        "Sensitivity": "93.8 (84.8\u221298.3)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.3%",
                        "NPV": "71.6%",
                        "ACC": "85.4%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.793, 93.8, 55.6, 88.3, 71.6, 85.4]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "161 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.756 \u00b1 0.065, 0.649\u20130.844]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "223 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.793 \u00b1 0.058",
                        "AUC CI": "0.689\u22120.874",
                        "Sensitivity": "93.8 (84.8\u221298.3)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.3%",
                        "NPV": "71.6%",
                        "ACC": "85.4%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.793, 93.8, 55.6, 88.3, 71.6, 85.4]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "161 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[89.1, 78.8\u201395.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "223 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.793 \u00b1 0.058",
                        "AUC CI": "0.689\u22120.874",
                        "Sensitivity": "93.8 (84.8\u221298.3)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.3%",
                        "NPV": "71.6%",
                        "ACC": "85.4%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.793, 93.8, 55.6, 88.3, 71.6, 85.4]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "161 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[55.6, 30.8\u201378.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "223 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.793 \u00b1 0.058",
                        "AUC CI": "0.689\u22120.874",
                        "Sensitivity": "93.8 (84.8\u221298.3)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.3%",
                        "NPV": "71.6%",
                        "ACC": "85.4%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.793, 93.8, 55.6, 88.3, 71.6, 85.4]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "161 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Negative predictive value (NPV)]",
                    "outcomes": "[58.9%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "223 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.793 \u00b1 0.058",
                        "AUC CI": "0.689\u22120.874",
                        "Sensitivity": "93.8 (84.8\u221298.3)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.3%",
                        "NPV": "71.6%",
                        "ACC": "85.4%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.793, 93.8, 55.6, 88.3, 71.6, 85.4]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "161 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Accuracy (ACC)]",
                    "outcomes": "[81.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "223 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.793 \u00b1 0.058",
                        "AUC CI": "0.689\u22120.874",
                        "Sensitivity": "93.8 (84.8\u221298.3)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.3%",
                        "NPV": "71.6%",
                        "ACC": "85.4%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.793, 93.8, 55.6, 88.3, 71.6, 85.4]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "189 mm^2",
                        "optimal cutoff value": "1.75 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.770 \u00b1 0.062, 0.664\u20130.856]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "223 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.793 \u00b1 0.058",
                        "AUC CI": "0.689\u22120.874",
                        "Sensitivity": "93.8 (84.8\u221298.3)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.3%",
                        "NPV": "71.6%",
                        "ACC": "85.4%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.793, 93.8, 55.6, 88.3, 71.6, 85.4]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "189 mm^2",
                        "optimal cutoff value": "1.75 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[90.6, 80.7\u201396.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "223 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.793 \u00b1 0.058",
                        "AUC CI": "0.689\u22120.874",
                        "Sensitivity": "93.8 (84.8\u221298.3)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.3%",
                        "NPV": "71.6%",
                        "ACC": "85.4%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.793, 93.8, 55.6, 88.3, 71.6, 85.4]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "189 mm^2",
                        "optimal cutoff value": "1.75 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[55.6, 30.8\u201378.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "223 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.793 \u00b1 0.058",
                        "AUC CI": "0.689\u22120.874",
                        "Sensitivity": "93.8 (84.8\u221298.3)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.3%",
                        "NPV": "71.6%",
                        "ACC": "85.4%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.793, 93.8, 55.6, 88.3, 71.6, 85.4]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "189 mm^2",
                        "optimal cutoff value": "1.75 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Negative predictive value (NPV)]",
                    "outcomes": "[62.5%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "223 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.793 \u00b1 0.058",
                        "AUC CI": "0.689\u22120.874",
                        "Sensitivity": "93.8 (84.8\u221298.3)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.3%",
                        "NPV": "71.6%",
                        "ACC": "85.4%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.793, 93.8, 55.6, 88.3, 71.6, 85.4]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "189 mm^2",
                        "optimal cutoff value": "1.75 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Accuracy (ACC)]",
                    "outcomes": "[82.9%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "223 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.793 \u00b1 0.058",
                        "AUC CI": "0.689\u22120.874",
                        "Sensitivity": "93.8 (84.8\u221298.3)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.3%",
                        "NPV": "71.6%",
                        "ACC": "85.4%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.793, 93.8, 55.6, 88.3, 71.6, 85.4]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "214 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.788 \u00b1 0.059, 0.684\u20130.871]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "223 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.793 \u00b1 0.058",
                        "AUC CI": "0.689\u22120.874",
                        "Sensitivity": "93.8 (84.8\u221298.3)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.3%",
                        "NPV": "71.6%",
                        "ACC": "85.4%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.793, 93.8, 55.6, 88.3, 71.6, 85.4]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "214 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[92.2, 82.7\u201397.4]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "223 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.793 \u00b1 0.058",
                        "AUC CI": "0.689\u22120.874",
                        "Sensitivity": "93.8 (84.8\u221298.3)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.3%",
                        "NPV": "71.6%",
                        "ACC": "85.4%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.793, 93.8, 55.6, 88.3, 71.6, 85.4]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "214 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[55.6, 30.8\u201378.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "223 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.793 \u00b1 0.058",
                        "AUC CI": "0.689\u22120.874",
                        "Sensitivity": "93.8 (84.8\u221298.3)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.3%",
                        "NPV": "71.6%",
                        "ACC": "85.4%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.793, 93.8, 55.6, 88.3, 71.6, 85.4]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "214 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Negative predictive value (NPV)]",
                    "outcomes": "[66.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "223 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.793 \u00b1 0.058",
                        "AUC CI": "0.689\u22120.874",
                        "Sensitivity": "93.8 (84.8\u221298.3)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.3%",
                        "NPV": "71.6%",
                        "ACC": "85.4%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.793, 93.8, 55.6, 88.3, 71.6, 85.4]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "214 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Accuracy (ACC)]",
                    "outcomes": "[84.2%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "223 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.793 \u00b1 0.058",
                        "AUC CI": "0.689\u22120.874",
                        "Sensitivity": "93.8 (84.8\u221298.3)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.3%",
                        "NPV": "71.6%",
                        "ACC": "85.4%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.793, 93.8, 55.6, 88.3, 71.6, 85.4]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "223 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.793 \u00b1 0.058, 0.689\u20130.874]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "223 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.793 \u00b1 0.058",
                        "AUC CI": "0.689\u22120.874",
                        "Sensitivity": "93.8 (84.8\u221298.3)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.3%",
                        "NPV": "71.6%",
                        "ACC": "85.4%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.793, 93.8, 55.6, 88.3, 71.6, 85.4]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "223 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[93.8, 84.8\u201398.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "223 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.793 \u00b1 0.058",
                        "AUC CI": "0.689\u22120.874",
                        "Sensitivity": "93.8 (84.8\u221298.3)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.3%",
                        "NPV": "71.6%",
                        "ACC": "85.4%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.793, 93.8, 55.6, 88.3, 71.6, 85.4]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "223 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[55.6, 30.8\u201378.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "223 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.793 \u00b1 0.058",
                        "AUC CI": "0.689\u22120.874",
                        "Sensitivity": "93.8 (84.8\u221298.3)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.3%",
                        "NPV": "71.6%",
                        "ACC": "85.4%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.793, 93.8, 55.6, 88.3, 71.6, 85.4]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "223 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Positive predictive value (PPV)]",
                    "outcomes": "[88.3%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "223 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.793 \u00b1 0.058",
                        "AUC CI": "0.689\u22120.874",
                        "Sensitivity": "93.8 (84.8\u221298.3)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.3%",
                        "NPV": "71.6%",
                        "ACC": "85.4%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.793, 93.8, 55.6, 88.3, 71.6, 85.4]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "223 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Negative predictive value (NPV)]",
                    "outcomes": "[71.6%]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "245 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.800 \u00b1 0.056",
                        "AUC CI": "0.697\u22120.881",
                        "Sensitivity": "95.3 (86.9\u221299.0)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.4%",
                        "NPV": "76.9%",
                        "ACC": "86.6%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.694 \u00b1 0.077, 0.582\u20130.791]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "245 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.800 \u00b1 0.056",
                        "AUC CI": "0.697\u22120.881",
                        "Sensitivity": "95.3 (86.9\u221299.0)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.4%",
                        "NPV": "76.9%",
                        "ACC": "86.6%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[90.6, 80.7\u201396.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "245 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.800 \u00b1 0.056",
                        "AUC CI": "0.697\u22120.881",
                        "Sensitivity": "95.3 (86.9\u221299.0)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.4%",
                        "NPV": "76.9%",
                        "ACC": "86.6%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[50.0, 26.0\u201374.0]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "245 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.800 \u00b1 0.056",
                        "AUC CI": "0.697\u22120.881",
                        "Sensitivity": "95.3 (86.9\u221299.0)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.4%",
                        "NPV": "76.9%",
                        "ACC": "86.6%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Negative predictive value (NPV)]",
                    "outcomes": "[59.9%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "245 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.800 \u00b1 0.056",
                        "AUC CI": "0.697\u22120.881",
                        "Sensitivity": "95.3 (86.9\u221299.0)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.4%",
                        "NPV": "76.9%",
                        "ACC": "86.6%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "82 mm^2",
                        "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Accuracy (ACC)]",
                    "outcomes": "[81.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "245 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.800 \u00b1 0.056",
                        "AUC CI": "0.697\u22120.881",
                        "Sensitivity": "95.3 (86.9\u221299.0)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.4%",
                        "NPV": "76.9%",
                        "ACC": "86.6%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "99 mm^2",
                        "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.707 \u00b1 0.074, 0.596\u20130.802]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "245 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.800 \u00b1 0.056",
                        "AUC CI": "0.697\u22120.881",
                        "Sensitivity": "95.3 (86.9\u221299.0)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.4%",
                        "NPV": "76.9%",
                        "ACC": "86.6%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "99 mm^2",
                        "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[90.6, 80.7\u201396.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "245 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.800 \u00b1 0.056",
                        "AUC CI": "0.697\u22120.881",
                        "Sensitivity": "95.3 (86.9\u221299.0)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.4%",
                        "NPV": "76.9%",
                        "ACC": "86.6%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "99 mm^2",
                        "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[50.0, 26.0\u201374.0]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "245 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.800 \u00b1 0.056",
                        "AUC CI": "0.697\u22120.881",
                        "Sensitivity": "95.3 (86.9\u221299.0)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.4%",
                        "NPV": "76.9%",
                        "ACC": "86.6%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "99 mm^2",
                        "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Negative predictive value (NPV)]",
                    "outcomes": "[59.9%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "245 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.800 \u00b1 0.056",
                        "AUC CI": "0.697\u22120.881",
                        "Sensitivity": "95.3 (86.9\u221299.0)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.4%",
                        "NPV": "76.9%",
                        "ACC": "86.6%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "99 mm^2",
                        "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Accuracy (ACC)]",
                    "outcomes": "[81.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "245 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.800 \u00b1 0.056",
                        "AUC CI": "0.697\u22120.881",
                        "Sensitivity": "95.3 (86.9\u221299.0)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.4%",
                        "NPV": "76.9%",
                        "ACC": "86.6%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "134 mm^2",
                        "optimal cutoff value": "1.74 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.731 \u00b1 0.070, 0.622\u20130.823]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "245 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.800 \u00b1 0.056",
                        "AUC CI": "0.697\u22120.881",
                        "Sensitivity": "95.3 (86.9\u221299.0)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.4%",
                        "NPV": "76.9%",
                        "ACC": "86.6%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "134 mm^2",
                        "optimal cutoff value": "1.74 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[90.6, 80.7\u201396.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "245 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.800 \u00b1 0.056",
                        "AUC CI": "0.697\u22120.881",
                        "Sensitivity": "95.3 (86.9\u221299.0)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.4%",
                        "NPV": "76.9%",
                        "ACC": "86.6%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "134 mm^2",
                        "optimal cutoff value": "1.74 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[50.0, 26.0\u201374.0]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "245 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.800 \u00b1 0.056",
                        "AUC CI": "0.697\u22120.881",
                        "Sensitivity": "95.3 (86.9\u221299.0)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.4%",
                        "NPV": "76.9%",
                        "ACC": "86.6%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "134 mm^2",
                        "optimal cutoff value": "1.74 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Negative predictive value (NPV)]",
                    "outcomes": "[59.9%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "245 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.800 \u00b1 0.056",
                        "AUC CI": "0.697\u22120.881",
                        "Sensitivity": "95.3 (86.9\u221299.0)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.4%",
                        "NPV": "76.9%",
                        "ACC": "86.6%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "134 mm^2",
                        "optimal cutoff value": "1.74 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Accuracy (ACC)]",
                    "outcomes": "[81.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "245 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.800 \u00b1 0.056",
                        "AUC CI": "0.697\u22120.881",
                        "Sensitivity": "95.3 (86.9\u221299.0)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.4%",
                        "NPV": "76.9%",
                        "ACC": "86.6%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "152 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.751 \u00b1 0.067, 0.643\u20130.840]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "245 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.800 \u00b1 0.056",
                        "AUC CI": "0.697\u22120.881",
                        "Sensitivity": "95.3 (86.9\u221299.0)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.4%",
                        "NPV": "76.9%",
                        "ACC": "86.6%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "152 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[89.1, 78.8\u201395.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "245 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.800 \u00b1 0.056",
                        "AUC CI": "0.697\u22120.881",
                        "Sensitivity": "95.3 (86.9\u221299.0)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.4%",
                        "NPV": "76.9%",
                        "ACC": "86.6%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "152 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[55.6, 30.8\u201378.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "245 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.800 \u00b1 0.056",
                        "AUC CI": "0.697\u22120.881",
                        "Sensitivity": "95.3 (86.9\u221299.0)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.4%",
                        "NPV": "76.9%",
                        "ACC": "86.6%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "152 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Negative predictive value (NPV)]",
                    "outcomes": "[58.9%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "245 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.800 \u00b1 0.056",
                        "AUC CI": "0.697\u22120.881",
                        "Sensitivity": "95.3 (86.9\u221299.0)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.4%",
                        "NPV": "76.9%",
                        "ACC": "86.6%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "152 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Accuracy (ACC)]",
                    "outcomes": "[81.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "245 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.800 \u00b1 0.056",
                        "AUC CI": "0.697\u22120.881",
                        "Sensitivity": "95.3 (86.9\u221299.0)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.4%",
                        "NPV": "76.9%",
                        "ACC": "86.6%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "161 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.756 \u00b1 0.065, 0.649\u20130.844]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "245 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.800 \u00b1 0.056",
                        "AUC CI": "0.697\u22120.881",
                        "Sensitivity": "95.3 (86.9\u221299.0)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.4%",
                        "NPV": "76.9%",
                        "ACC": "86.6%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "161 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[89.1, 78.8\u201395.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "245 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.800 \u00b1 0.056",
                        "AUC CI": "0.697\u22120.881",
                        "Sensitivity": "95.3 (86.9\u221299.0)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.4%",
                        "NPV": "76.9%",
                        "ACC": "86.6%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "161 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[55.6, 30.8\u201378.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "245 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.800 \u00b1 0.056",
                        "AUC CI": "0.697\u22120.881",
                        "Sensitivity": "95.3 (86.9\u221299.0)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.4%",
                        "NPV": "76.9%",
                        "ACC": "86.6%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "161 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Negative predictive value (NPV)]",
                    "outcomes": "[58.9%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "245 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.800 \u00b1 0.056",
                        "AUC CI": "0.697\u22120.881",
                        "Sensitivity": "95.3 (86.9\u221299.0)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.4%",
                        "NPV": "76.9%",
                        "ACC": "86.6%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "161 mm^2",
                        "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Accuracy (ACC)]",
                    "outcomes": "[81.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "245 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.800 \u00b1 0.056",
                        "AUC CI": "0.697\u22120.881",
                        "Sensitivity": "95.3 (86.9\u221299.0)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.4%",
                        "NPV": "76.9%",
                        "ACC": "86.6%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "189 mm^2",
                        "optimal cutoff value": "1.75 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.770 \u00b1 0.062, 0.664\u20130.856]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "245 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.800 \u00b1 0.056",
                        "AUC CI": "0.697\u22120.881",
                        "Sensitivity": "95.3 (86.9\u221299.0)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.4%",
                        "NPV": "76.9%",
                        "ACC": "86.6%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "189 mm^2",
                        "optimal cutoff value": "1.75 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[90.6, 80.7\u201396.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "245 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.800 \u00b1 0.056",
                        "AUC CI": "0.697\u22120.881",
                        "Sensitivity": "95.3 (86.9\u221299.0)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.4%",
                        "NPV": "76.9%",
                        "ACC": "86.6%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "189 mm^2",
                        "optimal cutoff value": "1.75 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[55.6, 30.8\u201378.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "245 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.800 \u00b1 0.056",
                        "AUC CI": "0.697\u22120.881",
                        "Sensitivity": "95.3 (86.9\u221299.0)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.4%",
                        "NPV": "76.9%",
                        "ACC": "86.6%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "189 mm^2",
                        "optimal cutoff value": "1.75 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Negative predictive value (NPV)]",
                    "outcomes": "[62.5%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "245 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.800 \u00b1 0.056",
                        "AUC CI": "0.697\u22120.881",
                        "Sensitivity": "95.3 (86.9\u221299.0)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.4%",
                        "NPV": "76.9%",
                        "ACC": "86.6%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "189 mm^2",
                        "optimal cutoff value": "1.75 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Accuracy (ACC)]",
                    "outcomes": "[82.9%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "245 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.800 \u00b1 0.056",
                        "AUC CI": "0.697\u22120.881",
                        "Sensitivity": "95.3 (86.9\u221299.0)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.4%",
                        "NPV": "76.9%",
                        "ACC": "86.6%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "214 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.788 \u00b1 0.059, 0.684\u20130.871]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "245 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.800 \u00b1 0.056",
                        "AUC CI": "0.697\u22120.881",
                        "Sensitivity": "95.3 (86.9\u221299.0)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.4%",
                        "NPV": "76.9%",
                        "ACC": "86.6%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "214 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[92.2, 82.7\u201397.4]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "245 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.800 \u00b1 0.056",
                        "AUC CI": "0.697\u22120.881",
                        "Sensitivity": "95.3 (86.9\u221299.0)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.4%",
                        "NPV": "76.9%",
                        "ACC": "86.6%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "214 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[55.6, 30.8\u201378.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "245 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.800 \u00b1 0.056",
                        "AUC CI": "0.697\u22120.881",
                        "Sensitivity": "95.3 (86.9\u221299.0)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.4%",
                        "NPV": "76.9%",
                        "ACC": "86.6%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "214 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Negative predictive value (NPV)]",
                    "outcomes": "[66.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "245 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.800 \u00b1 0.056",
                        "AUC CI": "0.697\u22120.881",
                        "Sensitivity": "95.3 (86.9\u221299.0)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.4%",
                        "NPV": "76.9%",
                        "ACC": "86.6%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "214 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Accuracy (ACC)]",
                    "outcomes": "[84.2%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "245 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.800 \u00b1 0.056",
                        "AUC CI": "0.697\u22120.881",
                        "Sensitivity": "95.3 (86.9\u221299.0)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.4%",
                        "NPV": "76.9%",
                        "ACC": "86.6%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "223 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.793 \u00b1 0.058, 0.689\u20130.874]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "245 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.800 \u00b1 0.056",
                        "AUC CI": "0.697\u22120.881",
                        "Sensitivity": "95.3 (86.9\u221299.0)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.4%",
                        "NPV": "76.9%",
                        "ACC": "86.6%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "223 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[93.8, 84.8\u201398.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "245 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.800 \u00b1 0.056",
                        "AUC CI": "0.697\u22120.881",
                        "Sensitivity": "95.3 (86.9\u221299.0)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.4%",
                        "NPV": "76.9%",
                        "ACC": "86.6%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "223 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[55.6, 30.8\u201378.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "245 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.800 \u00b1 0.056",
                        "AUC CI": "0.697\u22120.881",
                        "Sensitivity": "95.3 (86.9\u221299.0)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.4%",
                        "NPV": "76.9%",
                        "ACC": "86.6%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "223 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Positive predictive value (PPV)]",
                    "outcomes": "[88.3%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "245 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.800 \u00b1 0.056",
                        "AUC CI": "0.697\u22120.881",
                        "Sensitivity": "95.3 (86.9\u221299.0)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.4%",
                        "NPV": "76.9%",
                        "ACC": "86.6%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "223 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Accuracy (ACC)]",
                    "outcomes": "[85.4%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "245 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.800 \u00b1 0.056",
                        "AUC CI": "0.697\u22120.881",
                        "Sensitivity": "95.3 (86.9\u221299.0)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.4%",
                        "NPV": "76.9%",
                        "ACC": "86.6%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "245 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Area under curve (AUC) \u00b1 standard error, 95% CI]",
                    "outcomes": "[0.800 \u00b1 0.056, 0.697\u20130.881]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "245 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.800 \u00b1 0.056",
                        "AUC CI": "0.697\u22120.881",
                        "Sensitivity": "95.3 (86.9\u221299.0)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.4%",
                        "NPV": "76.9%",
                        "ACC": "86.6%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "245 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Sensitivities, 95% CI]",
                    "outcomes": "[95.3, 86.9\u201399.0]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "245 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.800 \u00b1 0.056",
                        "AUC CI": "0.697\u22120.881",
                        "Sensitivity": "95.3 (86.9\u221299.0)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.4%",
                        "NPV": "76.9%",
                        "ACC": "86.6%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "245 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Specificities, 95% CI]",
                    "outcomes": "[55.6, 30.8\u201378.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Differential diagnosis": "MFCP vs PDAC",
                        "Clinical significance": "Different treatment strategies",
                        "Imaging challenge": "Similarity of imaging presentations",
                        "Technique": "Diffusion-weighted imaging (DWI)",
                        "Measurement": "Apparent diffusion coefficient (ADC)",
                        "ROI size": "245 mm\u00b2",
                        "Optimal cutoff value": "1.79 \u00d7 10\u207b\u00b3 mm\u00b2/s",
                        "AUC \u00b1 SE": "0.800 \u00b1 0.056",
                        "AUC CI": "0.697\u22120.881",
                        "Sensitivity": "95.3 (86.9\u221299.0)",
                        "Specificity": "55.6 (30.8\u221278.5)",
                        "PPV": "88.4%",
                        "NPV": "76.9%",
                        "ACC": "86.6%"
                    },
                    "measures": "[AUC, Sensitivity, Specificity, PPV, NPV, ACC]",
                    "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "ROC analysis",
                        "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                        "ROI size": "245 mm^2",
                        "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s"
                    },
                    "measures": "[Positive predictive value (PPV)]",
                    "outcomes": "[88.4%]"
                },
                "match": "yes"
            }
        ],
        "total_extracted_claims": 10,
        "total_ground_truth_claims": 54,
        "number_of_matches": 9
    }
}